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ABSTRACT 
Early vertebrate cardiogenesis involves the movement of heart progenitor cells 
from their initial lateral positions to the embryonic midline, where they assemble into a 
primitive (tubular) heart. The early heart consists of the myocardium on the outside, a 
medial extracellular matrix layer (cardiac jelly), and the endocardium comprising the 
inner surface of the tube. Cardiac morphogenesis in avians and mammals is 
inseparable from the development of the foregut, an embryonic predecessor of the 
upper gastrointestinal system, liver, and pancreas. The foregut provides molecular cues 
to regulate endocardial and myocardial differentiation from mesodermal progenitors. 
Also, concomitantly with the initiation of midline-directed cardiac progenitor movements, 
foregut endoderm undergoes dramatic folding and elongation. Upon initial assembly the 
heart and foregut remain connected through a mesentery until later stages. Research 
yielded many insights as to molecular factors involved in guiding cardiac progenitors to 
the midline, yet cellular and tissue mechanisms coordinating these movements remain 
poorly understood. 
This work investigates motion of all three early heart constituents – the 
endocardial and myocardial progenitors, and surrounding ECM - in live quail embryos 
using a combination of time-lapse microscopy, chemical and mechanical perturbations, 
computational analysis and modeling. By visualizing the tissue environment for cell 
displacements, we distinguish the active (tissue-independent) movements from those 
cells undergo in a manner coordinated with the surrounding tissues. In the first part, we 
analyzed the movements of fluorescently-labeled ECM (fibronectin, fibrillin-2) and those 
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of endocardial progenitors.  We found that the bulk of observed midline-directed 
movement of pre-endocardial cells occurs in a coordinated fashion with their 
surrounding ECM. Further, that ECM from extracardiac sources is transferred to and 
incorporated into the growing heart. By assessing the contributions of active cell motility 
to the observed endocardial displacements we found its role to be secondary to that of 
convective tissue movement within the anterior embryo, for the arrival of endocardial 
progenitors at the midline. 
Second, we assessed the myocardial progenitor movements relative to the 
fibronectin ECM and the endoderm. We found that an observed antero-medial direction 
of myocardial displacements towards the midline is driven by a combination of: 1) 
medial movement, coordinated with surrounding tissue, and 2) anterior-directed 
movement, accomplished via a coordinated deformation of myocardial progenitors, 
organized into a continuous epithelial sheet.  
Finally, we investigated the effects of VEGF overexposure on progenitor 
movements during early cardiogenesis. We found that a dramatic VEGF-induced 
increase in the size of the cardiac inflow region can affect coordinated 
movements/deformations displayed by myocardial progenitors, and result in defects in 
heart tube elongation. 
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An overview of events of early heart formation in avian embryos 
Heart morphogenesis in all vertebrates, including fish, avians, and humans 
involves a similar sequence of events (reviewed in Fishman and Chien, 1997). After 
gastrulation endocardial and myocardial progenitor cells are located in bilateral “heart 
fields” on either side of the midline. An assembly of the organ begins as endocardial and 
myocardial cells from heart fields fuse at the ventral midline. The resultant tubular heart 
consists of three layers: myocardium on the outside of the organ, acellular ECM layer of 
cardiac jelly in the middle, and endocardium on the inside of the tube. The onset of 
contractile function of the myocardium follows the fusion event shortly. The tubular heart 
maintains a close association with the foregut endoderm via a mesentery called the 
dorsal mesocardium (Fig. 1.1). At later stages, the dorsal mesocardium gets degraded, 
and the cardiac tube undergoes looping to the right side. After this initial looping event 
the heart tube folds several more times during chamber specification. At this stage the 
differences between 2-, 3-, and 4-chambered hearts of different groups of vertebrates 
become very evident. Concluding steps of cardiac morphogenesis include the 
establishment of coronary circulation, development of the conductive system and 
innervation etc. Close resemblance of early heart development in avians and mammals 
was taken into consideration by many generations of researchers that used chick and 
quail embryos as models for studies of heart and vascular development. Their work 
provided insight into the intricate details of early heart development in avians. 
During gastrulation in birds epiblast cells ingress through the primitive streak and 
give rise to all three germ layers of the embryo. Cardiac progenitor cells were shown to 
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be one of the first cell populations to undergo ingression (Garcia-Martinez and 
Schoenwolf, 1993), which in turn is followed by their rapid anterior and lateral 
movement. Then cardiac progenitor cells assume their residency within a specific area 
of the lateral plate mesoderm, referred to as the “heart field”.  
The definition of the margins of the heart field and development of the position-
fate maps for cardiac progenitor cells has been a goal of several generations of 
investigators, beginning with Rawles (1943). They used a wide array of techniques 
ranging from physical labeling of the cells and observing their position at advancing 
developmental stages (Stalsberg and DeHaan, 1969; Rosenquist, 1970; Hochgreb et 
al., 2003; Abu-Issa and Kirby, 2008) to localization of molecular markers associated 
with myocardial differentiation, such as the transcription factor Nkx2.5 and the TGFβ 
family member Bmp-2 (Schultheiss et al., 1995; Yutzey and Kirby, 1999). Results from 
the most recent position-fate mapping studies (Abu-Issa and Kirby, 2008) place the 
anterior border of the heart field near the forming buccopharyngeal membrane at early 
somitic stages in avian embryo. Posteriorly the area extends to the level of the 3rd-4th 
somite, and mediolaterally it lies between the paraxial mesoderm and the border of the 
area pellucida (Fig. 1.2). Surprisingly, when position fates determined by cell labeling 
were compared with molecular marker expression profiles, the two areas did not fully 
overlap until later stages (HH6 for Bmp-2 and HH10 for Nkx2.5) (Redkar et al., 2001). 
Although these fate mapping studies have contributed significantly to the field, certain 
technical limitations complicated the interpretation of the results. For example, in the 
experiments of DeHaan, Rosenquist and Stalsberg with grafting of radioactively labeled 
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fragments of an embryo, mesodermal cells could not be labeled exclusively. Multiple 
investigators (Ehrman and Yutzey, 1999; Redkar et al., 2001; Abu-Issa and Kirby, 2008) 
utilized targeted injection of lipophilic dyes to label mesoderm. However, this strategy 
did not exclude the possibility of labeling the endoderm along with mesoderm at the site 
of injection. Endodermal derivatives, in turn, could potentially have obscured the 
resultant fate maps. 
 Some of these concerns were addressed in a recent study by Cui et al. (2009), 
where a subset of ingressing epiblastic cells was electroporated with a plasmid 
encoding a fluorescent marker. A portion of labeled cells then contributed to the 
precardiac mesoderm, and subsequently to the myocardial layer of the heart proper. 
Movements and fate of this cell population were followed by time lapse imaging and cell 
tracking analysis. This study revealed many previously undescribed aspects of the 
origin and morphogenetic movements of the myocardial progenitor cell population. 
These cells were shown to reside in a precardiac field that is contiguous and circular in 
shape. The much debated question of cranial-caudal patterning of the heart tube has 
also been addressed. In addition, the role of global tissue movements (“rolling-up”) of 
the endoderm in determination of positional fate of myocardial progenitors has been 
demonstrated. The outcomes of the study by Cui et al. illustrate that dynamic, time 
lapse imaging-based fate maps of precardiac mesoderm need to be developed as they 
will help integrate multiple (and often conflicting) results obtained by many research 
groups over the course of more than 60 years.  
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Figure 1.1: Morphogenetic events during early heart development (illustration 
from Mikawa, 1999).  
Top panel – precardiac mesoderm cells (red) ingress through the primitive streak at HH 
4. Second panel – endocardial precursors (green) segregate from the layer of 
presumptive myocardium (red) at HH 7-8. Bottom panel – the tubular heart is formed as 
a result of the fusion of bilateral cardiac primordia (illustration from Mikawa T. (1999). 
Cardiac Lineages. In: Harvey RP, Rosenthal N, editors. Heart development. New York: 
Academic Press. p 20). 
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Figure 1.1 
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Figure 1.2: Location of cardiogenic fields in the avian embryo at HH5 according 
to different investigators (A) and a schematic representation of Nkx 2.5 and Bmp-
2 expression patterns at the same stage of development (illustration from Kirby ML. 
(2007). Cardiac Development. Oxford University Press, Oxford, UK, p. 24). 
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Figure 1.2 
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Origin and specification of endocardial and myocardial cell lineages 
Endocardial cells represent a specialized subset of endothelium. They form the 
interior surface of the heart that is contiguous with the endothelial lining of the inflow and 
outflow regions. Myocardial cells form the contractile tissue of the heart. 
Endocardiocytes are important for multiple aspects of cardiac development and 
function, such as heart valve formation (Armstrong, Bischoff, 2004). They functionally 
interact with myocardium, participating in regulation of proliferation and contractility of 
adult myocardium (Brutsaert, Andries, 1992), maintenance of a smooth surface for 
laminar blood flow and others. In addition, recent work by Holtzman et al. (2007) 
demonstrated the importance of the endocardium for cardiomyocyte migration and 
establishment of proper interactions between the layers of the developing heart in 
zebrafish embryos. Stalsberg and DeHaan (1969) had shown that endocardial cells 
originate from the same regions of the embryo as cardiomyocyte progenitors. Since this 
discovery it has been debated whether a common precursor exists for the myocardial 
and endocardial lineages of the heart.  
To address this issue several approaches have been taken. By retroviral cell 
labeling (Cohen-Gould and Mikawa, 1996; Wei and Mikawa, 2000) it was demonstrated 
that descendants of progenitor cells labeled at the primitive streak at HH3 or within 
precardiac mesoderm at HH4 became either exclusively myocardial or endocardial, but 
the mix of the two was never observed in a clonal population. Another group (Eisenberg 
and Baden, 1995) created a cell line (QCE-6) derived from anterior mesoderm of the 
quail embryo at HH4. QCE-6 cells proved capable of expressing either myocardial or 
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endocardial cell markers in response to different cell culture conditions. Unfortunately, at 
present there are no reliable lineage-specific markers that would allow distinguishing 
between myo- and endocardial lineages at gastrulation and early postgastrulation 
stages. However, the results of in vivo cell lineage tracing strongly suggest that 
endocardial cells and cardiomyocytes arise from distinct progenitor populations. 
It was also shown that commitment of endocardial cells is independent from 
gastrulation, and possibly occurs before this step of development (Christ et al., 1991). 
Von Kirschhofer et al. (1994) utilized cytochalasin B to block gastrulation movements in 
quail embryos. By elegant quail-chick grafting experiments, they demonstrated that 
unlike the endocardium, myogenic cells did not undergo commitment without having 
gastrulated. 
Although apparently the determination of endocardial progenitors occurs prior to 
gastrulation, their differentiation depends on inducing signals from the endoderm (Sugi, 
Markwald, 1996). Among those signals TGFβ ligands TGFβ2, -3, and -4 were shown to 
induce endocardial differentiation in mesodermal explants in vitro (Sugi and Markwald, 
2003). Differentiating endocardial cells in vivo acquire the characteristics of 
mesenchymal cells and sort from the splanchnic layer of mesoderm in small groups 
(Sugi and Markwald, 1996). At the same time myocardial progenitors remain organized 
in large clusters with epithelial properties. Differential expression of N-cadherin has 
been implicated in cell sorting of the myo- and endocardial progenitor populations 
(Linask and Lash, 1993). Commitment to the myocardial fate, and further myocardial 
differentiation most likely requires integration of Bmp, Fgf, Nodal, and Hedgehog signals 
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(reviewed in Evans et al., 2010). 
FGF-2 and VEGF signaling from the endoderm regulate differentiation of 
endocardial cells (reviewed in Lough and Sugi, 2000). Like vascular endothelial cells, 
differentiated endocardial cells express a number of genes, examples of which include 
receptors for VEGF (Flt-1, Flk-1) and angiopoietins 1-4 (Tie1, Tie2), cell adhesion 
molecule vascular endothelial (VE) cadherin, connexin 37, endothelial-specific 
transcription factor Epas1 and others (reviewed in Kirby, 2007). Both endocardial and 
endothelial cells in quail embryos possess the recognition site for QH1 antibody 
(Pardanaud et al., 1987). Although the identity of the QH1 epitope was not identified, 
this antibody has been an invaluable asset in vascular developmental biology. Reliable 
markers of such quality for distinguishing between vascular endothelial and endocardial 
cells are not available at present. 
 Nevertheless, multiple lines of evidence suggest that these two populations are 
biochemically distinct. Zebrafish mutants cloche and faust lack endocardial cells, but 
retain the blood vessel endothelium (Stainier et al., 1995; Reiter et al., 1999). In mice, it 
was shown that angiopoietin signaling through receptor kinase Tie2 is critical for 
endocardial, but not endothelial development (Puri et al., 1999). Expression of 
transcription factors GATA5 (disrupted in faust mutants) and NFATc are restricted to the 
endocardium, and are turned on sequentially during endocardial differentiation of 
mesodermal cells in vitro (Nemer and Nemer, 2002). It remains unknown what drives 
the movement of the endocardial cells towards the midline during fusion. As to the 
myocardial cells, it was shown that in zebrafish embryos fibronectin is important for 
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maintenance of epithelial organization by myocardial progenitors during their midline-
directed motion (Trihn and Stainier, 2004). Early work by Linask and Lash (1986) 
described an increasing amount of fibronectin fibrils at the mesoderm-endoderm 
interface as a mechanism that triggers the haptotaxis of precardiac cells towards the 
midline. However, other groups did not confirm an existence of such a concentration 
gradient in similar studies. In zebrafish, the sphingosine-1-phosphate receptor is 
implicated in the migration of heart primordia (Kupperman et al., 2000). Of note, most of 
the above mentioned studies were concerned with the movement of the myocardial 
progenitor cells, the organization and behavior of which during early cardiogenic stages 
was shown (Sabin, 1920) to differ from that of the endocardial cell population. 
  
 
 
 
 
 
 
 
 
 
 
 
	   13	  
Composition and functional significance of extracellular matrix (cardiac jelly) in 
the developing heart 
Cardiac jelly is an extensive layer of extracellular matrix that separates 
endocardial and myocardial layers of the developing heart (Davies, 1924). 
Morphologically CJ consists of two unequally sized apposing basement membranes. 
The larger BM is adjacent to the myocardium and comprises the bulk of the cardiac jelly. 
BM associated with endocardium is much thinner and consists only of lamina densa 
(Kitten et al., 1987). Although the assembly of cardiac jelly begins at HH8, it performs its 
main functions later in development, namely during the looping process, that begins at 
HH10 (Nakamura and Manasek, 1978; Nakamura and Manasek, 1981; Manner, 2000), 
and cardiac cushion formation (HH16-17; Martinsen, 2005). 
Extracellular matrix of the developing heart and CJ layer includes a variety of 
components, such as glycosaminoglycans (hyaluronic acid, chondroitin sulfate), 
collagens (types I, III, IV, XVIII), glycoproteins (fibronectin, laminin, vitronectin, 
cytotactin, fibrillins -1 and -2, thrombospondin), and proteoglycans (Little et al., 1989; 
Gallagher et al., 1993; Spence et al., 1992; reviewed in Little and Rongish, 1995). Most 
of the literature sources attribute the formation of the cardiac jelly to the synthetic 
activity of myocardial cells that are believed to produce the bulk of the CJ components 
shortly before and immediately after they assume their final positions in the tubular heart 
(Manasek, 1977; Eisenberg and Markwald, 1995; Kirby, 2007). However, the process of 
CJ assembly and the origins of its individual components have not been fully resolved. 
In Chapter 2 of this dissertation we demonstrate, that a fraction of CJ constituents is 
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transferred from extracardiac locations in association with individual cells and cell 
aggregates that undergo displacements during tubular heart formation. 
In our work we focused on the CJ constituents that are known to play important 
roles in multiple steps of heart development in several species. For instance, fibronectin 
is found in the precardiac mesoderm as early as HH5 in chicken embryos, and its 
abundance is increased during the period of cell migration (Icardo and Manasek, 1983; 
Linask and Lash, 1986). In zebrafish fibronectin allows cardiomyocytes to preserve their 
epithelial organization during migration, the condition necessary for successful cardiac 
tube fusion (Trihn and Stainier, 2004). The phenotype analysis of fibronectin null mice 
provides the evidence for the important role of fibronectin in mesodermal migration, 
proliferation and differentiation (George et al., 1993). 
Fibrillins-1 and -2 are integral components of extracellular microfibrils found in 
elastic and nonelastic tissues (reviewed in Hubmacher et al., 2006). During early heart 
development cell repositioning occurs in the environment abundant in such microfibrils 
that reach a diameter of 10-12 nm (Sakai et al., 1986). At more advanced stages of 
cardiogenesis, fibrillins associate with the endocardium and cardiac jelly (Hurle et al., 
1994; Wunsch et al., 1994). Fibrillins play a regulatory role in the elastic fiber assembly 
and possess physical properties that allow them to provide dynamic connective tissues 
(such as CJ or ECM of the precardiac mesoderm) with long-range elasticity (Kielty et al., 
2002). In addition to their mechanical role, fibrillins are involved in the extracellular 
control of TGFβ and BMP signaling (reviewed in Charbonneau et. al, 2004). 
Other constituents of the cardiac ECM are also capable of modulating growth 
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factor signaling by sequestration of secreted morphogens and thus limiting their 
bioavailability. For instance, defined oligosaccharide sequences within heparan sulfate 
proteoglycan were shown to specifically inhibit FGF-2 signaling (Ashikari-Hada et al., 
2009), and perlecan was demonstrated to modulate the VEGF-VEGFR2 signaling axis 
(Zoeller et al., 2009). 
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Mechanisms that regulate and guide cardiac progenitor movements during early 
heart formation 
A lot of evidence on important regulators of cardiac cell movements came from 
studies in zebrafish. A wide array of mutations causes defects in midline-directed 
migration, causing formation of two separated “half-hearts”, a condition known as cardia 
bifida. Out of these mutations, some affect morphogenesis of the endoderm in the 
vicinity of the developing heart, for instance casanova, bonnie and clyde, faust, miles 
apart (Alexander et al., 1999; Kikuchi et al., 2001; Kupperman et al., 2000; Reiter et al., 
1999). Another category of mutations  (natter, hands off) causes disruption in the 
organization of the fibronectin ECM that surrounds the cardiomyocytes (e.g., (Garavito-
Aguilar et al., 2010; Trinh and Stainier, 2004). Results of the above studies in zebrafish 
highlight the importance of myocardium–endoderm and myocardium–ECM interactions 
during heart tube formation. 
In avians, Wnt3a was shown to regulate cardiac progenitor motion via a 
chemorepulsion mechanism, dependent on RhoA function (Yue et al., 2008). In mice, 
GATA4 knockout causes cardia bifida (Molkentin et al., 1997), which can be rescued by 
transplantation of GATA4-positive endoderm (Narita et al., 1997). Mutations in 
transcription factors HIF1alpha and Foxp4 also lead to cardia bifida (Compernolle et al., 
2003; Li et al., 2004). 
Most of the above studies are concerned predominantly with the myocardial 
progenitor cell movements. Recently, however, a study by Fish et al. (2011) shed some 
light on molecular mechanisms driving endocardial progenitor movements towards the 
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midline in zebrafish embryos, demonstrating that Slit/miR-218/Robo/VEGF signaling 
axis is involved in the control of endocardial migration.  
For avian and mammalian models evidence regarding specific signaling and 
cellular mechanisms involved in motion of endocardial progenitors is very scarce. At the 
same time, vascular endothelial precursor cell migration has been studied extensively in 
various systems (reviewed in Lamalice et al., 2007, Schmidt et al., 2007). Directed 
motility of endothelial precursors can be regulated by a concentration gradient of soluble 
ligands (chemotaxis), insoluble ligands immobilized in surrounding tissue (haptotaxis), 
or mechanical forces (mechanotaxis). VEGF, bFGF, and angiopoietins are recognized 
as the main positive regulators of endothelial chemotaxis (Kazemi et al, 2002, Hiratsuka 
et al, 2005), and semaphorin 3A1 has a repulsive effect on vascular migration (reviewed 
in Schmidt et al., 2007).  
At the cellular level endothelial migration is based on remodeling of the actin 
cytoskeleton with the formation of filopodia, lamellopodia and stress fibers (reviewed in 
Shuster and Herman, 1998). Myosin IIA and B interact with the actin cytoskeleton and 
participate in protrusive activity and force generation in migrating endothelial cells 
(Kolega, 2006). RhoA was shown to be important in vascular progenitor and mature 
endothelial cell migration through participation in VEGF receptor-2 and phosphatidyl-
inositol 3-kinase activation (Gingras et al, 2000, Qi et al., 2001). Interestingly, RhoA is 
highly expressed in the anterior lateral plate, developing heart, and anterior intestinal 
portal at HH 6-9 in avian embryos. SiRNA-mediated downregulation of RhoA at these 
stages results in failure of cardiac progenitor field fusion, or cardia bifida (Kaarbo et al, 
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2003). However, it is still unknown whether endocardial and vascular endothelial cells 
share a common progenitor in avian embryos. Results of Bussmann et al. in zebrafish 
(2007) suggest that endocardial cells are derived from the hematopoietic and vascular 
lineage, and then migrate to the site of cardiogenesis. In contrast, Misfeldt and 
colleagues (2009) state in their recent publication that in mice the endocardium shares a 
common multipotent mesodermal progenitor with the myocardium, and is independent 
from other vascular lineages. Therefore, it is unclear if all of the above information on 
vascular progenitor migration is applicable to the migration of pre-endocardial cells in 
early avian development.  
Additional information relevant to endocardial cell migration comes from studies 
of cardiac cushion (primordial valve) formation. At HH14 the cardiac jelly at the atrio-
ventricular junction expands and by HH17 becomes the site of invasion of a specific 
JB3+ subset (Wunsch et al, 1994) of endocardial cells. These endocardial cells are 
induced to undergo epithelial-to-mesenchymal transformation (EMT) by a 
multicomponent signaling from the myocardium (reviewed in Eisenberg and Markwald, 
1995, Kirby, 2007). Cushion explant studies by Zhao and Rivkees (2004) and Sakabe et 
al. (2006) elucidated a prominent role for Rho-dependent kinases ROCK-1 and -2, and 
myosin light chain kinase in the regulation of the endocardial cell motility. 
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VEGF signaling in development 
Vascular endothelial growth factor A (VEGF A), a member of VEGF subfamily of 
growth factors, is an endothelial-specific mitogen that plays key roles in the processes 
of angiogenesis and vasculogenesis. VEGF-A is a principal regulator of the 
development of the embryonic vasculature and heart, and plays important roles in 
organogenesis of liver, kidney, lung, muscle and bone tissue, skin and nervous system 
(reviewed in Haigh, 2008). Secreted VEGF-A binds to VEGF receptors, which are highly 
expressed by the cells of the endothelial lineage, and stimulates endothelial 
proliferation, migration and survival, leading to the outgrowth of new blood vessels 
(reviewed in Ferrara, 2001).  
VEGF-A is a glycoprotein that forms homodimers of 34 – 46 kDa in size. In 
human, six different mRNA isoforms are produced from a single VEGF gene, containing 
8 exons, by means of alternative splicing (Tischer et al, 1991). VEGF isoforms differ in 
their ability to be secreted or cell- or ECM-bound, depending on the presence in of 
heparan sulfate proteoglycan (HSPG)-binding motives and cell surface consensus 
retention sequence (CRS). Predominant VEGF isoforms are VEGF121, VEGF165 and 
VEGF189; they are produced in most cells that express VEGF. Less abundant 
VEGF145 and VEGF 206 are mostly expressed in placental cells, whereas VEGF183 is 
expressed more ubiquitously (Haigh, 2008). Major VEGF isoforms expressed by mouse 
(VEGF120, 164, 188; reviewed in Ferrara, 2001) and quail (VEGF 122, 146, 166, and 
190; Finkelstein and Poole, 2003) slightly differ in size from human counterparts, but 
have similar functions. 
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Properties of VEGF isoforms are different. VEGF121 does not contain an HSPG-
binding domain and is freely diffusible in the extracellular space. VEGF165, VEGF189 
and VEGF206 all interact with HSPG and mostly associate with cell surface and ECM. 
Cell- and ECM-bound VEGF could be released as soluble forms by heparinase or via 
plasmin-dependent cleavage of longer isoforms (Houck et al, 1992). 
VEGF-A expression is positively regulated by a number of morphogenetic 
factors, e.g. Fgf2 and 7, PDGF, EGF (Pages and Pouyssegur, 2005). VEGF expression 
is strongly upregulated in cells by hypoxic conditions. Promoter of the VEGF gene 
contains a hypoxia responsive element (HRE) carrying a binding site for hypoxia-
inducible factor 1 (HIF1) that binds and activates the promoter (Forsythe et al, 1996). 
VEGF pre-mRNA contains an internal ribosome entry site that is being activated under 
the severe hypoxia and allows VEGF production when cap-dependent translation is 
impaired (Dibbens et al, 1999). Also, VEGF mRNA half-life is regulated by hypoxia-
induced factor HuR, which binds to untranslated regions of the mRNA molecules and 
stabilizes them. VEGF promoter is additionally positively regulated by a number of 
transcriptional factors such as AP-1, AP-2 and Sp1 (Tischer et al, 1991), and some 
other (reviewed in Xie et al., 2004; Pages and Pouyssegur, 2005). 
VEGF-A ligand binds to tyrosine kinase receptors VEGFR-1 (FLT1) and VEGFR-
2 (FLK1, KDR), with neuropilins 1 and 2 acting as co-receptors (NRP1 and 2; Gluzman-
Poltorak et al., 2001). Both VEGF-R1 and –R2 are critically important in embryonic 
development, as deficiency in any of the two receptors leads to prenatal lethality 
(Ferrara, 2001). 
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VEGFR-1 (FLT1) has higher affinity for VEGF ligand (in particular for the 
VEGF165 isoform) compared to VEGF-R2 (de Vries et al., 1992; Terman et al., 1992). 
Since the deletion of kinase domain of FLT1 in mice did not adversely affect 
cardiovascular development, it was suggested that the main function of VEGFR-1 was 
to inhibit VEGF activity by concurrent binding of VEGF-A molecules and sequestering 
them in non-signaling inactive complexes (“decoy receptor”; Hiratsuka et al., 2005). 
Additionally, FLT1 was shown to be important in recruiting VEGF molecules to the 
membranes of FLT1/FLK1-coexpressing cells (reviewed in Haigh, 2008). 
VEGFR-2, or KDR undergoes strong tyrosine phosphorylation after VEGF ligand 
binding. VEGF signaling through KDR is responsible for the majority of VEGF-A-induced 
effects on endothelial cells, such as stimulation of proliferation, migration, survival, and 
permeability (reviewed in Ferrara, 2001; Rohrberg, 2003). Neuropilins are involved in 
modulating VEGF-R2 signaling as co-receptors (Gluzman-Poltorak et al., 2001; 
Takashima et al., 2002). 
Results of multiple gain- and loss-of-function studies in rodent and avian models 
(Miquerol et al., 2000; Dor et al., 2001; Stalmans et al., 2003; Drake et al., 2006) 
indicate the importance of well-balanced contribution of VEGF signaling to various 
aspects of heart morphogenesis, e.g. heart tube bending, valve formation, cardiac 
septation and outflow tract development. However, little is known about the effects of 
VEGF overexposure on cardiac progenitor cell motility/migration during early steps of 
heart development. 
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Significance of the study 
 
Given the high temporal and spatial complexity of the cascade of events needed 
for proper heart formation, it is not surprising that many steps of this process are error-
prone. High incidence of such errors makes cardiac congenital malformations the most 
common form of birth defect (affecting 1 out of 100 newborns), as well as the number 
one cause for prenatal lethality and death from birth defects during the first year of life 
(Hoffman and Kaplan, 2002). According to the American Heart Association webpage, 
“nearly twice as many children die from congenital heart disease in the United States 
each year as die from all forms of childhood cancers combined” (www.heart.org). 
However, the causes for multiple congenital heart defects are unknown (Gruber and 
Epstein, 2004). 
The work included in this dissertation investigates the processes underlying 
assembly of three principal components of the early heart – the endocardial, myocardial 
and ECM layers. The overall goal of this work is to increase our current understanding 
of a connection between individual cell behaviors and more global tissue 
displacements/deformations during early vertebrate cardiogenesis. Early heart formation 
in quail provides an excellent framework for attacking the stated problem, as it involves 
an interplay between cells of mesenchymal (endocardial) and epithelial (myocardial, 
endodermal) morphologies, linked via interactions with the ECM into a coherent tissue, 
that progressively undergoes multiple types of deformations and displacements.  
 Our study helps elucidate how cardiac progenitor field movement is performed 
and regulated in amniote embryos; hence in combination with studies on roles of 
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individual genes in the process, our results may help identify factors with potential 
teratogenic effects on early cardiogenesis. In turn, this information may be useful for 
providing recommendations for genetic counseling or dietary/life style suggestions at 
early stages of pregnancy. Further, the results obtained in our study will broaden our 
understanding of principles of cardiac progenitor interactions and mechanical interplay 
with their ECM microenvironment. Such information is potentially useful for cardiac 
tissue engineering approaches, where ECM-like biomaterial-based scaffolds for heart 
progenitors are created in order to generate effective cardiac tissue substitutes 
(Fleischer and Dvir, 2012). 
A demand for imaging-based studies of dynamic morphogenetic processes and 
the clear advantages they offer over “classic” fixed tissue-based approaches have been 
clearly stated in a number of recent publications (Bussmann et al., 2007; Roeder et al., 
2012; Gregg and Butcher, 2012). Our study is unique, as it not only provides minute-by-
minute accounts of endocardial and myocardial precursors and ECM fibril movements 
towards the midline, but also quantifies the observed behaviors in normal and perturbed 
embryos by means of rigorous computational analysis. 
It is known that a significant percentage of congenital heart defects arise due to 
abnormal development of the cardiac valves (Eisenberg and Markwald, 1995). Although 
many genetic defects that lead to valve malformations have been identified, in 25% of 
the cases this morphogenetic event fails separate from any described genetic cause 
(Armstrong and Bischoff, 2004). This underscores the need for further understanding of 
the process of assembly and interactions of major participants in early cardiac valve 
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(endocardial cushion) formation, namely that of endocardial cells and the cardiac jelly 
ECM. In Chapter 2 we investigate the movements of endocardial progenitors towards 
the embryonic midline in comparison to their ECM (fibronectin and fibrillin-2) 
microenvironment. Using several computational analysis approaches we quantify the 
contributions of active (ECM-independent) and convective (coordinated with the 
surrounding tissue) movements to the observed endocardial displacements. Our results 
present the first published evidence that pre-assembled ECM can be transferred to a 
developing organ, proving both feasibility and importance of such “ECM fate mapping” 
studies. 
It is widely accepted that foregut endoderm and fibronectin are critical for the 
arrival of cardiac progenitors at the midline, yet most assume their functions to be 
limited to creating a passive environment for active pre-cardiac cell movements. In our 
study of myocardial displacements relative to both suggested movement substrata 
presented in Chapter 3, we uncover coordinated deformations that occur within the 
developing myocardial primordia. We demonstrate that these deformations may play an 
important role during heart tube assembly. The computational model developed based 
on the experimental results obtained herein represents both the anatomy of the 
myocardium and the surrounding mesoderm, as well as the mechanical activity 
(bending and spatially restricted contraction) we observe for the myocardium. Model 
simulations allow us to explore the tissue scale consequences of the assumed 
myocardial behavior. Thus, our mechanical model allows establishing connection 
between the tissue and cell-level behaviors. 
	   25	  
In Chapter 4, we use exogenous VEGF to induce expansion of the 
endothelial/endocardial lineage and assess the effects of the perturbation on myocardial 
movements and endoderm deformations. Our results provide a framework for 
understanding how mechanical imbalance in the developing tissue can lead to 
phenotypic defects, such as, in our experiments, delayed cardiac elongation.   
 Finally, in Chapter 5 we discuss some of the implications of our results as they 
relate to other studies in the field of cardiac and endoderm morphogenesis, and propose 
several areas of inquiry that could serve as a logical continuation of the presented work.  
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CHAPTER TWO: 
 
Convective tissue movements play a major role in avian endocardial 
morphogenesis 
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Abstract 
 
Endocardial cells play a critical role in cardiac development and function, forming 
the innermost layer of the early (tubular) heart, separated from the myocardium by 
extracellular matrix (ECM). However, knowledge is limited regarding the interactions of 
cardiac progenitors and surrounding ECM during dramatic tissue rearrangements and 
concomitant cellular repositioning events that underlie endocardial morphogenesis. By 
analyzing the movements of immunolabeled ECM components (fibronectin, fibrillin-2) 
and TIE1 positive endocardial progenitors in time-lapse recordings of quail embryonic 
development, we demonstrate that the transformation of the primary heart field within 
the anterior lateral plate mesoderm (LPM) into a tubular heart involves the precise co-
movement of primordial endocardial cells with the surrounding ECM. Thus, the ECM of 
the tubular heart contains filaments that were associated with the anterior LPM at earlier 
developmental stages. Moreover, endocardial cells exhibit surprisingly little directed 
active motility, that is, sustained directed movements relative to the surrounding ECM 
microenvironment. These findings point to the importance of large-scale tissue 
movements that convect cells to the appropriate positions during cardiac 
organogenesis. 
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Introduction 
 
Vertebrate heart morphogenesis, the assembly of a midline tubular heart from 
bilateral precursor fields, results from an elaborate interplay of events that occur at 
molecular, cellular and tissue levels of organization.  The resulting heart tube is 
comprised of an inner layer of endocardium separated from the outer myocardium by a 
layer of extracellular matrix (ECM) termed the cardiac jelly. The interactions between 
cardiac progenitors and the surrounding ECM during morphogenetic movements are a 
critical aspect of the development process: the cardiac ECM is involved in the 
proliferation, differentiation, survival, communication and migration of cardiac cells - by 
providing an adhesion substrate and sequestering growth factors (Bowers and Baudino, 
2010). 
Tubular heart assembly takes place in the swiftly moving environment of the 
forming foregut. The heart splanchnic mesoderm is physically coupled to the underlying 
endoderm that will form the ventral floor of the foregut. Both structures remain 
transiently connected via a mesentery until heart looping commences. In addition to 
tissue movements underlying the elongation of the foregut, the formation of the heart 
tube also involves substantial rearrangements of myocardial and endocardial precursors 
(reviewed in Linask, 2003).  
Little is known regarding the origin and movements of the endocardial precursors 
as they form the inner layer of the heart, continuous with the endothelial lining of blood 
vessels. It is widely believed that endocardial cells share a common precursor with the 
myocardial cells, but diverge to form a distinct lineage with some shared characteristics 
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of endothelial cells (Linask, 2003; Harris and Black, 2010).  The exact time and place of 
this divergence is unknown, but studies in avian embryos indicate the two cell lineages 
segregate prior to or at early gastrulation; i.e. before these cells populate the primary 
heart field at HH Stage 4 (Reviewed in Ishii et al., 2009). The endocardial precursors 
differentiate and move into an ECM-rich microenvironment located between the 
splanchnic mesoderm and endoderm.  However, the relationship of mesodermal and 
endodermal tissue level movements to movements of the endocardial precursor 
population is largely unknown.  
In this study, we establish the morphogenetic movements of both the endocardial 
precursor cells and ECM fibrils in their microenvironment. We show that the endocardial 
tube in an amniote (avian) embryo forms and elongates as a consequence of large-
scale tissue movements, which carry both endocardial progenitors and their local ECM 
environment into the forming heart. As a consequence, ECM filaments, originally 
associated with the anterior LPM are transferred medially where the fibrils incorporate 
into the cardiac jelly. We also find that the transport of endocardial progenitors is mostly 
a passive process; their autonomous migration relative to the ECM microenvironment is 
limited and can be characterized as a slightly biased random walk. 
 
 
 
 
 
	   30	  
Experimental Procedures 
 
Quail embryo preparation 
 
Fertile wild type (Coturnix coturnix japonica) or Tie1::H2B-YFP (Sato et al. 2010) 
quail eggs (Ozark Egg Co., Stover, MO) were incubated for varying periods of time 
(from 20 to 36 h) at 37°C to reach stages HH6 to HH11 (Hamburger and Hamilton, 
1951). Embryos were then isolated and cultured as in Cui et al., 2009 (modified EC 
culture; Chapman et al., 2001). 
 
Immunofluorescent labeling of ECM and endothelial/endocardial cells, in vivo 
 
Monoclonal antibodies directed against fibrillin-2 and fibronectin ECM proteins 
(JB3, B3D6; DSHB, Iowa City, IA) or a quail endothelial cell surface marker (QH1; 
Pardanaud et al., 1987; DSHB) were directly conjugated to AlexaFluor 488, 555 or 647 
(Molecular Probes) according to the manufacturerʼs instructions. The direct conjugates 
were injected into the lateral plate mesoderm as 5-40 nl boluses using a PLI-100 
(Harvard Instruments) microinjector as described in Little and Drake, 2000. 
Microinjections were performed 30-60 minutes prior to the beginning of the image 
acquisition to allow for antibody diffusion and antigen binding. 
 
 Wide-field time-lapse imaging 
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Automated microscopy of immunolabeled quail embryos was performed as 
described elsewhere (Czirok et al., 2002; Zamir  et al., 2008). To enhance contrast, 
selected epifluorescence image stacks were deconvolved by a commercial, blind 
adaptive deconvolution software (Autoquant X, MediaCybernetics). Manual tracing of 
image details, notably the ECM filaments, was performed using custom software (see, 
e.g., Czirok et al., 2004). As Fig. 3 of Czirok et al., 2004 and Supplemental Fig. 2.1 
demonstrate, despite overall changes in ECM organization, the details used to track 
ECM filaments (such as filament branch points or shapes) are clearly recognizable from 
frame to frame. The spatial extent of the recognizable features (up to 10 mm) is much 
smaller than the traced displacements (200 mm to 1 mm). The size of the tracked 
features thus limits the spatial resolution of the trajectories, but only to an extent 
comparable to the line width used in the images to represent them.  
 
Post-fixation immunofluorescence labeling 
 
Embryos were fixed and prepared for immunolabeling according to Little and 
Drake, 2000. Monoclonal antibodies against avian epitopes (JB3, B3D6, QH1), directly 
conjugated to AlexaFluor 488, 555 or 647, were added at 1:1000 dilutions in 3% BSA for 
overnight incubation. Nuclei were counterstained with 4ʹ′,6-diamidino-2-phenylindole 
(DAPI) at 300 nM in PBS.  
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Frozen sections were incubated in 0.5 M (NH4)2SO4 for 30 min to remove 
paraformaldehyde-induced autofluorescence and rinsed with PBS. Subsequently non-
specific epitopes were blocked by incubation in 3% BSA solution in PBS for 1h. 
Monoclonal antibodies against ECM epitopes were added at 1:1000 dilutions in 3% BSA 
for 2h of incubation. For confocal and epifluorescent imaging whole embryo specimens 
and sections were mounted on slides with ProLong Gold antifade reagent (Molecular 
Probes). 
 
Confocal imaging 
 
Confocal imaging of whole-mount embryo specimens was performed using a 
Nikon 90i upright microscope with a Nikon C1 confocal scan head and Nikon Plan 
Apochromat 10x and 20x objectives. 
 
Preparation of transverse cryosections 
 
Embryos were fixed in 3% paraformaldehyde for 30 min. Then tissue was rinsed 
in PBS and subjected to a sucrose gradient (5%, 15%, 30% in PBS), embedded in OCT 
(Sakura Finetek USA, Inc, Torrance, CA) and stored at - 80°C. Subsequently 10 µm 
transverse sections were prepared from frozen blocks using a Leica CM3050 cryostat. 
 
Particle Image Velocimetry (PIV) analysis 
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We used the two step algorithm of Zamir et al., 2005; implemented in MatLab 
(Mathworks, Inc.) and further detailed in Supplemental Fig. 2.2D, E. Briefly, images 
were divided into overlapping tiles, each 75 µm wide. The displacements of the tiles 
were determined by cross-correlation analysis; for each tile we searched the next image 
for the location that exhibited the most similar intensity pattern. The resulting 
displacement vectors were then interpolated and denoised by a thin-plate spline fit, 
yielding our coarse displacement map. This map was used to construct a second, 
higher resolution one. The cross-correlation procedure was repeated with tiles that were 
only 30 µm wide. To reduce ambiguities associated with smaller tiles (patterns within 
smaller tiles are less unique), the subsequent image was scanned only in the vicinity of 
positions predicted by the coarse map. In this study we did not apply a final smoothing 
(spline fitting) step, but kept the results of the second cross-correlation analysis.  
 Within the whole embryo, the ECM label was highly non-uniform, as some areas 
were exposed to more antibody than others. Image tiles corresponding to areas where 
the immunofluorescence was weak are very noisy; hence the cross correlation analysis 
was more error-prone. To reflect this, for each PIV-derived displacement vector we 
assigned a weight, the local standard deviation of fluorescence intensity. Thus, 
displacement vectors characterizing a detail-rich region carry more weight in the 
subsequent analyses than those obtained in a weakly labeled area (see Supplemental 
Fig. 2.2E). 
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Automated cell tracking 
 
To track fluorescent nuclei in 3D within a series of image stacks, a novel 
algorithm, referred to as the CIPA tracker, was developed (Hossain et al; MS in press). 
Briefly, the algorithm automatically detects a set of prominent cells in the image stack as 
bright objects, using a multi-stage segmentation approach (see Supplemental Fig. 
2.2H). To identify the same cell within a consecutive pair of images, objects that are 
located within a certain distance are compared by several measures, such as size, 
brightness or texture similarity.  In addition to in-plane searches, the program also 
probes the two immediately adjacent optical planes to deal with object motion along the 
z-axis. 
 
Motion analysis 
 
To characterize ECM and cell rearrangements at various stages of heart 
development, pairs of deconvolved image stacks were selected. The images within the 
stacks were taken 20 minutes apart. A given pair, P, was analyzed through the following 
procedure. By manual masking (see Supplemental Fig. 2.2C), two additional image 
stack pairs were derived: one containing the forming heart, the other the somites or the 
pre-somitic mesoderm (to be used as a reference). The corresponding optical sections 
and fluorescence channels were compared by PIV analysis as described above. For 
automated (CIPA) tracking we used all available recorded image stacks within the time 
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interval separating the image pair, P. Velocities (displacements normalized by the time 
lag between the images of P) were presented in a reference system co-moving with the 
somites. Thus, we use the term “velocity” to describe a vector-value characterizing both 
the rate and direction of the displacements of selected objects. The term “speed” is 
used to describe the magnitude of the velocity vector. 
Active cell velocities were calculated as the local vectorial difference between the 
cell- and ECM-derived velocity vectors (Supplemental Fig. 2.2G, I). The “reliability” 
weight assigned to the vectorial difference is the lesser of the two weights assigned to 
the vectors. As the CIPA-predicted displacement vectors may point in various directions, 
even within a small area, we obtained the locally prevalent direction and speed of active 
motion by replacing each vector by a local average within a radius of 100 µm 
(Supplemental Fig. 2.2J). To show how disorganized the initial set of vectors within the 
zone of averaging was, we plotted the standard deviation of the set as a color code.  For 
statistical comparison of embryos, certain areas were selected in the caudal heart and 
on both sides of the future omphalomesenteric veins. Velocity vectors from different 
embryos, but within the same location, were pooled. Data obtained from different 
embryos were considered statistically independent. 
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Results 
 
The structure of early cardiac ECM 
 
We collected quail embryos at stages ranging from HH8-, when endothelial and 
endocardial progenitors first demonstrated a strong QH1 immunoreactivity, to HH11. 
Whole-mount embryos were immunolabeled for QH1 and selected ECM components, 
fibronectin and fibrillin-2, and the anterior embryonic tissues were subjected to confocal 
microscopy. At HH8-, ECM fibrils were already abundant in the vicinity of QH1-positive 
endothelial/endocardial progenitors (Fig. 2.1A, Aʹ′), however for later stages we noted an 
increasing degree of association between fibronectin and vascular progenitors. By 
HH10, the forming cardiac tube and omphalomesenteric veins were surrounded by a 
fibronectin  “sheath” (red arrows in Fig. 2.1Bʹ′, Cʹ′).  
Fibrillin-2 was organized in coarser structures than fibronectin.  Fibrillin-2 fibrils 
also indicated a certain degree of association with the membranes of 
endothelial/endocardial progenitors. At HH10 and 11 fibrillin-2 was detected only on the 
endocardial side of the cardiac jelly (red arrows in Fig. 2.1Dʹ′), whereas fibronectin was 
present on both the myocardial (blue arrow in Fig. 2.1Dʹ′) and endocardial sides of the 
cardiac tube ECM.  At the stages investigated, both ECM components were 
interspersed, but did not colocalize to identical filamentous structures.  
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Figure 2.1. Endocardial tube assembly takes place in a microenvironment 
abundant in fibronectin and fibrillin-2 ECM.  
A-D: maximum intensity dorso-ventral projections of confocal stacks obtained at HH8- 
(A), HH8 (B), HH10 (C), HH11 (D) stages of development. Whole mount specimens 
were immunostained with monoclonal antibodies QH1 (red), B3D6 anti-fibronectin 
(green), and JB3 anti-fibrillin-2 (blue).  Aʹ′ - Dʹ′: single, 2.5-4 µm thick optical plane 
images selected from the regions marked with rectangles in panels A-D. In addition to 
the multicolor merged image, distinct panels show each immunofluorescence label 
inverted for better contrast.  Scale bars:  A-D ⎯ 100 µm, Aʹ′, Cʹ′ ⎯ 40 µm, Bʹ′, Dʹ′ ⎯ 20 
µm.  Fibronectin fibrils demonstrate an increasing degree of association with 
endocardial cell surfaces at progressively later developmental stages (red arrows). 
Fibronectin is also associated with the myocardium at HH11 (blue arrow). Fibrillin-2 
fibrils are somewhat larger in diameter and appear to be aligned with the QH1-positive 
cell surfaces (A-C, Aʹ′-Cʹ′, red arrows). Both types of ECM surround the endocardial layer 
in the assembled heart tube (D, Dʹ′). 
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Figure 2.1 
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ECM from the caudal embryo contributes to the caudal heart tube  
 
Fibronectin and fibrillin-2 were immunolabeled in vivo with distinct fluorophores in 
live, HH7 quail embryos  (n=9). The specimens were recorded in time-lapse between 
stage HH8- and HH12. The displacements of individual ECM fibrils were followed using 
a manual tracking procedure.  ECM structures preserved recognizable features during 
the transition from their initial, lateral positions in the precardiac mesoderm to their 
inclusion into the cardiac tube ECM at HH10. The large ECM density within the forming 
heart tube precludes filament tracking at later stages of development. Figure 2.2 and 
demonstrates that both fibronectin and fibrillin-2 fibrils are engaged first in a centripetal, 
then in a midline-directed movement. Adjacent trajectories are very similar, regardless 
of the molecular identity of the tracked ECM component.  
By extensive ECM tracing, the anatomical origin of ECM filaments that contribute 
to the developing heart tube was determined in HH8 embryos. We analyzed n=3 
embryos in which both ECM constituents were labeled. Tracking was performed 
independently for each ECM component. The obtained trajectories were assigned four 
groups depending on the filamentʼs fate at HH10. 
By superimposing the four groups on DIC image sequences, the approximate 
boundaries were identified for each category of markers (Fig. 2.2B). The resulting ECM 
positional fate maps were similar for each embryo analyzed as well as for both 
fibronectin and fibrillin-2.  We consistently found that ECM flanking the AIP at HH8- 
contributed to the anterior one third of the heart tube at HH10 (the red area in Fig. 2.2B). 
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Bilateral areas located laterally to the caudal segments of the  “red” or cranial ECM zone 
(denoted as yellow areas in Fig. 2.2B) are the source of ECM fibrils that were 
translocated to the middle portion of the cardiac tube by HH10. The regions contributing 
ECM to the caudal heart tube and omphalomesenteric veins maps to the posterior ends 
of the AIP and caudally extends to the level of the second or third somite pair (green 
areas in Fig. 2.2B). The lateral borders of this caudal-most region closely approach the 
boundary of the area opaca. 
 
ECM from the cranial embryo is incorporated into the growing heart tube from the 
cranial end  
 
Upon initial assembly at HH10, the heart tube undergoes rapid elongation of all three 
contributing layers (endocardium, cardiac jelly and myocardium), concomitant with the 
onset of looping (Fig. 3.3B). We followed immunolabeled individual ECM fibrils on the 
ventral surface of the foregut, in the vicinity of the tubular heart. These fibrils are 
included in the ECM layer separating the foregut endoderm and ventrally positioned 
splanchnic mesoderm (Fig. 3.3A). Between HH10 and early HH11 a number of ECM 
fibrils were displaced towards the ventral midline with subsequent inclusion into the 
anterior pole of the elongating cardiac tube and dorsal mesocardium (Fig. 3.3B). Due to 
dramatic changes in morphology of the anterior embryo that occur between HH7 and 
HH10, we could not reliably trace the earlier (prior to HH10) origins of these filaments. 
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Figure 2.2. Fibronectin (red) and fibrillin-2 (green) fibrils derived from the LPM at 
HH8- translocate to the heart by HH10.  
 
A: Corresponding epifluorescence (left) and DIC (right) image pairs, representing 
development between HH8- and HH10. ECM movements are indicated by the 
superimposed trajectories. Scale bars ⎯ 100 µm. B: Schematic fate map of ECM fibrils 
in a HH8- stage embryo. ECM from the colored areas incorporates into the cranial (red) 
or middle (yellow) portions of the heart tube, or to the caudal heart tube and the 
omphalomesenteric veins (green) by HH10. Blue dots indicate ECM fibrils that do not 
incorporate into the heart. The fate map shown is a representative example out of 3 
specimens that were imaged and analyzed by identical methods.  
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Figure 2.2 
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Figure 2.3. ECM positioned ventral to the pharyngeal endoderm is translocated 
towards the anterior portion of the tubular heart and contributes to its elongation 
after HH10. 
 
 A: Schematic transverse section, adopted from Lillie, 1930. B: Corresponding fibrillin-2 
immunofluorescence (left) and DIC (right) image pairs are shown. During the elapsed 4 
hours, the length of the cardiac tube substantially increases (DIC panels).  
Superimposed trajectories of individual fibrils are color-coded: red, green and blue 
colors indicate progressively later trajectory segments. The movements of fibrillin-2 
fibrils are indicated by the red arrows in panel A. Scale bar-100 m. 
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Figure 2.3 
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Exogenous fibronectin participates in tissue movement and incorporates into the heart 
tube along with the endogenous precardiac mesoderm ECM  
 
To show that tagged ECM filaments, suitably located in the anterior LPM, indeed 
incorporate in the cardiac jelly, we performed experiments utilizing exogenous, 
fluorescently conjugated human serum fibronectin (BD Biosciences). 7-10 ng of either 
AlexaFluor647 or 555 fluorophore-labeled fibronectin was delivered subendodermally 
into the LPM of quail embryos at HH6-8- (n=6). The endogenous fibronectin network of 
these embryos was also immunolabeled. Recordings of subsequent embryonic 
development revealed that the exogenously added human fibronectin incorporated into 
the quail ECM network and participated in its displacements in a manner 
indistinguishable from endogenous fibronectin molecules (Supplemental Fig. 2.3).  
As a control, we delivered 100-150 ng of BSA conjugated to AlexaFluor 647 to the 
contralateral side of each embryo. Time-lapse recordings demonstrated that the BSA 
signal completely dissipated within 4 hours after injection, whereas the exogenously 
added fibronectin signal was detectable for up to 12 hours. Furthermore, the distribution 
of fluorescent BSA was devoid of any fibril-like patterns throughout the experiment.  
To determine the position-fates of exogenously added fibronectin in the LPM, 25-
30 ng of fluorescently conjugated fibronectin were microinjected into 6-10 adjacent sites 
along the LPM of HH7-8- embryos (n=12). Injections were performed in such a way that 
medial (paraxial) and lateral (precardiac) portions of the anterior mesoderm were 
targeted with differentially labeled fibronectin molecules (Fig. 2.4A, top panel). Time-
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lapse imaging was used to record the rearrangements of exogenously added fibronectin 
occurring between HH8- and 11.  Beginning at stage HH8, ECM aggregates derived 
from the laterally positioned human fibronectin pool are seen to move towards the 
ventral midline, where fibrils eventually become incorporated in the tubular heart 
(arrowheads in Fig. 2.4A). 
In transverse cryosections of the heart tube we compared the distribution of 
endogenous and exogenously added fibronectin (Fig. 2.4). The former was detected by 
immunostaining sections with monoclonal anti-fibronectin antibody, B3D6. In each 
embryo sectioned following the time-lapse acquisition (n=5), exogenously added 
fibronectin was found exclusively on the endocardial side of the cardiac jelly (i.e., the 
basal side of the endocardium). In embryos fixed at HH10 (n=2; data not shown), 
exogenous fibronectin, delivered to the caudal embryo, was found on the basal side of 
the endocardium, throughout the length of the cardiac tube. This is consistent with our 
tracking results (Fig. 2.2), suggesting that (endogenous) fibronectin derived from the 
caudal embryo gives rise to ECM of the early heart tube (at HH10). At the same time, in 
embryos fixed at HH11-12 (Fig. 2.4) caudally-derived exogenous fibronectin was mostly 
found associated with the endocardium in the caudal half of the heart (n=3). 
However, if a 10-fold greater amount (200-250 ng) of exogenous fibronectin was 
delivered to the LPM at HH7, the fluorescent molecule was also found in small amounts 
on the myocardial side of the cardiac jelly throughout the length of the heart tube, in 
embryos fixed at HH11 (Supplemental Fig. 2.4). In contrast, no contribution to the 
cardiac jelly was detected from the medially positioned exogenous fibronectin (green in 
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Fig. 2.4A) either by time-lapse imaging of live embryos or in transverse sections of fixed 
tissue (data not shown). 
 
Early endocardial development, visualized by TIE1 promoter activity 
 
The TIE1 promoter is active in endothelial cell progenitors beginning at late HH6 (Sato 
et al., 2010). Thus, the TIE1:H2B-YFP transgenic embryos offer a novel way to study 
the movements of future endocardial cells throughout heart development. To analyze 
the developmental stage-dependent movements of future cardiac ECM and endocardial 
cells, we identified seven characteristic morphological states of the anterior embryo that 
we further refer to as endocardial stages, ES1-7 (Supplemental Fig. 2.5). These stages 
represent a 14-16 hour interval from HH8- to 11. During this time the nascent 
endocardium undergoes a dramatic transition from a predominantly single-cell 
progenitor organization to a tubular, lumenized tissue. Our classification scheme is 
based on the apparent changes in (TIE1+) endocardial organization, and stands in 
contrast to the standard HH classification of avian embryonic development. 
Classification of HH stages 7-14 is primarily based on the somite pair number 
(Hamburger and Hamilton, 1951; Bellairs and Osmond, 2005). However, addition of new 
somites and progression of endocardial morphogenesis are not always precisely 
temporally correlated.   
At ES1-3 endothelial/endocardial progenitors are flanking the AIP; at this stage 
the apparent linear distance between the caudal border of the headfold and the 
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posterior margin of the anterior intestinal portal is minimal, with few Tie1::H2B-YFP+ 
endocardial progenitors seen at the ventral midline. Although the foregut and the heart 
tube are at different dorsal/ventral planes, we used an increase in the projected distance 
between the two anatomical landmarks (viewed ventrally) as the index of foregut 
regression and midline mesoderm fusion. Both the headfold-to-AIP index (distance) and 
the number of Tie1::H2B-YFP+ progenitors progressively increased during ES2 and 3.  
The ES4 stage was typified by an elongated plexus of Tie1::H2B-YFP+ pre-
endocardial cells assembled at the ventral midline, i.e., the nascent endocardial tube. 
Also, at ES4, aggregations of endothelial/endocardial progenitors mark the sites of the 
omphalomesenteric veins, which form anterior and ventral to the AIP. By ES5 the 
developing endocardial plexus/tube has nearly doubled in length. Nascent 
omphalomesenteric veins incorporate an increasing number of cells at subsequent 
stages (ES5-7), with the concomitant organization of endothelial cells into tubes. 
Subsequently, individual small-caliber endocardial tubes fuse to form a single lumenized 
tube (confirming the findings of Drake et al., 2006). We ranked embryos with linear heart 
tubes displaying a slight asymmetry to the right as ES6, while “C-shaped” hearts are 
defined as ES7. With respect to the HH classification, ES1 corresponds to HH8-, ES2-4 
to HH8-8+, ES5 to HH9, ES6 to HH10, and ES7 to early HH11. 
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Figure 2.4. Exogenous fibronectin, injected into the LPM, incorporates into the 
cardiac tube.  
 
Human fibronectin conjugated to Alexa555 (red) was injected into the anterior LPM at 
HH7, while fibronectin-Alexa647 (green) was delivered to the paraxial mesoderm and 
medial-most regions of the LPM. A: Corresponding epifluorescence (left) and DIC (right) 
image pairs, showing an embryo at HH8- (top), HH8+, HH10, and HH11 (bottom) stages 
of development. Some fibronectin fibrils derived from the lateral (red) pool are 
progressively displaced towards the forming heart tube, which begins to exhibit 
Alexa555 fluorescence at HH10 and 11 (white arrowheads). At the same time, a large 
portion of the laterally injected fibronectin pool remains associated with mesodermal and 
endodermal tissues in the anterior embryo. The medially delivered (green) fibronectin 
pool does not contribute to the cardiac jelly. Scale bars ⎯ 100 µm. B-D: Transverse 
cryosections through the heart tube of the same embryo shown in panel A, fixed at HH 
11. Approximate planes of section are indicated in the bottom right frame of panel A. 
Red fluorescence signal corresponds to the exogenous fibronectin-Alexa555. The green 
signal shows the distribution of endogenous quail fibronectin, labeled with B3D6 
antibody post-sectioning. DAPI staining of cell nuclei is shown in blue.  Human 
fibronectin is present at the endocardial-cardiac jelly interface (asterisks).  nc: 
notochord, e: endocardium, m: myocardium. Scale bars ⎯ 40 µm. 
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Figure 2.4 
 
 
 
 
 
 
	   51	  
Tissue movements visualized by ECM displacements 
 
Quantitative characterization of ECM movements during early heart development 
was performed using epifluorescence recordings of 6 embryos, each microinjected with 
fluorophore-conjugated antibodies labeling fibronectin and fibrillin-2. Image pairs that 
correspond to the various endocardial stages (ES) were subjected to PIV analysis. In-
plane (two-dimensional) ECM displacements were measured in each deconvolved focal 
plane by independent computations. The velocity data are presented in a reference 
system co-moving with the somitic mesoderm. This procedure allows us to establish the 
typical “local” ECM movements characteristic for each stage of the heart development 
process as well as to compare movements of fibronectin to those of fibrillin-2. 
Figure 2.5 shows the pattern and distribution of fibronectin and fibrillin-2, as well 
as a typical velocity snapshot of their movements in an early (ES1, panel A) and later 
(ES7, panel B) stage of heart development. In the early stages, the ECM moves 
centripetally, quite uniformly along the posterior margin of the AIP. In later stages, 
movements diminish at the anterior aspect of the forming heart, while the posterior 
aspect of the heart continues its centripetal, medio-posterior expansion. 
We compared ECM displacement speeds at three distinct reference points: one 
located at the most anterior, and two at the left and right portions of the AIP “arch” (Fig. 
2.5A and B). An ANOVA analysis comparing the velocity magnitudes at the three 
locations failed to reveal statistically significant differences at any of the seven 
endocardial stages investigated (p>0.5). Thus, we consider the centripetal contraction of 
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the posterior margin of the foregut (endodermal tissue) uniform along the whole 
posterior margin. The speed of centripetal expansion is fastest at ES2 (around 70 µm/h) 
and drops continuously afterwards (Fig. 2.5C). 
At each grid point of the PIV calculation, we can calculate the difference between 
the displacement vectors characterizing the two ECM components. Except for the first 
stage (ES1), the mean magnitude of the calculated difference is less than 10% of the 
magnitude of the total tissue displacement, and this difference may reflect systematic 
errors in our PIV analysis. Thus, while fibronectin and fibrillin-2 do not co-localize in the 
same filaments, their tissue-scale displacements are virtually identical at each stage of 
the transition from planar precardiac mesoderm to formation of the heart tube. 
Therefore, either fibrillin-2 or fibronectin can be used as a reporter for tissue-scale 
movements. 
 
Movement of endocardial and endothelial progenitors 
 
To characterize the motile behavior of endocardial and endothelial cells, Tie1::H2B-YFP 
nuclei were traced in consecutive image stacks both manually and by using the 
automatic tracker program CIPA.  As Fig. 2.6 demonstrates, endocardial and endothelial 
progenitors may be located near one another at HH8, but then the two groups 
progressively separate as the endocardial progenitors, located within a horseshoe-
shaped field, begin their centripetal movement towards the embryonic midline. The 
boundary, which separates future endocardial cells from endothelial cells, is quite sharp 
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(Fig. 2.6A, right panel). Furthermore, the anatomical origin of the cardiac jelly ECM (Fig. 
2.2B) closely corresponds to that of the endocardial progenitors.   
Representative recordings of Tie1:H2B-YFP embryos, which were also 
microinjected with fluorophore-labeled ECM antibodies, were analyzed by manually 
tracking TIE1+ nuclei and ECM filaments. As Fig. 2.6B reveals, cell and ECM 
trajectories are surprisingly similar. This degree of similarity suggests that the active 
motility of future endocardial cells is small relative to the local ECM environment. To 
estimate active cell motility, at each recorded time point we subtracted the average 
displacement of nearby-traced ECM filaments from the observed cell displacements. As 
Figs. 2.6C and D demonstrate, the trajectories of active cell movements (red) are 
random, with little persistence compared to the trajectories of total cell displacements 
(green) corresponding to Fig. 2.6B. 
At HH9-10 the endothelial/endocardial progenitors form a vascular plexus 
(DeRuiter et al. 1993), associated with splanchnic mesoderm ventral to the foregut. 
Cells constituting this plexus engage in a midline-directed movement commencing at 
HH10 and continuing until at least HH12 (Supplemental Fig. 2.6). This movement also 
correlates in location and timing with the medial-ward ECM motion seen in Fig. 2.3.  
To characterize better the active movement of Tie1+ cells, we selected on 
average six, but at least four, embryos at each stage of heart development (ES1-7). We 
determined the local ECM movements by PIV analysis; YFP-expressing nuclei were 
tracked either by the automatic CIPA tracker (raw data not shown) or by PIV analysis 
(Supplemental Fig. 2.5, panel three). Active cell movements (Supplemental Fig. 2.5, 
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panel four) were established as the difference between the local (PIV- or CIPA-
estimated) cell-based and ECM displacement vectors.  This analysis reveals that while 
the total cell displacements (just like the ECM movements) are centripetal 
(Supplemental Fig. 2.5, ES3), active cell movements have a medially-directed bias in 
the medial-most regions of the omphalomesenteric veins (Supplemental Fig. 2.5, ES5), 
while in the more lateral aspects of these veins, such a medial bias is not observed. 
Cellular movement speeds, averaged from multiple specimens, are shown in Fig. 
2.7C. As expected, due to the local averaging, values obtained by PIV are somewhat 
smaller than the values obtained by the CIPA tracker, and both are higher than the 
values obtained for ECM displacements. The average speed of active cell movement 
decreases slightly from 20 µm/h to 15 µm/h between the early and later stages of heart 
development. The calculated mean speed of the lateral drift is 7 +/- 2 µm/h; thus 
fluctuations in cell speed are substantial, which is in agreement with the random walk-
like trajectories calculated in Fig. 2.6D (red plots). 
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Figure 2.5. Large-scale displacements of fibronectin and fibrillin-2 structures are 
identical.  
 
A, B: Fibronectin and fibrillin-2 immunostaining (inverted for better contrast) and their 
superimposed images (third column) are shown together with the corresponding PIV 
velocity vector map (fourth column). The embryos shown represent an early (ES1, panel 
A) and a later (ES7, panel B) stage of development. The velocity fields show fibronectin 
(red vectors) and fibrillin-2 (green vectors) movements in a selected frontal optical plane 
intersecting the forming heart. Vectors represent velocities as extrapolated 
displacements during one hour. The reliability of the vectors is indicated by color 
brightness. Overlap between the two colors appears as yellow. Dots indicate the 
absence of movement, i.e., velocities smaller than 10 µm/h. Scale bars ⎯ 100 µm.  C: 
Mean speed of centripetal ECM movements along the AIP and the inflow region, 
measured within locations similar to the indicated circles in panels A and B. For each 
endocardial stage of development, the average speed of ECM displacements is shown 
for both fibronectin (red) and fibrillin-2 (green).  The average magnitude of the difference 
between the two is presented in yellow. Error bars indicate SEM; distinct specimens 
were considered statistically independent. 
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Figure 2.5 
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Figure 2.6. TIE1+ endocardial progenitors are spatially segregated from the 
endothelial population and participate in coordinated midline-directed 
displacement along with the ECM in the adjacent tissue.  
 
A: Epifluorescent images of a Tie1::H2B-YFP transgenic embryo at early (HH8, left) and 
later (HH9, right) stages of development, with superimposed trajectories of endothelial 
and endocardial progenitors. Cell trajectories were obtained using the CIPA automated 
tracking software; the color-code conveys timing information as in Fig. 3. Scale bars ⎯ 
100 µm.   B: Trajectories of manually-traced Tie1::H2B-YFP pre-endocardial cells 
(green) are compared with those of fibrillin-2 filaments (red). C: Trajectories 
representing the total (green) and active (red) movements of tracked pre-endocardial 
cells. Trajectories shown in panel C are re-plotted in such a way that each cell starts 
from the origin (green trajectories). Active cell movements (red trajectories) were 
estimated by subtracting the local ECM movements at each frame from the total 
displacements. D: Mean displacement vs. elapsed time for the total (green symbols) 
and active (red symbols) cell movements. On a double logarithmic plot a line with slope 
1 (green line) indicates persistent motion (displacement and elapsed time are 
proportional), while a line with slope 1/2 (red line) indicates random walk (displacement 
is proportional to sqrt(t)). Error bars represent standard deviation, obtained from a pool 
of all tracked cells.  
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Figure 2.6 
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Figure 2.7. Active and total movements of Tie1::H2B-YFP pre-endocardial cells.  
 
A representative specimen is shown at an early (panels A and Aʹ′, ES 1) and a later 
(panels B and Bʹ′, ES 7) stage of heart development. Images in panels A and B show 
velocity vectors (red for ECM and green for cells) in a selected frontal optical plane 
intersecting the forming heart. Velocities are indicated as extrapolated displacements 
over a 1h long time period, the yellow square indicates a linear size of 100 µm. The 
reliability of the vectors is estimated by the contrast of the local fluorescence, and 
indicated as color brightness. The locally prevalent direction and speed of active cell 
movements was determined by averaging the vectors of active cell velocities within a 
radius of 100 µm. These vectors, projected to a frontal plane, are shown in Aʹ′ and Bʹ′, 
and thus represent the local directional bias of active cell movements. The color 
assigned to the vectors indicates the local standard deviation of active cell movements: 
blue and red colors indicate locally ordered (small standard deviation ⎯ vectors pointing 
in similar directions) and disordered movements, respectively. Notice the tendency to 
move towards the heart in the vicinity of the forming heart tube (asterisks). C: Speeds of 
active (bars 1 and 2) and total (bars 3 and 4) cell movements, the corresponding speed 
of ECM displacements (bar 6), and for comparison the calculated difference in the 
movements of the two ECM components (bar 5) are shown for the seven stages of 
endocardial development (See Supplemental Fig. 5). Cell displacements are estimated 
by two methods, PIV (bars 1 and 3) and automated cell tracking (bars 2 and 4), and 
yield similar results. 
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Figure 2.7 
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Tissue movements are able to convect passive objects 
 
To give further support to the idea that minimal autonomous directed motion is 
required from the endocardial cells to construct the heart, we tested whether passive 
objects placed in the vicinity of the precardiac mesoderm are transferred to the heart 
tube by means of global tissue flow. We performed the experiments using embryos 
(n=3) in which fibrillin-2 was immunolabeled at HH7-8- (right before or at ES1). 
Subsequently, latex beads, 6.5 µm, were placed under the endoderm by a series of 
microinjections. Delivery of the beads was targeted to the regions that correspond to the 
position of precardiac mesoderm at HH 7 as defined in recent fate mapping studies (Cui 
et al,  2009; Abu-Issa, Kirby, 2008). Time-lapse imaging commenced at HH8 (ES1-2) 
and continued until HH11-12 (ES7 and beyond). For analysis, we selected the groups of 
beads that moved towards the ventral midline and incorporated into the heart tube 
(based on subsequent confocal analysis). 
Beads placed caudal to the AIP entered the heart tube from the inflow end (e.g. 
the group of beads indicated with an (a) in Fig. 8). Beads positioned ventrally to the 
foregut at HH8 [groups marked with (b) and (c) in Fig. 8] were incorporated into the 
forming heart tube from its anterior (outflow) pole. Both outcomes correlate with the 
position-fates of the ECM in corresponding areas (Figs. 2.2 and 2.3). Moreover, PIV 
analysis of bead velocities results in similar values to those of adjacent fibrillin-2 ECM 
(data not shown). The calculated difference between the displacement vectors of the 
two components is less than 10% of the magnitude of total tissue displacements: a 
finding that also serves as a negative control for our active motility calculations. 
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Figure 2.8. Tissue motion transfers passive objects to the site of cardiogenesis. 
 
 A: Microinjected latex beads (green) within a HH8- embryo, also immunolabeled for 
fibrillin-2 (red). Arrows a-c indicate groups of beads that were incorporated in the 
forming heart tube at HH12. B: Confocal micrograph of the same embryo at HH12, 
immunostained with QH1 antibody. A 24 µm thick confocal stack through the heart tube 
was obtained along the dorso-ventral axis. The image shown is a maximum intensity 
projection, beads are shown in green, fibrillin-2 in red and QH1 in blue.  As determined 
by tracking the beads through the time-lapse image sequence, arrows a-c indicate 
identical groups of beads in both panels. In agreement to our results shown in Figs. 2 
and 3, the group of beads indicated by (a) entered the heart tube from the caudal end, 
and those indicated by (b) and (c) were included in the forming heart from the cranial 
pole. 
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Figure 2.8
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Discussion 
 
The source of early cardiac ECM 
 
At early stages, components of the primitive heart ECM (including ECM 
associated with the heart splanchnic mesoderm and endoderm) include collagens I, IV, 
fibrillins -1 and -2, fibronectin, and laminin (Drake et al., 1990). It is believed that many 
of these components persist and contribute to the cardiac jelly at tubular heart stages 
(reviewed in Little and Rongish, 1995). 
The current understanding of cardiac jelly formation between the myocardium 
and endocardium relies on the biochemical studies of Krug et al (1985). As the 
endocardial and myocardial tubes are fusing at the ventral midline, the myocardium 
secretes a thick acellular matrix that helps to separate the two cell layers of the heart. 
The cardiac jelly exists as the fusion between this larger myocardially-derived BM 
(having a lamina densa and an extended reticular lamina) and an attenuated, 
endothelial-associated BM (composed only of a lamina densa), but is not itself 
organized as a basement membrane-like structure (Kitten et al., 1987). 
The myocardium, however, does not secrete all components of the cardiac ECM. 
In rat embryos the mesoderm actively expresses fibronectin at the early primitive streak 
stages, but then this expression ceases at the pre-headfold stage. Fibronectin 
expression is resumed by endocardial cells in the early heart tube at the 5-somite stage 
(Suzuki et al., 1995), which morphologically corresponds to HH8+ in avians. The 
endocardium continues to actively express fibronectin until the 14-somite (HH11 stage). 
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In contrast, myocardial cells do not express fibronectin at any of these early stages of 
development. Thus, the endocardium is believed to be the main source of fibronectin in 
the cardiac jelly. 
In addition to ECM components produced “de novo”, in this work we demonstrate 
that fibronectin and fibrillin-2 filaments (both endogenous and exogenously-added), 
which are associated with the LPM at HH8, become incorporated into the cardiac jelly 
by HH11. The ratio of the transported and newly-synthesized ECM is difficult to 
estimate. Our time-lapse recordings as well as confocal microscopy studies indicate that 
the incorporated, endogenous, labeled ECM is abundant enough to form an ECM-dense 
layer that is continuous at the resolution of optical microscopy. 
 
ECM movements 
 
This work represents the first demonstration of ECM filaments being translocated 
and incorporated into a future organ. Our group has previously shown that fibrillin or 
fibronectin-containing ECM fibrils are convected during primitive streak formation and 
gastrulation (Zamir et al., 2006; 2008) and vertebrate axis formation (Czirok et al., 
2004). Further, recent work by others showed fibronectin fibrils are translocated in the 
presomitic mesoderm during avian axis elongation (Benazeraf at al., 2010).  
Like cardiac precursor cells, ECM filaments are displaced and enter into the 
forming heart tube at both the anterior and posterior regions. The ECM is added to the 
elongating heart tube concomitantly with the addition of cardiac segments. The area of 
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the LPM that contributes ECM to the forming heart closely corresponds to the fate map 
of myocardial precursors (Cui et al., 2009) and our data on endocardial precursor cell 
origin (See Fig. 6). Like the cells contributing to the primary heart field, the ECM fibrils 
come from specified regions of the embryo and maintain their anterior-posterior 
relationships to one another (Figure 2.2). Thus, both cellular and ECM fate maps have 
three somewhat overlapping regions which distribute to different portions of the heart 
along the anterior-posterior axis. The ECM and cells contributing to the anterior portion 
of the Stage 10 heart tube were observed in the anterior-most “arch” spanning the 
embryonic midline (Figs. 2.2 and 2.6).  
 
ECM movements and morphogen gradients 
 
The maintenance of anterior-posterior positional order during the time the cardiac 
jelly (fibronectin and fibrillin-2) is accumulated (Fig. 2.2) has implications for the 
establishment/maintenance of ECM-bound morphogen gradients. If gradients of 
morphogens are “pre-established” outside of the forming heart tube, and if the ECM-
bound morphogens are then swept into the heart with the same relative positions, a 
corresponding anterior-posterior morphogen gradient may be maintained. Similarly, any 
left/right asymmetry in the distribution of ECM molecules/bound morphogens in the 
lateral plate would likely be maintained in the heart tube.  
Although we have no direct evidence that fibronectin and/or fibrillin-2 are binding 
morphogens key to heart morphogenesis, other studies have shown that fibronectin 
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controls the availability of growth factors such as TGFbeta (Fontana et al., 2005; Leiss 
et al, 2008), and can bind VEGF (Wijelath et al. 2002), in some cases acting in a 
synergistic manner with heparan sulfate (Stenzel et al., 2011). In addition, although this 
study focused on the movements of fibronectin and fibrillin-2, we propose that other 
ECM components (including those that bind morphogens) likewise are displaced as part 
of an interconnected ECM scaffold; indeed it is difficult to argue that the ECM does not 
move as a composite material.  
In general terms, the cells closest to a source of a given morphogen are believed 
to be exposed to a higher concentration gradient of that morphogen. Thus, endocardial 
cells moving with their nearby ECM (and any ECM bound morphogens) toward the 
midline have the potential to be exposed to a relatively “static” morphogen level, 
provided the morphogen bioavailability also remains constant. The degree to which cells 
are sensitive to the ECM-bound morphogens is influenced by numerous factors, 
including: 1) the rate of morphogen accumulation, 2) the time between morphogen 
secretion and binding to the ECM, 3) the length of time a given morphogen remains 
bound to the ECM, 4) the spatiotemporal activity of potential proteolytic enzymes, 5) the 
“half-life of the morphogen in solution, 6) the location of binding partners/receptors and 
7) the morphogen diffusion rate (Yu et al., 2009; Drocco et al., 2011). Thus, although 
potential target cells and ECM-bound morphogens move together, it is entirely possible 
that the displacements of the ECM could have little bearing on the morphogen gradient. 
If a morphogen is secreted by a cell and is quickly bound to nearby ECM, and if that 
morphogen remains bound for only a short period of time, then the movement of the 
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ECM is not a major influence on the repositioning of the morphogen (i.e. the morphogen 
is not “carried” by the ECM any substantial distance).  
The fact remains that the ECM is highly dynamic, and that at the tissue-level 
scale, its movements are predictable and reproducible (Fig. 2.2). These empirical data 
indicate the need to study cell signaling within the context of a physiologically relevant, 
highly dynamic ECM environment. 
 
The source of endocardial cells 
 
Cardiac progenitors are among the first cell populations to undergo ingression 
through the primitive streak, which in turn is followed by their rapid anterior and lateral 
movements. Subsequently, cardiac progenitor cells, i.e. those cells that will reside in the 
midline heart tube by HH 10, assume their temporary residency within a specific area of 
the anterior lateral plate splanchnic mesoderm, generally referred to as the primary 
heart field. It is a widely-held belief that early in avian cardiovascular development (HH 
5), both the myocardial and endocardial cells are found in this primary heart-forming 
region. However, recent work by Tzahor and colleagues (Milgrom-Hoffman et al., 2011) 
in the chick embryo indicate the endocardial-forming field is situated outside of the 
cardiac crescent, and is continuous with the vascular endothelial plexus. Their work 
suggests an endothelial origin of the endocardium. Thus, controversy still exists over 
when and where the two avian cardiac lineages and the endothelial lineage(s) are first 
specified and the exact location and extent of the respective precursor fields (Cui et al., 
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2009; reviewed in Harris and Black, 2010). In contrast, in zebrafish the endocardium 
originates from a distinct region in the anterior cardiogenic mesoderm, located more 
rostral than the source of myocardial progenitors (Bussmann et al., 2007; Schoenebeck 
et al., 2007). 
Regardless of when and where the endocardial precursors are first specified, the 
endocardium arises through a process of de novo vasculogenesis from a distinct 
population of precursors in the anterior lateral plate mesoderm. We have demonstrated 
that pre-endocardial cells and vascular endothelial cells are separated by a sharp 
horseshoe-shaped boundary within the anterior LPM (Fig. 2.6). We believe that cells 
located on the “endocardial” side of this boundary are subject to the midline-directed 
tissue movement. While we are not in a position to claim that position fate is the only 
determinant of these two cohorts of Tie1+ precursors, we do believe that position fate 
plays an important role in the formation of blood vessels versus the endocardium. 
The endocardial tube is formed from the bilateral field of endocardial precursors 
by the centripetal movement of these cells along the posterior margin of the anterior 
intestinal portal; importantly the cells positioned at the midline and lateral margins 
appear to move with the same speed. After HH10, as the endocardial tube continues to 
elongate, we see cells contributing to the endocardium from the closely associated 
vascular plexus located ventral to the foregut endoderm (Supplemental Fig. 2.6). 
By developing a system of substages between HH8- to 11 (Supplemental Fig. 
2.5), which better characterize endocardial morphology, we show the reproducibility in 
the progression of endocardial formation from a scattered pool of precursors initially 
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located between the anterior LPM and endoderm. The seven substages, which we refer 
to as ES1 - ES7, are distinguishable from one another by the characteristics of the Tie+ 
positive cells and the morphological events that are occurring concomitant with 
endocardial morphogenesis. As discussed in detail in the results, defining 
characteristics included the number, location and organization of the Tie+ endocardial 
precursors as well as the general morphology of the cranial embryo as it relates to 
elongation of the foregut, regression of the anterior intestinal portal, and elongation of 
the endocardial tube and cardiac bending. 
 
Tissue and active cell movements 
 
The most likely interpretation for the shared large-scale movement pattern 
between the two ECM components and endocardial progenitors is a model whereby the 
whole tissue (cells and the associated ECM as a composite material) moves and 
deforms in response to mechanical forces, exerted by cells within the heart field or in 
adjacent tissue layers. The finding that microinjected inert objects also translocate to the 
forming heart, in an identical manner, is entirely consistent with such a view. In previous 
works, we have operationally defined “tissue motion” as the coordinated movements of 
cells and their local ECM environment (Zamir et al., 2006; 2008; Czirok et al., 2006; 
Perryn et al., 2008; Sato et al., 2010). Displacements associated with tissue motion are 
correlated over large distances, up to a several hundred microns (Szabo et al., 2011). 
As we have shown in this work, active motility of endocardial progenitors, defined as the 
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difference between the local cell and ECM displacements, is much smaller and more 
random than the movements characterizing tissue deformation. The randomness and 
smaller scale of active cell movements was recently also demonstrated for cells of the 
pre-somitic mesoderm (Benazeraf et al., 2010). 
Although our work clearly shows that tissue motion predominates in the 
repositioning of pre-endocardial cells to form the midline endocardial tube, it is important 
to determine what role the cell autonomous motility plays in endocardial morphogenesis. 
The random active cell movements can play an important role in the reorganization of 
the local ECM. At later stages of cardiac development, the observed directional 
component of the autonomous motion may be critical for the precise repositioning of the 
precursors. The calculated autonomous speeds of 20 µm/h are in the same range as 
those reported for endothelial cells moving in culture (10 µm/h: Szabo et al., 2010, 50 
µm/h: Kouvroukoglou et al., 2000). In comparison, the active movement of gastrulating 
mesoderm cells are somewhat faster, in the range of 60 µm/h (Zamir et al., 2006).  
The driving forces for endocardial progenitor motion are likely to differ between 
avian (and other higher vertebrate) embryos and zebrafish; the latter model system has 
been used for studies of endocardial morphogenesis in a number of recent studies 
(Bussmann et al., 2007; Schoenebeck et al., 2007; Fish et al., 2011). Even though many 
aspects of cardiac development are very similar in zebrafish and avians (reviewed in 
Alexander and Stainier, 1999), some significant differences exist and must be taken into 
account. For instance, Bussmann et al. (2007) described two facets of endocardial 
morphogenesis distinct in zebrafish and higher vertebrates. First, unlike in avian 
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embryos, zebrafish endocardial progenitors engage in posterior movements from the 
discrete region they occupy in the cardiogenic mesoderm to the site of the heart tube 
assembly. Second, in contrast to our results in the avian embryo, in fish embryos, 
endocardial precursors appear to rapidly migrate to the site of heart tube formation, 
where they arrive and form a sheet prior to the formation of bilateral myocardial 
primordia and initiation of their midline-directed movements (Bussmann et al., 2007). 
After their arrival at the ventral midline, endocardial cells direct angular movements of 
myocardial progenitors in zebrafish (Holtzman et al., 2007). Bussmann et al. also 
pointed out the virtual absence of dynamic imaging-based studies of endocardial 
progenitor motion in avian or mouse embryos, a gap that the current study aims to help 
fill. 
In contrast to zebrafish endocardial morphogenesis, assembly of the avian 
endocardium occurs simultaneously with that of the myocardium, and both cell types 
simultaneously engage in antero-medial motion. This points to myocardial movements 
as the potential driving force for tissue motion, a force in turn that leads to endocardial 
cell displacements. The coordinated movements of myocardial cell populations were 
indeed suggested to “drive” the formation of the heart tube in chick (DeHaan 1963) and 
in rat (Suzuki et al., 1995). However, since the endocardial cells are clearly moving with 
the associated ECM, such a mechanism would require another adhesion substrate, i.e., 
a layer of ECM distinct from the one associated with the endocardial precursors. Our 
monoclonal antibody labeling of endogenous fibrillin-2 and fibronectin do not show such 
distinct ECM layers in optical or physical sections. Potentially myocardial progenitors 
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could move relative to ECM components not fluorescently labeled in this study. 
However, given the importance of fibronectin for myocardial movements (Linask and 
Lash, 1986; Trinh and Stainier, 2004) one would expect myocardial progenitors to rely 
on it as the adhesion substrate, at least in part. Surprisingly though, our recent 
preliminary data suggest that myocardial cell movements relative to fibronectin ECM are 
relatively small, and are very similar in speed and magnitude to endocardial precursor 
active movements.  
Another tissue candidate potentially responsible for driving tissue movement in 
the anterior embryo is the endoderm. This function would complement an important 
signaling role of the endoderm in cardiac development, reported for zebrafish, Xenopus, 
chick and mouse (Lough and Sugi, 2000). In avian embryos (as well as mouse and 
human), the endoderm undergoes a series of morphogenetic movements, involving 
dramatic tissue folding events, to form the gut tube. Elongation of the formed gut 
involves rapid posterior movement of the anterior intestinal portal (AIP), concomitant 
with narrowing of the endodermal tube.  The foregut and the heart tube are physically 
associated via a mesentery (dorsal mesocardium) throughout the initial cardiac 
assembly stages, making the movements of the endoderm and cardiogenic mesoderm 
tightly coupled.  
The mechanisms that drive foregut assembly and elongation remain poorly 
understood in avian and mammalian systems. Stalsberg and DeHaan (1968) suggested 
that in avians, the foregut elongates as a result of tension applied at the anterior 
intestinal portal, and the tension arises from the regression of the primitive streak and 
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elongation of the notochord. The same force may be transmitted to the subjacent 
splanchnic mesoderm (including cardiogenic mesoderm), acting to drag that layer 
medially and caudally (Stalsberg and DeHaan, 1968). In the mouse, foregut and heart 
tube formation were suggested to depend upon visceral extraembryonic endoderm 
movements (Narita et al., 1997). Further, in studies in which the transcription factor 
GATA4 (expressed in precardiac splanchnic mesoderm and foregut endoderm) has 
been knocked out, visceral endoderm defects, gut malformations, and abnormal heart 
morphogenesis result (Kuo et a., 1997; Molkentin et al., 1997; discussed in Rojas et al., 
2010). The authors demonstrate that GATA4 has a role in the formation of the anterior 
intestinal portal, and subsequent foregut and heart tube morphogenesis via a role in 
lateral to ventral folding. The mechanism of gut formation is different in zebrafish and 
Xenopus, where the endoderm forms from a “rod” of cells, which develops a lumen and 
gives rise to the gut tube (reviewed in Spence et al., 2011).  
Recently the local residual stresses were mapped in the early epiblast and a 
tissue mechanical model was proposed for headfold formation (Varner et al., 2010). We 
expect an approach similar to Varner and colleagues would aid in our understanding of 
the underlying mechanisms of foregut formation and its possible role in driving cardiac 
progenitor displacements to the ventral midline.  
The work presented here lays the basis for our ongoing and future studies aimed 
at the characterization of the relative movements of endocardial and myocardial 
progenitor cells, their ECM environment and surrounding non-cardiac cell populations in 
live developing avian embryos. In addition to experimental embryology and imaging 
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approaches, it is clear that mathematical modeling will prove useful in determining what 
biophysical mechanism(s), such as force generation, are necessary to form the cardiac 
tube at the midline. 
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Supplemental figures 
 
 
Figure S2.1. Fluorescent antibody-mediated in vivo labeling of ECM, combined 
with epifluorescence time lapse microscopy, provides sufficient resolution to 
allow tracing of ECM aggregates (fibrils) in time and space.  
 
Top panels demonstrate individual frames from a time-lapse image sequence, 
describing the development of a quail embryo with the fibrillin-2 ECM labeled (in vivo) 
using JB3 antibody-AlexaFluor488 conjugate. Bottom panels contain the regions 
delineated with rectangles in each of the top panels. Time elapsed from the beginning of 
image acquisition is indicated in the top left corner of each image. Example ECM 
aggregates with recognizable morphology are demarcated with red, blue, and green 
ellipses in each of the bottom panels, with each color corresponding to the same ECM 
aggregate in every image. Scale bars – 100 µm. 
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Figure S2.1 
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Figure S2.2. Image processing workflow to analyze cell and ECM displacements 
during heart formation. 
 
 A: Block diagram representing the various stages of data analysis. The process is 
demonstrated through images shown in panels B-J. B: Image pairs characteristic for a 
certain stage of heart development are selected. The two sets of images were acquired 
20 minutes apart, in multiple focal (Z) planes and multiple microscopy modes. Here two 
deconvolved sections are shown, characteristic for an endocardial stage (ES) 3 heart. 
The red and green channels represent fibronectin immunofluorescence and TIE1 
positive nuclei, respectively. C: By a manual masking procedure, image regions are 
selected that contain either the forming heart (Ca), or the paraxial or somitic mesoderm 
for anatomical reference used later (Cb). Images shown are obtained from panel Ba: a 
similar procedure is applied for the image shown in panel Bb. D: PIV displacement 
estimation for the TIE1+ nuclei (Da), pre-cardiac ECM (Db) and reference ECM (Dc). 
The images depict the analyzed fluorescence pattern both at the earlier (red) and later 
(green) time points. The PIV-derived displacement vectors are represented with white 
lines, with a circle at their end point. Areas shown in higher magnification allow the 
comparison of the PIV vectors with the corresponding patterns. Easily recognizable 
patterns are marked by cyan circles. E: The PIV data are weighted by the local standard 
deviation of the immunofluorescence intensity. Here the weights are represented as 
gray scales: white vectors represent highly reliable data obtained from detail-rich areas, 
while black (or transparent) displacement vectors indicate data obtained from low signal 
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areas. F: Cell (green) and ECM (red) displacement data in a reference system co-
moving with the embryonic axis. Thus, the lateral shift of the embryo apparent in Panels 
Dc and Ec was compensated for. The square represents an area of 100 mm X 100 mm. 
G: Active cell movements (white), calculated as the difference of the apparent cell 
displacements (green) and ECM displacements (red) displayed in panel F. 
Displacements smaller than 10 µm are represented as dots. H: Individual displacements 
of TIE1+ nuclei, obtained using the automatic CIPA tracker. Two deconvolved images 
acquired within three minutes are shown, the earlier in the red and the later in the green 
channel. The CIPA-predicted displacements are represented as white tracks with the 
current location denoted by an open circle. I: Active movement of TIE1+ cells (white), 
calculated as the difference of the apparent CIPA-predicted displacements (green) and 
PIV-predicted ECM displacements (red). J: As the CIPA-predicted displacement vectors 
may point in various directions even within a small area (asterisk), we obtained the 
locally prevalent direction and speed of active motion by replacing each vector by a 
local average within a 100 µm radius. To show how disorganized the initial set of 
vectors within the zone of averaging are, we plot the standard deviation of the set as a 
color code. Red colors represent smaller standard deviation (hash mark), while blue 
colors designate more disoriented movements (asterisk). 
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Figure S2.2A 
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Figure S2.2B, C, D, E 
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Figure S2.2F, G, H, I 
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Figure S2.3. Fluorescently labeled human fibronectin incorporates into the quail 
fibronectin network and participates in tissue displacements.  
 
Fluorophore-conjugated human fibronectin (green) was injected into the LPM at the 
embryonic left (observerʼs right) side of a HH6 quail embryo (A). The site of injection is 
demarcated with the rectangle and shown in higher magnification in (C). A 10-fold 
higher amount of fluorescent BSA (green) was injected at the embryonic right 
(observerʼs left) side. The endogenous fibronectin network was immunolabeled by B3D6 
antibody (red). Images in (B) were taken 7 hours after injection. Note the characteristic 
network-like arrangement of exogenous (green) fibronectin that undergoes deformations 
and displacements concomitantly with the endogenous quail ECM. BSA did not form 
any pattern upon injection, and was not detected in the embryo after 7 hours. Scale bars 
⎯ 100 µm.  
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Figure S2.3 
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Figure S2.4. Exogenous fibronectin can incorporate into both myocardial and 
endocardial sides of the cardiac jelly when delivered in large quantities. 
 
The anterior lateral plate mesoderm of a quail embryo was injected with 200-250 ng of 
fluorescent human fibronectin at HH7. After fixation at HH11, 10 µm transverse 
cryosections were prepared. A-C are transverse sections through the heart tube at the 
levels schematically shown in D. The immunolabeled endogenous fibronectin is shown 
as green (right panels of A-C). The exogenous fibronectin (red) is associated with both 
myocardial (asterisks) and endocardial cell layers. e: endocardium, m: myocardium, cj: 
cardiac jelly. Scale bars – 40 µm. (D) is modified from Lillie, 1930. 
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Figure S2.4 
 
 
 
 
 
 
 
 
	   87	  
 
Figure S2.5. Stages of endocardial morphogenesis between HH8- (ES1) and HH11 
(ES7).  
 
Left panels show DIC images, the second column contains epifluorescence images with 
ECM (fibronectin or fibrillin-2) in red and nuclei of endothelial/endocardial cells in green. 
The third panel (derived from PIV data) demonstrates corresponding cell (green) and 
ECM (red) movements within selected frontal planes as vectors extrapolating 
displacements for a 1h time period. The reliability of the vectors is estimated by the 
contrast of the local fluorescence, and indicated as color brightness. The locally 
prevalent direction and speed of active cell movements was determined by averaging 
within a radius of 100 µm the vectors of active cell velocities. These vectors, projected 
to a frontal plane, are shown in panel 4, and thus represent the local directional bias of 
active cell movements. The color assigned to the vectors indicates the local standard 
deviation of active cell movements: blue and red colors indicate locally ordered and 
disordered movements, respectively (see Fig. 2.7 and Supplement Fig. 2.2J). Notice the 
tendency to move towards the heart in the vicinity of the forming heart tube (asterisks). 
HF - headfold, AIP - anterior intestinal portal, NC - notochord, VV - vitelline 
(omphalomesenteric) veins, HT - heart tube, DA - dorsal aortae. Scale bars - 100 µm.  
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Figure S2.5A 
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Figure S2.5B 
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Figure S2.6. An extensive vascular plexus is flanking the forming heart tube at 
HH10 and later.  
 
DIC (A) and epifluorescence (B) image of a Tie1::H2B-YFP transgenic embryo at HH11. 
Panel C represents a magnified region delineated with a rectangle in (B). Note a large 
number of endothelial/endocardial progenitors located ventrally to the foregut:  a 
population that engages in movement towards the anterior heart tube at the same time 
as similarly positioned ECM fibrils do (Fig. 3). Scale bars ⎯ 100 µm.   
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Figure S2.6. 
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CHAPTER THREE: 
 
Coordinated deformation of myocardial progenitor fields precedes 
their fusion at the midline, and contributes to the heart tube formation 
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Abstract 
 
Development of a contractile layer of the heart, the myocardium, involves the movement 
of bilateral progenitor fields to the embryonic midline. The driving forces for this antero-
medial movement have been researched and debated for almost a century. In the 
current study, we demonstrate that myocardial progenitor fields undergo a series of 
coordinated deformations that are able to propel their displacements in the anterior 
direction. These deformations are independent of the endoderm folding during foregut 
formation, which drives the medial component of the myocardial displacement. 
Collectively, these two events contribute to the displacement of myocardial primordia to 
the site of heart tube assembly. By co-labeling myocardial progenitors with either 
fibronectin ECM or the endoderm in live quail embryos, we demonstrate that motion of 
all three components to the midline is largely coordinated during heart tube assembly 
stages. At the same time, myocardial cells demonstrate distinct anterior-directed 
movement relative to the endoderm. We describe cell rearrangements at the medial 
myocardial field edge that mediate its contraction (shortening). Based on the results of 
mechanical perturbations that remove the constraining influences of the surrounding 
tissues on the heart fields, and computational modeling, we propose that uniform 
deformation (curling) of the myocardial sheet can drive the anterior-directed movement 
of the heart fields. The same activity in the context of the surrounding mesoderm also 
explains the observed c-shaped folding of the myocardium in the dorsal direction (a 
feature that naturally develops within the cardiogenic mesoderm in caudal to cranial 
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progression; van den Berg et al., 2009; Abu-Issa and Kirby, 2008).  
We conclude that antero-medially directed movement of cardiac progenitor fields 
to the site of tubular heart assembly relies on a coordinated influence from: 1) endoderm 
folding and foregut elongation that drive the convergence at the midline, and 2) 
deformations intrinsic to the myocardial primordia that mediate apparent movement in 
the anterior direction, and reposition the myocardia along the dorso-ventral embryonic 
axis, to achieve the optimal orientation for their fusion at the midline. Finally, in contrast 
to previous suggestions, we see little evidence of active (relative to the ECM) migration 
of myocardial cells in avian embryos. 
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Introduction 
Early formation of a vertebrate heart includes a sequence of carefully timed and 
regulated cell movements. In chick, cardiac progenitors (including both endocardial and 
myocardial precursors) are among the first to ingress through the primitive streak during 
gastrulation. From the primitive streak pre-cardiac cells travel to the anterior lateral plate 
mesoderm, where they organize into the bilateral cardiogenic, or heart, fields.  Later, the 
two heart fields translocate to the embryonic midline and fuse to give rise to the tubular 
heart (reviewed in Fishman and Chien, 1997; Opitz and Clark, 2000; Abu-Issa and 
Kirby, 2007). In avians and mammals convergence of cardiac progenitor fields at the 
midline occurs in a very morphologically complex tissue environment. Firstly, the 
developing heart tube in these organisms is physically linked to the forming foregut via a 
mesentery. The foregut is lined by endoderm, which forms through three-dimensional 
tissue folding, followed by rapid elongation (Stalsberg and DeHaan, 1968, Varner et al., 
2012). Mechanisms of foregut formation, and the positional relationship between the 
developing foregut and heart in zebrafish and Xenopus differ from those in avians and 
mammals (Wallace and Pack, 2003; Reed et al., 2009; Spence et al., 2011). 
Secondly, throughout their movement to the embryonic midline, myocardial 
progenitors remain incorporated into a cohesive epithelial sheet, continuous with the 
adjacent splanchnic mesoderm that will form the muscular wall of the foregut (Bellairs 
and Osmond, 2005). Integrity of epithelial organization (maintained through interactions 
with fibronectin ECM) was shown to be critically important for myocardial movements 
(Trinh and Stainier, 2004). Several studies proposed that myocardial progenitors 
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actively propel the midline-directed movement of cardiogenic fields (DeHaan, 1963; 
Rosenquist and DeHaan, 1966; Wiens 1996). Myocardial migration was suggested to 
be a major force for heart tube assembly; occuring relative to the underlying endoderm 
of the foregut, with fibronectin as a possible source of the directional information (Linask 
and Lash, 1986; Linask and Lash, 1988a; Linask and Lash, 1988b).  
Recently, Varner et al. (2012) challenged this view by providing evidence for a 
primary role of endoderm contraction in driving convergence of heart fields at the 
midline. These authors, however, did not exclude the possibility that myocardial 
progenitors may play a role in this process, in addition to or parallel to that of the 
endoderm. Therefore, the extent to which myocardial progenitors are involved in 
mediating their relocation to the site of tubular heart assembly remains to be 
determined. Also, very little is known of individual cell behaviors of differentiating 
myocardial cells within the progenitor field en route to the embryonic midline. 
In the current study, we demonstrate that myocardial progenitor fields undergo a 
series of coordinated deformations that are able to propel their displacements in the 
anterior direction. These deformations are independent of endoderm folding during 
foregut formation, however both contribute to the displacement of myocardial primordia 
to the site of heart tube assembly. By co-labeling myocardial progenitors and fibronectin 
ECM or the endoderm in live quail embryos, and employing a particle image velocimetry 
(PIV)-based motion analysis algorithm (Aleksandrova et al., 2012), we demonstrate that 
motion of all three components to the midline is largely coordinated in HH8-9 quail 
embryos. At the same time, myocardial cells demonstrate anterior-directed movement 
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relative to both substrata. We describe cell rearrangements and shape changes that 
occur at the medial edge of the myocardial field and mediate its contraction. Using 
mechanical perturbations to remove the constraining influences of the surrounding 
tissue, we demonstrate that isotropic deformation (curling) of the myocardial sheet in a 
dorsal direction (a feature that naturally develops within the cardiogenic mesoderm in 
caudal to cranial progression; van den Berg et al., 2009; Abu-Issa and Kirby, 2008) can 
drive the movement of the myocardial field forward past the incision site. We use 
computational modeling to confirm that folding of the myocardial sheet in a ventral 
direction in combination with its contraction along the medial edge can reproduce the 
behavior of myocardial progenitor fields during normal cardiogenesis, as well as in 
mechanically perturbed states. Finally, using pharmacological inhibitors, we compare 
the sensitivity of endodermal and myocardial tissue contractility to perturbation of the 
actin cytoskeleton, cell proliferation, Rho kinase (ROCK) signaling and focal adhesion 
kinase function. 
We conclude that antero-medially directed movement of cardiac progenitor fields to the 
site of tubular heart assembly relies on a coordinated influence from: 1) endoderm 
folding and foregut elongation that drive the convergence at the midline, and 2) 
deformations intrinsic to the myocardial primordia that mediate apparent movement in 
the anterior direction, and reposition the myocardia along the dorso-ventral embryonic 
axis, to achieve the optimal orientation for their fusion at the midline. 
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Experimental Procedures 
 
 
 
Quail embryo preparation 
 
Fertile wild type quail (Coturnix coturnix japonica) eggs (Ozark Egg Co., Stover, 
MO) were incubated for varying periods of time (from 20 to 36 h) at 37°C to reach 
stages HH6 to HH11 (Hamburger and Hamilton, 1951). Embryos were then isolated and 
cultured as in Cui et al., 2009 (modified EC culture; Chapman et al., 2001). 
 
Plasmid generation and transfection for myocardial progenitor labeling 
 
Genomic DNA was prepared from three HH12 chick embryos using Tri Reagent 
(Sigma) according to the manufacturerʼs instructions. Primer sequences                                    
5ʼ-	  AAAAAATTAATCAAGGCTATGACTGCTGGAGTG-3ʼ and                                        
5ʼ-AAAAAGCTAGCCAGAGGTGCTGGTGGTGCTG-3ʼ were used to PCR amplify the 
region between -931 and +56 of Cardiac Myosin Light Chain 2 (CMLC2) gene. This 
region was defined based on significant sequence and regulatory element position 
correspondence to the well-characterized CMLC2 promoter in zebrafish (Huang et al., 
2003). To generate pCMLC2::EGFP plasmid, CMLC2 promoter was subcloned into 
pEGFP-C1 vector (Clontech) between AseI and NheI restriction sites in place of the 
CMV promoter. To generate pCMLC2::MitoRFP, CMLC2 promoter was similarly 
subcloned into pEGFP-N1 vector (Clontech) between AseI and NheI sites. Then, EGFP 
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ORF was replaced by the cassette consisting of a mitochondrial localization signal fused 
to RFP (MitoRFP) using XhoI and NheI restriction sites. MitoRFP cassette was derived 
from pCoxIV-RFP (a generous gift from Dr. Rusty Lansford, University of Southern 
California). To generate constructs for myocardial-specific expression of constitutively 
active (caRho) and dominant negative (dnRho) variants of RhoA we placed chicken 
CMLC2 promoter to substitute for the original chicken beta-actin promoter into RhoA-CA 
and RhoA-DN constructs described in Rupp and Kulesa, 2007 (plasmids were a kind gift 
from Dr. Paul Kulesaʼs laboratory). CMLC2 promoter sequences were obtained by PCR 
amplification from pCMLC2::mito-RFP plasmid using primers                                          
5’-AAAAAATTAATCAAGGCTATGACTGCTGGAGTG-3’ and                                        
5’-AAAAAGCTAGCCAGAGGTGCTGGTGGTGCTG-3’. PCR product was digested with 
AseI/NheI and cloned into the corresponding restriction sites of the RhoA-CA and 
RhoA-DN constructs.  
For transfection, plasmid DNA was delivered into the sub-endodermal space of 
HH6 quail embryos in complex with Lipofectamine 2000 (Invitrogen) by microinjection 
using a PLI-100 (Harvard Instruments) apparatus. Embryos were incubated at 37°C until 
the fluorescent signal from reporter expression became detectable, usually 4-5 h.  
 
Immunofluorescent labeling of ECM in vivo 
 
Monoclonal antibodies directed against fibrillin-2 and fibronectin ECM proteins 
(JB3, B3D6; Rongish et al., 1998, Czirok et al., 2006; DSHB, Iowa City, IA) or a quail 
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endothelial cell surface marker (QH1; Pardanaud et al., 1987; DSHB) were directly 
conjugated to AlexaFluor 488, 555 or 647 (Molecular Probes) according to the 
manufacturerʼs instructions. The direct conjugates were injected into the lateral plate 
mesoderm as 5-40 nl boluses using a PLI-100 (Harvard Instruments) microinjector as 
described in Little and Drake, 2000. Microinjections were performed 30-60 minutes prior 
to the beginning of the image acquisition to allow for antibody diffusion and antigen 
binding. 
Endoderm labeling in vivo 
MitoTracker® Green FM dye (Invitrogen) was diluted in DMSO to 1 mM 
concentration according to the manufacturerʼs recommendations. Obtained stock 
solution was further dissolved to 500 nM in PBS. HH8 embryos, placed on paper rings 
as described above, were submerged into the resultant solution with ventral side down, 
and placed into a humidified incubator at 37°C for 30 min. Following three 5 min washes 
with PBS at room temperature, the quality of labeling and integrity of the endoderm in 
each embryo was assessed under a Leica DM6000 epifluorescent microscope. 
 Wide-field time-lapse imaging 
Automated microscopy of immunolabeled quail embryos was performed as 
described elsewhere (Czirok et al., 2002; Zamir et al., 2008). To enhance contrast, 
selected epifluorescence image stacks were deconvolved by a commercial, blind 
adaptive deconvolution software (Autoquant X, MediaCybernetics). Manual tracing of 
image details was performed using custom software (see, e.g., Czirok et al., 2004).  
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Post-fixation immunofluorescence labeling 
 
Embryos were fixed and prepared for immunolabeling according to Little and 
Drake, 2000. Monoclonal antibodies against avian epitopes (JB3, B3D6, QH1; DSHB, 
Iowa City, IA), directly conjugated to AlexaFluor 488, 555 or 647, were added at 1:1000 
dilutions; rabbit polyclonal anti-GFP antibody, conjugated to AlexaFluor 488 (Molecular 
Probes, Eugene, OR) – at 1:400, and mouse monoclonal antibody MF20 (DSHB, Iowa 
City, IA) – at 1:10 dilution in 3% BSA for overnight incubation. Goat anti-mouse 
secondary antibodies, conjugated to AlexaFluor 488, 555 or 647 (Molecular Probes, 
Eugene, OR), were used to follow the MF20 staining at 1:10 dilution in 3% BSA. Nuclei 
were counterstained with 4ʹ′,6-diamidino-2-phenylindole (DAPI) at 500 nM in PBS.  
 
Confocal imaging 
 
Confocal imaging of whole-mount embryo specimens was performed using a 
Nikon 90i upright microscope with a Nikon C1 confocal scan head and Nikon Plan 
Apochromat 10x and 20x objectives. 
 
Preparation of transverse plastic sections 
 
Embryos were dehydrated through the graded ethanol series, placed in JB4 
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infiltration medium (Electron Microscopy Sciences, Hatfield, PA) at 4ºC overnight, and 
embedded in JB-4 resin following manufacturerʼs protocol. Subsequently, 10μm 
sections were prepared. 
 
Pharmacological inhibitor treatments  
 
The following inhibitors were used in this study: Cytochalasin D (actin polymerization 
inhibitor; Sigma), Y27632 (ROCK inhibitor; Sigma), PF 573228 (FAK inhibitor; Tocris 
Bioscience), Mitomycin C (DNA cross-linking agent; Sigma). Stock solutions were 
prepared at 10-100 mM concentrations in DMSO or ddH2O following manufacturerʼs 
instructions for each reagent. Stock solutions were then diluted in PBS to 10 µM – 1mM 
working concentrations as specified in the Results section for each experiment. 20-30 µl 
of reagent solutions or solvent controls were delivered by pipetting to the ventral surface 
of embryos in EC culture. 
 
Microincisions 
 
50 – 800 µm cuts through the endoderm and adjacent splanchnic mesoderm of 
HH8 embryos were performed under a Leica stereomicroscope using tungsten needles. 
Embryos were then incubated at 37ºC on a microscope stage (Czirok et al., 2002; 
Zamir, et al., 2008) for 0.5 – 1.5 h prior to initiation of time-lapse image acquisition. 
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Particle Image Velocimetry (PIV) analysis 
 
We used the two step algorithm of Zamir et al., 2005; implemented in MatLab 
(Mathworks, Inc.) and as described in Aleksandrova et al., 2012. Briefly, images were 
divided into overlapping tiles, each 75 μm wide. The displacements of the tiles were 
determined by cross-correlation analysis; for each tile we searched the next image for 
the location that exhibited the most similar intensity pattern. The resulting displacement 
vectors were then interpolated and denoised by a thin-plate spline fit, yielding our 
coarse displacement map. This map was used to construct a second, higher resolution 
one. The cross-correlation procedure was repeated with tiles that were only 30 μm wide. 
To reduce ambiguities associated with smaller tiles (patterns within smaller tiles are less 
unique), the subsequent image was scanned only in the vicinity of positions predicted by 
the coarse map. In this study we did not apply a final smoothing (spline fitting) step, but 
kept the results of the second cross-correlation analysis.  
 Within the whole embryo, the ECM label was highly non-uniform, as some areas 
were exposed to more antibody than others. Image tiles corresponding to areas where 
the immunofluorescence was weak are very noisy; hence the cross correlation analysis 
was more error-prone. To reflect this, for each PIV-derived displacement vector we 
assigned a weight, the local standard deviation of fluorescence intensity. Thus, 
displacement vectors characterizing a detail-rich region carry more weight in the 
subsequent analyses than those obtained in a weakly-labeled area. 
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 The PIV comparing displacements of the endoderm and myocardial progenitors 
has been performed by identical methods. However, the images of the MitoTracker-
mediated labeled endoderm were not suitable for deconvolution. Hence, we projected 
the maximal image intensities of the 'z-stack' into a single image for each frame, and 
used the resulting 'z-projected' image for PIV analysis. Thus, instead of performing the 
PIV analysis on each collected z-plane, it was performed only at a single collapsed 
image. To compare endoderm and myocardial movements, both optical channels were 
analyzed the same way.  
 
Motion analysis  
 
To characterize ECM and cell rearrangements at various stages of heart 
development, pairs of deconvolved image stacks were selected. The images within the 
stacks were taken 20 minutes apart. A given pair, P, was analyzed through the following 
procedure. By manual masking, two additional image stack pairs were derived: one 
containing the forming heart, the other the somites or the pre-somitic mesoderm (to be 
used as a reference). The corresponding optical sections and fluorescence channels 
were compared by PIV analysis as described above. Velocities (displacements 
normalized by the time lag between the images of P) were presented in a reference 
system co-moving with the somites. Thus, we use the term “velocity” to describe a 
vector-value characterizing both the rate and direction of the displacements of selected 
objects. The term “speed” is used to describe the magnitude of the velocity vector. 
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Active cell velocities (Aleksandrova et al., 2012) were calculated as the local 
vectorial difference between the cell- and ECM-derived velocity vectors (Aleksandrova 
et al., 2012). The “reliability” weight assigned to the vectorial difference is the lesser of 
the two weights assigned to the vectors. For statistical comparison of embryos, certain 
areas were selected around the anterior intestinal portal (AIP). Velocity vectors from 
different embryos, but within the same location, were pooled. Data obtained from 
different embryos were considered statistically independent. 
 
Computational modeling  
 
Modeling biological pattern formation typically involves the use of partial 
differential equations (PDE), which offer a well-respected way to represent tissue 
mechanical quantities such as stresses and strains. The use of PDEs in simple systems 
allows full analytical solution, i.e., predicting model behavior for arbitrary parameter 
choices. Individual cell activity, however, is not resolved using a PDE approach. In order 
to connect cellular-scale activities, such as active “intercalation” or collective migration, 
directly to organ pattern formation it is necessary to model individual cells and then 
reconcile these data with tissue scale behavior. Thus, we make a connection between 
cellular events and the next larger scale of biological organization. 
Presently, the most widely used models of morphogenesis represent cell-cell 
adhesive interactions as "fluid" droplets; for example, the cellular Potts model and its 
grid-free version, the Subcellular element model. These model choices are motivated by 
the non-Newtonian fluid-like behavior of simple cell aggregates. Such cell-based models 
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have been used to formulate hypotheses for cellular activities, such as chemotactic 
guidance. While results from these models have been encouraging, in our estimation 
the available simulations include biomechanical artifacts, which present difficulties, 
notably, friction against a non-existing (undescribed) frame of reference. 
We have developed a substantially modified version of Dr. Timothy Newman's 
(University of Dundee) subcellular element model, which eliminates some of its 
mechanical limitations. In our model, the mechanical connectivity of the cells are 
explicitly represented as elastic beams connecting adjacent particles. The beams, 
connecting individual cells, can be compressed and stretched, bent and twisted. The 
great advantage of explicit cell-cell contact representation is that we can formulate 
plastic stress relaxation by removing and inserting these links, as well as by changing 
the equilibrium properties of the links. 
The mechanical equilibrium of the resulting structure can be calculated by solving 
the steady state of a coupled Ordinary Differential Equation system. The model will be 
further refined as information on the mechanical properties of the relevant tissues 
become available.  
 
Quantitative analysis of the AIP regression and myocardial displacement speeds in 
control and experimentally treated embryos 
 
 To characterize AIP regression, we placed markers at the first somite pair and 
the anterior most portion of the AIP (illustrated in Fig. 3.11A). The distance between the 
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center of mass of the somite markers and the marker at the AIP was used as our 
measure of AIP position. Foregut elongation speeds were defined as the change in the 
AIP-somite distance. As this speed decreases as development progresses, we 
distinguished between three phases of foregut elongation. Depending on the AIP-somite 
distance, we assigned the AIP as early, intermediate and late, when the distance was 
larger than 600 um, between 300 and 600 um and less than 300 um, respectively.   
 The significance of observed changes in AIP regression/foregut elongation 
speeds were established by the following procedure. Each analyzed embryo contributed 
a single (time-averaged) AIP speed value, in three possible categories: early, 
intermediate and late (depending on the somite-AIP distance). Data obtained from 
control and specifically treated samples were pooled, and each resulting data set was 
compared with the data set obtained from control embryos (untreated embryos, except 
for the transfected Rho constructs, which were compared with embryos transfected with 
myocardial-specific GFP constructs).  The significance of alteration in sample mean was 
established using a two-tailed Welch's t-test. 
To assess the movements of myocardial cells in embryos perturbed as in Fig. 
3.6E, CMLC2::GFP or CMLC2::MitoRFP-expressing cells were tracked manually at the 
incision boundary (as demonstrated in Fig. 3.11C). To determine the local ECM 
movement, or that of the wound/incision edge, we implemented the following procedure: 
i) the center of mass of the tracked cells were calculated at both side of the embryo. 
Since the tracked cells are in close proximity, the center of mass gives a convenient 
approximate location of the myocardial cells. ii) Centered around the position of the 
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center of mass, a PIV cross-correlation calculation was performed on the ECM images, 
yielding the typical ECM displacements at those areas. As the most prominent feature 
on these images is the wound edge, the PIV analysis essentially returns the movement 
of the incision boundary. iii) Knowing the positions of the myocardial cells as well as the 
incision boundary, their relative speed, v, was calculated for each frame. iv) The 
autonomous myocardial activity was characterized as the magnitude of v, averaged 
over 10 frames following experimental perturbation (addition of reagents). 
 The significance of observed changes in myocardial “curling” activity was 
established by the following procedure. Each analyzed incision contributed a single 
(time-averaged) activity value. Data obtained from control and specifically treated 
samples were pooled, and each resulting data set was compared with the data set 
obtained from control embryos (subjected to transfection and incisions, but no additional 
reagents). The significance of alteration in sample mean was established using a two-
tailed Welch's t-test.   
If the t-test based comparison of measurement results in control and 
experimentally-treated embryos yielded p<0.05, the induced changes in AIP regression 
speeds or speeds of myocardial displacements at the incision edge for a given reagent 
were considered significant. 
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Results 
 
Myocardial progenitors at HH8-11 move relative to the fibronectin ECM, but the speed 
of this relative (“active”) motion is insufficient to account for apparent displacement. 
 
To generate reporter constructs for specific labeling of individual myocardial 
progenitors within heart fields, we used the region between -931 and +56 of chick 
Cardiac Myosin Light Chain 2 gene (CMLC2; thereafter referred to as CMLC2 
promoter). Constructs mediating CMLC2 promoter-driven expression of GFP and RFP 
were delivered to quail embryos at HH5-6. According to Goswami et al. (1994), 
transcription of CMLC2 initiates at HH5 in chick. Fluorescent reporter expression was 
usually detectable by HH7+ – HH8- (3-4 somites), and found in a representative number 
of myocardial progenitors by HH8 (5-6 somites) in transfected embryos (Fig.2.1A, top 
panels). This is in good agreement with results of Han et al. (1992) on timing of 
sarcomeric myosin assembly. 
The appearance and behavior of CMLC2::GFP and CMLC2::mitoRFP-expressing 
cells were typical of those expected for cells in the myocardial fields they were 
incorporated in as the former: 1) were distributed throughout the MF20+ myocardial 
fields, 2) did not differ in morphology from their untransfected neighbors, 3) were 
positive for sarcomeric myosin heavy chain (MF20; Bader et al., 1982) – a bona fide 
marker of myocardial differentiation, and 4) were able to proliferate as evidenced by 
formation of clonal groups and cell division events registered in time lapse sequences 
(Fig. 3.1A and data not shown). 
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In some embryos at HH8-9 we observed occasional fluorescent reporter-
expressing cells in the splanchnic and somatic mesoderm outside of the continuous 
heart field. However, by HH11-12 expression of CMLC2 promoter-driven reporters was 
confined to the heart tube and the mesoderm immediately adjacent to it at its anterior 
and posterior ends (Fig 3.1A, bottom panels). In all cases we limited our analyses to 
cells located within crescent-shaped heart fields at HH8 as defined by others (Abu-Issa 
and Kirby, 2008; van den Berg et al., 2009). 
To visualize the fibronectin ECM in the vicinity of myocardial fields, we 
microinjected fluorescently conjugated antibody B3D6 (DSHB; Little and Drake, 2000), 
into the sub-endodermal space of CMLC2::EGFP or CMLC2::mitoRFP-transfected quail 
embryos at HH7-8- (n=21), and recorded their development until HH11-12 in time lapse. 
Within obtained image sequences, we specified image pairs acquired 18-26 minutes 
apart from one another. Selected image pairs described progressive stages of 
myocardial progenitor movement to the midline, and were chosen in a way that allowed 
direct comparison between movement speeds of myocardial progenitors, measured in 
the current study, and those of their endocardial counterparts (Aleksandrova et al., 
2012). A representative example of an embryo at initial and final stages of development 
included in the analysis is shown in Fig. 3.1B. In Fig. 3.1C stage 3 corresponds to HH8, 
stage 4 – to HH8+, stage 5 – to HH9, stage 6 – to HH10, and stage 7 – to HH11. Stages 
1 and 2 were omitted from Fig. 3.1C as they described the events at HH7-8-, at which 
time the number of CMLC2::mitoRFP-expressing cells was insufficient for motion 
analysis. 
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Analysis of myocardial progenitor and fibronectin movements was performed 
using particle image velocimetry (PIV) as described in detail in Aleksandrova et al. 
(2012). Right panels in Fig. 3.1B show examples of vector maps that represent 
apparent movements of each component at stage 3 (HH8) and stage 7 (HH11). Values 
for apparent and active (relative to the ECM) motion speeds of myocardial progenitors 
are plotted alongside the displacement speed of fibronectin ECM in Fig. 3.1C. For the 
purposes of comparison Fig. 3.1C also includes information on apparent and active 
motion speeds of endocardial progenitors, measured in Aleksandrova et al., 2012. To 
ensure that results of the latter and our current study were directly comparable, three 
out of twenty one embryos used for PIV analysis were Tie1::H2B-YFP positive to allow 
for simultaneous visualization and measurements of endocardial, myocardial, and 
fibronectin movements. Endocardial motion data obtained from these embryos did not 
differ significantly from those reported in Aleksandrova et al., 2012. Similarly, values for 
ECM displacement measured in both studies were very similar at all stages (data not 
shown). 
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Figure 3.1. Characterization of myocardial progenitor movements relative to the 
fibronectin ECM: 
A - maximum intensity dorso-ventral projections of confocal stacks obtained at HH8 (top 
panels), and HH11 (bottom panels). Whole mount specimens were immunostained with 
antibodies MF20 (red), B3D6 anti-fibronectin (blue), and anti-GFP (green) to enhance 
pCMLC2-GFP expression-mediated labeling of transfected cells.  Aʹ′, Aʼʼ -10 µm plastic 
section taken at the levels indicated with horizontal white lines. Scale bars: 100 µm 
B – representative epifluorescent images of embryos at the first and last stages 
included in the PIV analysis, with representative vector maps on the right. Red – 
fibronectin ECM, green – pCMLC2::EGFP-transfected myocardial cells. Scale bar and 
white squares – 100 µm. 
C – mean speeds of apparent and active myocardial progenitor movements, compared 
to speeds of endocardial and ECM displacements at progressive stages of heart tube 
assembly. 
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Figure 3.1A 
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Figure 3.1B, C 
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Analysis of myocardial field movement relative to the underlying endoderm 
 
 To achieve endodermal labeling in quail embryos in vivo, we used MitoTracker 
Green dye, which is retained in mitochondria of live cells. An example of a labeled 
embryo is presented in Fig. 3.2A. As seen in Fig. 3.2Aʼ, MitoTracker Green staining 
allows the discernment of individual cells within the endodermal tissue. In our 
experiments we found that short exposure of the ventral side of the embryo to the dye 
solution causes retention of MitoTracker Green only in the endoderm, if its integrity was 
not compromised during treatment. Embryos transfected with CMLC2::mitoRFP (n=11) 
were stained with a 350-500 nm solution of MitoTracker Green as described above, at 
HH8. Subsequently, development of labeled embryos was recorded in time lapse for 4-5 
hours with 10-12 min intervals between frames. Unfortunately, fading of MitoTracker 
Green fluorescent signal prevented further imaging.  
In order to compare magnitudes and directions of endodermal and myocardial 
movements, we selected several image pairs (with images taken 20-24 min apart) for 
each specimen. Our PIV algorithm was used to generate vector maps such as those 
represented in Fig. 3.2B. Vectors describing apparent myocardial (red) and endodermal 
(green) movements were similarly directed towards the ventral midline, indicating that at 
HH8-9 both tissues move toward the midline in a coordinated fashion. At the same time, 
motion of the myocardium relative to the endoderm, illustrated with blue vectors in Fig. 
3.2B, had a pronounced anterior directionality. Displacement speeds, calculated for the 
region represented in Fig. 3.2B, are shown in Fig. 3.2C. 
	   116	  
 
 
 
 
 
Figure 3.2: Analysis of myocardial progenitor movements relative to the 
endoderm 
A, Aʼ – HH8 quail embryo with endoderm labeled with MitoTracker Green dye. Scale 
bars: A-100 µm, Aʼ – 40 µm ; 
B – A representative vector field from PIV analysis of myocardial movement relative to 
the endoderm. Red vectors correspond to myocardial progenitor displacements, green 
vectors illustrate movements of the endoderm, and blue vectors show relative 
movement between the two tissue types. Scale bar: 100 µm. 
C – apparent myocardial, apparent endodermal, and active myocardial (relative to the 
endoderm) displacement speeds, measured for the region outlined in B. 
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Figure 3.2 
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Myocardial progenitors and fibronectin ECM-containing fibrils demonstrate differential 
behaviors at the medial and lateral aspects of the heart field  
 Next, we set out to investigate the mechanism responsible for the anterior-
directed movement of myocardial fields relative to the endoderm. To probe the 
morphology of heart fields at HH8-9 (a time within the HH8-11 interval when the 
apparent speed of myocardial progenitor movement is the highest; stages 3-5 in Fig. 
3.1C) we performed serial sectioning of embryos (n=4) that were stained with MF20 to 
visualize myocardial progenitors, and DAPI. Cross-sectional anatomy of MF20+ 
myocardial fields closely matched that reported by the following 3D reconstruction-
based studies. Abu-Issa and Kirby, 2008 used Nkx2.5 expression to visualize 
myocardial progenitors at HH8-12 for studies of patterning of the heart field. Later, van 
den Berg et al., 2009 utilized cardiac troponin I as a myocardial marker in their work on 
cell proliferation within the developing heart. 
Abu-Issa and Kirby, 2008 reported that heart fields undergo a 120-130º inversion 
concomitantly with caudal movement of the AIP. In agreement with their results, we 
observe the change in positions of myocardial fields relative to the dorso-ventral axis of 
the embryo at different cranio-caudal levels at HH8-9.  Fig. 3.3Aʼ (reproduced from van 
den Berg et al., 2009) illustrates the overall morphology of cardiogenic fields at HH8, 
and serves as a reference for the position of individual sections shown in Fig. 3.3B 
along the cranio-caudal embryonic axis. As seen in Fig. 3.3B, myocardial progenitors 
(green) are continuous with the splanchnic mesoderm (MF20-negative tissue adjacent 
to the myocardial progenitors) comprising the ventral coelomic wall in the caudal aspect 
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of the heart fields. In the more anterior position, orientation of myocardial fields changes 
to dorso-lateral and, eventually, dorsal at their most cranial aspect (please refer to the 
provided guide for orientation).  
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Figure 3.3: Myocardial progenitor fields undergo a dramatic change in position 
along the dorso-ventral embryonic axis in caudal-to-cranial progression.  
Aʼ – a panel from Fig. 3 by van den Berg et al., 2009 (p. 182), illustrating the anatomy of 
myocardial fields at HH8; 
B - a series of 10 µm-thick sections (taken 30-200 µM apart from each other) through 
the HH8 embryo at the level of the cardiac fields. An approximate position of each 
section relative to the cranio-caudal axis is indicated by lines connecting to Aʼ. Green – 
MF20 antibody-labeled myocardial progenitors, blue – DAPI. d – dorsal, and v - ventral 
side of the embryo. All sections are presented in the same orientation. Scale bar: 100 
µm. 
 
 
 
 
 
 
 
 
 
 
	   121	  
Figure 3.3
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In order to investigate the behavior of individual myocardial progenitors within 
heart fields at progressive steps of their antero-medial movement, we subjected three 
HH8 embryos (each expressing CMLC2::GFP in one or both myocardial fields) to time 
lapse imaging with 60-90 s interval between the consecutive frames. In Fig. 3.4A top 
panels show DIC, and bottom panels – epifluorescence (GFP) images of the embryonic 
right myocardial field at progressive time points between HH8 and 9. Epifluorescence 
images were colorcoded to render ventrally-positioned cells red, those positioned 
dorsally – blue, with the remaining z-planes acquiring intermediate colors of the 
spectrum in accordance with their position along the dorso-ventral embryonic axis. 
Cells along the medial aspect of the heart field undergo pronounced elongation 
perpendicular to the AIP edge (example cell groups are marked by asterisks Fig. 3.4A). 
Laterally positioned cells appear to maintain more constant shapes. Simultaneously with 
cellular elongation at the medial aspect, the lateral edge of the heart field turned 
ventrally (note the change in color from blue/green in Fig. 3-4Aa to yellow/red portion of 
the spectrum in Fig. 3-4Ab-c, apparent for the lateral aspect of the myocardial field).  
To generate Fig. 3.4B, outlines of CMLC2::EGFP expressing cells from the 
region marked with brackets in Fig. 3.4A were traced at selected time points using tools 
of Adobe Photoshop CS4 (Adobe Systems Inc.). Then resultant shapes were plotted 
against the white background in black for the medial, and in grey – for the lateral aspect 
of the myocardial field. Outlines of medial cells changed progressively as the latter 
aligned with their long axes perpendicular to the AIP, and underwent further elongation. 
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At the same time, most of the lateral cells maintained relatively constant orientations 
and shapes.   
Further, to assess the dynamics of ECM displacements in the vicinity of 
converging myocardial fields at HH8-9, we used PIV to assess the local differences in 
movement directionality in individual frames of time-lapse image sequences, where 
fibronectin or fibrillin-2 ECM was labeled in vivo as described above. Four image 
sequences were analyzed, two each for fibronectin and fibrillin-2. Representative 
images are shown in Fig. 3.5. There, PIV-derived 20 min displacement trajectories 
(green) are plotted over the second image in the pair used for analysis. Note that in the 
vicinity of the AIP (in the area corresponding to the medial edge of the myocardial field) 
trajectories indicate displacement in the antero-medial direction, whereas in more lateral 
regions this direction is strictly medial.  
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Figure 3.4: Medial and lateral compartments of the myocardial field show 
differential cell behaviors  
A – DIC (top panels) and epifluorescence (GFP; bottom panels Aa-Ac) images of the 
embryonic right myocardial progenitor field in pCMLC2::GFP-transfected embryo. 
Individual planes within the z-stack were colorcoded to reflect the position of objects 
along the dorso-ventral embryonic axis as described in the text and illustrated by the 
provided spectrum bar. Elapsed times from the beginning of image acquisition are 
shown in the top left corners in Aa-Ac. Scale bar: 100 µm.  
B – outlines of the cells within the region demarcated by brackets in Aa, traced and 
plotted as described in the text. Blue segmented line marks the AIP border. Elapsed 
times from the beginning of image acquisition are shown in the top left corner of each 
image. 
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Figure 3.4 
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Figure 3.5: Differences in directionalities of fibronectin displacements in the 
vicinity of the AIP 
A – HH8 embryo with in vivo labeled fibronectin ECM. Scale bar: 100 µm.  
B - PIV was used to trace fibronectin displacements in the vicinity of the AIP. Red dots 
in the top panel indicate the centers of individual pixel arrays, traced by PIV. Resultant 
trajectories of ECM displacement during 20 min were plotted over the second image in 
an analyzed pair (green trajectories; bottom panel). Blue line separates areas with 
predominantly medial fibronectin displacements from those with prevailing antero-
medial fibronectin displacements (illustrated by green arrows). 
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Figure 3.5 
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Mechanical perturbations, placed within specific regions of the heart fields, 
abrogate endoderm folding and reveal autonomous myocardial movements 
In the attempt to release myocardial progenitor fields from the displacement-
inducing influences of other tissues, most notably of the endoderm, we used tungsten 
needles to perform a series of incisions through the endoderm and underlying 
splanchnic mesoderm in selected regions within the anterior embryo at HH8. Myocardial 
progenitors and fibronectin ECM were labeled in each embryo as described above, prior 
to the surgery. Incision site positions are illustrated in Fig. 3.6A. In most cases (except 
for Fig. 3.6B), incisions were placed symmetrically at both sides of the embryo, to 
maintain the symmetrical distribution of forces (characteristic for normal development) 
acting on the wound. The number of embryos that underwent each type of perturbation, 
with time-lapse recording of subsequent events, ranged from n=6 for Figs. 3.6C and D 
to 34 for Fig. 3.6E.  
Perturbations to the ventral midline endoderm have been shown to induce 
separation of cardiac progenitor fields, termed cardia bifida, by a number of early 
researchers (Glanzer and Peasley, 1970; Rosenquist, 1970; Satin et al., 1988). We 
were interested to determine if deformations within the myocardial field, described in the 
previous section (i.e. medial aspect contraction and concomitant ventral bending of the 
lateral heart field aspect), were affected by endodermal perturbation.  Fig. 3.6B 
illustrates, that cell elongation along the medial edge of the heart field persists in 
embryos exhibiting cardia bifida (Fig. 3.6Ba). Likewise, ventral displacement of the 
lateral edge of the myocardial field (as in Fig. 3.4) was also evident (note the change in 
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color of the cells located at the lateral edge of the myocardial field from blue/green to 
yellow/red portions of the spectrum in Fig. 3.6Bb, where images were colorcoded as 
previously described). 
 In Fig. 3.6C, incisions were targeted laterally at approximately 100 um distance 
from the edge of the heart field. These types of incisions, as well as those placed medial 
to the myocardial fields (at the paraxial mesoderm or notochord; data not shown), had 
very little or no effect on the heart field movement towards the midline, and AIP 
regression. 
Further, if 500-600 µm longitudinal incisions were placed within the myocardial 
field, a series of striking deformations ensued (Fig. 3.6D, Da). First, the myocardial 
fields gained unattached lateral edges, which bent ventrally and medially. Later, a 
portion of the heart field initially located posterior to the incision, advanced in the 
anterior direction past the wound edge. We propose, that observed deformations can be 
viewed as a cumulative result of forces exerted within the perturbed myocardial field. As 
illustrated in a schematic form in Fig. 3.6Db, the differentiating myocardium (dark 
green), attached to the surrounding non-myocardial mesoderm (light green), is 
undergoing a contraction along the medial edge (as in Fig. 3-4; magenta arrows). At the 
same time, it is also bending dorsally (via uniform curling) to generate a cup-shaped 
groove (as in Fig. 3-3; illustrated by blue arrows). The incision (red contour line) 
introduces an unattached edge, which in turn bends inwards (medially) as a result of the 
uniform dorsal bending/curling (blue arrows). The force generated by the isotropic 
curling in the myocardial field posterior to the incision propels the latter anteriorly (blue 
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segmented arrow) past the wound edge (red line), and causes further deformation of the 
perturbed myocardial primordium. 
Even more pronounced myocardial field movement was achieved, when 200-300 
µm-long incisions were placed perpendicular to the AIP arch within the region 
demarcated with a white bracket in Fig. 3.6A. As seen in Fig. 3.6E, myocardial fields 
move anteriorly past the incision site. At the wound edge, the myocardium continues to 
advance over the ventral surface of the endoderm. This “rolling forward” movement of 
the myocardial fields drives cells at the wound edge to progressively more ventral and 
posterior positions (Fig. 3.6Ea). Figures 3.6Ec and 3.6Ed illustrate the cross-sectional 
anatomy of an embryo in Fig. 3.6E caudal to the posterior wound edge and at the level 
of the incision site, respectively. Note the characteristic cup shapes formed by the 
myocardial fields in the absence of endoderm folding. A portion of the myocardial field 
positioned ventrally relative to the endoderm in Fig. 3.6Ed also maintains a convex 
shape. Fig. 3.6Eb includes a schematic representation of the possible combination of 
forces acting on the perturbed myocardial field to generate the observed phenotype. As 
in Fig. 3.6Db the differentiating myocardium (dark green), attached to the surrounding 
non-myocardial mesoderm (light green), is undergoing a contraction along the medial 
edge (magenta arrows). Concomitantly it is also bending dorsally (by the uniform 
contraction) to generate a cup-shaped groove (blue arrows). The incision (red contour 
line) separates the myocardium and the adjacent non-myocardial mesoderm from the 
anterior tissues. The force generated by the uniform contraction (curling) of the 
myocardial field posterior to the incision propels the latter anteriorly (blue segmented 
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arrow) past the wound edge (red line). This process continues as bending is initiated at 
progressively more posterior levels of the differentiating myocardium. This drives further 
anterior displacement of the myocardial primordium and thus propels the formation of a 
characteristic “curl” at the wound edge. 
As Figs. 3.6D and E demonstrate, the anterior-ward movement of the heart field 
continued when the anterior or lateral edge of the myocardial field was separated from 
the adjacent tissues, and in the absence of AIP regression-driven movement. Further, 
the myocardial fields in perturbed embryos underwent a characteristic c-shaped 
deformation similar, but more pronounced than that observed in normal embryos at 
HH8-9 (see Fig. 3.3B). We hypothesized that this deformation (driven by uniform 
curling), as it occurs progressively at more caudal aspects of the developing myocardial 
field, is responsible for the apparent myocardial endoderm-independent anterior-
directed movements (quantified for normal embryos in Fig. 3.2). Our ongoing modeling 
efforts provide support to the stated hypothesis. 
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Figure 3.6. Typical phenotypes, induced by localized incisions through the 
endoderm and splanchnic mesoderm of HH8 embryos. 
A – locations of incision sites (labeled B-E) that upon perturbation result in phenotypes 
shown in panels B-E. 
Red – fibronectin ECM, green – CMLC2::GFP or CMLC2::mitoRFP-expressing 
myocardial cells. Gray contours delineate the wound edges at the beginning of an 
image acquisition. Myocardial fields are schematically outlined in red. Time elapsed 
from the beginning of time lapse image acquisition is listed on image panels. 
Acquisitions were typically initiated 0.5-1.5 h post-incision. Scale bars: 100 µm unless 
otherwise indicated. 
B – selected images from the time-lapse sequence, illustrating that the incision placed 
through the endoderm at the ventral midline leads to the formation of two lateral 
“hearts” in the absence of midline fusion (a phenotype referred to as cardia bifida).  
Ba, Bb – images of the embryonic left CMLC2::GFP-transfected myocardial field, color-
coded to convey the information on dorso-ventral position as described previously. 
White contours illustrate the position of the AIP edge over time. Note the elongated 
shapes of CMLC2::GFP-expressing cells (indicative of a contraction; compare to Fig. 3-
4) in Ba. An arrow and arrowhead in Bb indicate positions of the same cell groups in 
both images. Marked cells, along with the myocardial field region they were included in, 
assumed a more ventral position at the later time point. 
Bc – confocal image of the embryo shown in B, stained with MF20 post-fixation (green) 
to visualize myocardial morphology in the bifid “hearts”. 
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C – representative frames from a time-lapse sequence describing the development of 
an embryo, in which incisions were placed through the endoderm and underlying 
splanchnic mesoderm lateral to the myocardial fields (outlined by grey contours).  
Ca - confocal image of the embryo shown in C, stained with MF20 post-fixation (green) 
to visualize myocardial morphology. Note that this type of perturbation does not prevent 
myocardial precursor arrival at the midline. 
D – left panel: an initial time frame of an image sequence taken from an embryo with the 
longitudinal incision placed within the myocardial fields (through the endoderm 
and differentiating myocardium) on both sides. Subsequent deformations occurring 
within the region marked by the white rectangle are shown in the adjacent panels.  
Da - confocal image of the region shown in D, stained with MF20 antibody (green) after 
post-imaging fixation to visualize myocardial morphology. 
Db – a schematic representation of forces acting within the perturbed myocardial field to 
generate the observed phenotype. The differentiating myocardium (dark green), 
attached to the surrounding non-myocardial mesoderm (light green), is undergoing a 
contraction along the medial edge (as in Fig. 3-4; magenta arrows). At the same time, it 
is also bending dorsally to generate a cup-shaped groove (as in Fig. 3-3; illustrated by 
blue arrows). The incision (red contour line) introduces an unattached edge, which in 
turn bends inwards (medially) as a result of the uniform dorsal bending (blue arrows). 
The force generated by the dorsal bending in the myocardial field posterior to the 
incision propels the latter anteriorly (blue segmented arrow) past the wound edge (red 
line), and causes further deformation of the perturbed myocardial primordium. 
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E – representative frames from a time-lapse sequence describing the development of a 
specimen where incisions were placed bilaterally perpendicular to the AIP arch 
through the endoderm and the underlying myocardium/splanchnic mesoderm.  
Ea shows color-coded (as described previously) images that illustrate incision-induced 
deformations in the embryonic left myocardial primordium (positioned as the one 
outlined by the white rectangle in E). Note the progressive ventral displacement of the 
primordium (“curling”).  
Eb – a schematic representation of the possible combination of forces acting on the 
perturbed myocardial field to generate the observed phenotype. As in Fig. 3.6Db the 
differentiating myocardium (dark green), attached to the surrounding non-myocardial 
mesoderm (light green), is undergoing a contraction along the medial edge (as in Fig. 3-
4; magenta arrows). Concomitantly it is also bending dorsally (by the uniform 
contraction) to generate a cup-shaped groove (as in Fig. 3-3; illustrated by blue arrows). 
The incision (red contour line) separates the myocardium and the adjacent non-
myocardial mesoderm from the anterior tissues. As in Db, the force generated by the 
uniform contraction (dorsal bending) of the myocardial field posterior to the incision 
propels the latter anteriorly (blue segmented arrow) past the wound edge (red line). This 
process continues as bending is initiated at progressively more posterior levels of the 
differentiating myocardium. This drives further anterior displacement of the myocardial 
primordium and thus propels the formation of a characteristic “curl” at the wound edge. 
Ec and Ed are images of transverse sections taken through the embryo in E at the 
levels indicated in the right panel. Note that the myocardium forms pronounced cup-
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shaped grooves posterior to the incision site (Ec), whereas the endoderm remains 
relatively planar. At the incision site (Ed), deformed (“curled”) myocardium is found 
ventral to the endoderm. En – endoderm, mc – myocardium, nc – notochord, nt – neural 
tube, s – somite; D – dorsal, V - ventral, L – left, R – right. Scale bars in Ec and Ed:  
50 µm.  
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Fig. 3.6A, B 
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Figure 3.6C, D 
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Figure 3.6E 
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Computational modeling of myocardial progenitor field behavior 
 
Recently, we developed a substantially modified version of Dr Newman's 
subcellular element model (ScEM; Newman, 2005). Currently one particle represents a 
single cell, but the mechanical connectivity of the cells is explicitly represented as elastic 
beams connecting adjacent particles. The beams can be compressed and stretched, 
bent and twisted. Therefore, instead of the central forces of the original ScEM, these 
links can exert torques and forces that are not parallel to the line connecting the 
particles. The great advantage of explicit cell-cell contact representation is that we can 
formulate plastic stress relaxation by removing and inserting these links, as well as by 
changing the equilibrium properties of these links. Thus, for example, convergent-
extension movements can be simulated by preferentially creating new links along one 
direction while removing links in the perpendicular direction. As each link is a simple 
elastic beam, the mechanical equilibrium of the structure can be calculated by solving 
the steady state of a coupled Ordinary Differential Equations (ODE) system. We argue, 
that the tissue is always in mechanical equilibrium, i.e., cell activity (contraction, 
rearrangement of the links) is slow compared to the time needed for the environment to 
accommodate these changes. 
To analyze the tissue mechanics of the myocardial cell sheet, first we created a 
3D model of the splanchnic (ventral) and somatic (dorsal) mesodermal layers 
surrounding the coelom as shown in Fig. 3.7A-C. In this hypothetical configuration the 
tissue is at rest as there are no cellular activities. By computational simulations we 
	   140	  
evaluated the effect of a specific myocardial activity, which (in the absence of other 
mechanical constraints) would generate a uniform and isotropic curvature of the sheet. 
As Figs. 3.7D-F and 3.8 demonstrate, due to the mechanical interplays within the 
model, such a simple cellular activity can result in tissue deformations which are 
markedly distinct from the prescribed behavior, and show a great degree of similarity 
with the empirically observed myocardial movement patterns. In particular, at the 
anterior AIP the myocardium dislocates anteriorly relative to the more ventral endoderm 
layer. Furthermore, by moving the ventral (splanchnic) mesodermal layer medially, such 
a myocardial activity would contribute to the regression of the AIP. As an additional test, 
the model (with the same parameters) can also reproduce the observed ventrally curled 
myocardial layer, which develops as a response to a mechanical incision across the 
lateral AIP (Fig. 3.9). 
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Figure 3.7: Two characteristic states of a computational model developed to 
analyze the interplay between myocardial field deformations and the AIP 
movement. 
The myocardium (red) is represented in a three dimensional arrangement within its 
mesodermal environment (white) shown from a posterior (a,d), anterior (b,e) and ventral 
(c,f) viewpoint. a-c: A hypothetical configuration in which myocardial cells do not exert 
any influence on their neighbors. This state serves as an initial condition for the 
simulations d-f: A configuration obtained by a simulation with active myocardial shape 
changes. A myocardial groove (arrows) develops, which protrudes into the coelomic 
cavity. A: anterior, P: posterior, D: dorsal, V: ventral. L: left, R: right. 
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Figure 3.7 
 
 
 
 
 
 
 
 
 
 
 
	   143	  
 
 
 
 
Figure 3.8: Myocardial and mesodermal cell displacements in the computational 
model, induced by a prescribed shape change of the myocardial fields resulting 
in a uniform and isotropic curvature. 
Ventral-projected myocardial and mesodermal (non-myocardial) cell displacements are 
represented as red and green arrows, respectively. The sole myocardial activity was 
prescribed as a shape change resulting in a uniform and isotropic curvature (i.e., the 
same bending in the A-P and lateral-medial directions). Yet, due to the mechanical 
coupling with the surrounding tissue, this activity resulted in a lateral-anterior directed 
displacement of the myocardium in the anterior region (asterisk). The deformation of the 
myocardial cell stripe also induced a medially directed displacement of the ventral 
(splanchnic) mesoderm (bracket). 
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Figure 3.8 
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Figure 3.9: Computational simulation of endoderm/splanchnic mesoderm 
disrupting incision, placed perpendicular to the AIP arch. A mechanical 
discontinuity was introduced into the initial configuration by removing interconnecting 
beams along a line at the embryonic right side (yellow arrows), shown from a ventral (a) 
and lateral (b) aspect. The same myocardial behavior that was shown in Figs 3-7 and 3-
8 here resulted in a pronounced ventral curling of the myocardium (blue arrows), shown 
from a ventral (c), lateral (d) and posterior (e) aspect. Compare to the incision-induced 
phenotype in Fig. 3-6E. A: anterior, P: posterior, D: dorsal, V: ventral. L: left, R: right. 
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Figure 3.9 
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Proposed model to explain antero-medial displacements of the myocardial fields prior to 
heart tube assembly 
 Based on the data available to us, we propose the following combination of the 
concomitantly acting forces to act on and within the developing myocardial fields, and 
promote their observed antero-medial displacement. As seen in Fig. 3.10, the 
myocardial field (dark green) is incorporated into the cohesive mesodermal layer (light 
green). The myocardial field is located in the close vicinity of the AIP (purple semi-arch), 
and the mesoderm is overlain by the endoderm (the top, light purple tissue layer), 
continuous with the AIP. The latter undergoes a uniform contraction (purple arrows), 
leading to the midline-directed displacement of the mesoderm along with the 
incorporated myocardial field (a single purple arrow above the AIP). At the same time, 
the myocardial field undergoes the previously discussed deformations, namely the 
medial side contraction (pink arrows) and dorsal bending/curling (blue arrows). We 
argue that the combination of the above events leads to the net displacement of the 
myocardial field in the anterior and medial direction, illustrated by the segmented arrow 
in Fig. 3.10. 
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Figure 3.10: Proposed model to explain antero-medial displacements of the 
myocardial fields prior to heart tube assembly 
A schematic representation of tissue deformations that occur within the myocardial 
fields at each side of the embryo, and within the adjacent tissues. Please refer to the 
text for an explanation. 
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Figure 3.10 
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Comparison of the effects of known regulators of tissue contractility and cell movement 
on endodermal and myocardial tissue deformations 
 
 To determine whether AIP regression and autonomous myocardial field 
deformations are driven by similar cellular mechanisms, we subjected unperturbed and 
incised (as in Fig. 3.6E) HH8 embryos to treatments with various concentrations of the 
following: cell proliferation inhibitor Mitomycin C (Sigma), actin depolymerizing agent 
Cytochalasin D (Sigma), Rho kinase (p160ROCK) inhibitor Y27632, and focal adhesion 
kinase (FAK) inhibitor (Tocris Biosciences). The reagents we chose for analysis have 
been used in studies of cardiac morphogenesis, inducing measurable effects (Latacha 
et al., 2005; Wei et al., 2001; Doherty et al., 2010). The analyses described below were 
on applied to 3-6 time lapse sequences for each reagent and concentration, listed in 
Figs. 3.11B and D.  
 We used the speed of AIP regression as a way to assess the effect of each of the 
above reagents on foregut elongation, a process that relies predominantly on the 
endoderm contractility. The distance was measured between the center of the AIP arch 
and the anterior borders of the first visible pair of somites, at each time point of the 
image sequence, as schematically shown in Fig. 3.11A. Positions of the above 
anatomical landmarks were traced manually through the image sequences. From 
tracking data, the speed of AIP movement was calculated. Averaged values for AIP 
regression speed in the presence of the above reagents, or solvent controls, are listed 
in Fig. 3.11B. Out of all applied treatments, the following caused a statistically significant 
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decrease in the AIP regression speed: 250 and 500 µM of ROCK inhibitor Y27632, 750 
µM of FAK inhibitor PF573228, and both 10 and 50 µM of Cytochalasin D. 
To assess the effects of each reagent on myocardial deformation, movements of 
individual CMLC2::GFP+ or CMLC2::mitoRFP+ myocardial progenitors in the vicinity of 
the wound edge were traced manually throughout the image sequences (see Fig. 3.11C 
for illustration). The position of the ECM-rich incision edge was assessed at each time 
point using a version of the PIV algorithm as described in Experimental Procedures. 
Effects of the above reagents on the speed of the myocardial progenitor movement 
relative to the incision edge are shown in Fig. 3.11D. The observed decreases in the 
myocardial progenitor displacement speeds were only statistically significant in embryos 
treated with 500 µM of Y27632 and those subjected to 750 µM of PF573228, suggesting 
a significantly lower sensitivity of the myocardial deformations to actin depolymerization 
and ROCK inhibition compared to the endodermal deformations in the contracting AIP. 
Further, we used the above experimental strategy to quantify the effects of 
myocardially-expressed constitutively active isoform of Rho (CMLC2::caRho) on the on 
the AIP regression speed and on myocardial displacement speed in the incised 
embryos. CMLC2::GFP-expressing embryos were used as controls for both assays. The 
results of measurements are shown in Fig. 3.11E for the effect of CMLC2::caRho 
expression on the AIP regression speed (n=15), and in Fig. 3.11F for its effect on the 
speed of myocardial displacements relative to the incision edge (n=4). Both AIP and 
myocardial displacement speeds were slightly decreased in CMLC2::caRho-expressing 
embryos compared to the controls. Despite is small magnitude, the difference in each 
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case was proven to be statistically significant with p<0.05 based on the results of two-
tailed Welch's t-test. In our early experiments we have also attempted to assess the 
effects of dominant negative isoform of Rho (CMLC2::dnRho), but neither of our 
measured parameters was affected by the myocardial-specific dnRho expression (data 
not shown). 
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Figure 3.11. Analysis of effects of inhibition of cell proliferation, Rho kinase and 
focal adhesion kinase function, and actin polymerization on the AIP regression 
(endoderm contraction) speed and myocardial field deformations. 
A – a DIC image of an HH8 embryo illustrating the anatomical landmarks traced for the 
AIP regression speed analysis (the center of the AIP arch and borders of the first somite 
pair). The linear trajectory of AIP regression is shown, and the extent of its early, 
intermediate, and late portions according to our convention are defined. Scale bar: 100 
µm. 
B – a bar chart reflecting the speeds of AIP regression in control- and reagent-treated 
embryos at the intermediate portion of the regression trajectory (3.11A). Reagents and 
treatment concentrations are listed. Error bars: SEM. 
C – epifluorescence images illustrating the anatomy of a myocardial field progressively 
undergoing deformations in the embryo perturbed as in Fig. 3.6E, and defining the 
landmarks used in tracing analysis. Arrowheads indicate the positions of the myocardial 
cells (additionally marked with numbers 0-2) tracked through the 13.6 h-long time-lapse 
sequence. Asterisks mark the incision edge positions. Red – fibronectin ECM, green – 
CMLC2::GFP-transfected myocardial cells. Scale bar: 100 µm. 
D - a bar chart reflecting the speeds of myocardial progenitor movements relative to the 
incision edge in control- and reagent-treated embryos in specimens that were perturbed 
as in Figs. 3.6E and 3.11C. Reagents and treatment concentrations are listed. Error 
bars: SEM. 
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E, F – bar charts representing the effects of the myocardial-specific expression of 
caRho on the speeds of AIP regression (E) and those of the myocardial progenitor 
movements relative to the incision edge (F) in CMLC2::caRho-expressing embryos 
compared to the controls. 
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Figure 3.11A-D 
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Figure 3.11E,F 
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Discussion 
 
The relationship between fibronectin, endoderm, and myocardial progenitor movements 
 
 Fibronectin was suggested to be organized in an anterior-to-posterior gradient, 
and to serve as a substrate for haptotactic movements of cardiac progenitors in a series 
of publications by Linask and Lash (Linask and Lash, 1986; Linask and Lash, 1988a; 
Linask and Lash, 1988b). On the contrary, Wiens (1996) proposed that myocardial 
movement is driven by the contractile activity of the anterior-most cells within a cohesive 
epithelial sheet. These cells were expected to interact with the anteriorly-positioned 
“patch” of fibronectin, activate their motility mechanisms, and create the contractile force 
needed to propel the remainder of the myocardial fields forward. Very recently, Varner 
et al. (2012) published a study where the endoderm, and not the myocardium, was 
implicated as the source of a midline-directed contractile force.  
 In order to determine if myocardial progenitors undergo displacements relative to 
any (or both) of the suggested substrates, we performed a series of time-lapse 
microscopy and PIV analysis-based motion analyses. 
As seen in Fig. 3.1A, fibronectin is associated with both the myocardium and 
endoderm. In our in vivo fibronectin labeling strategy, both fractions become tagged 
(data not shown). Hence, we can detect movement relative to both the endoderm- and 
myocardium-associated fibronectin. As illustrated in Fig. 3.1B, most of the midline-
directed myocardial movement is shared with fibronectin displacement. Accordingly, 
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speeds of apparent myocardial movement (green bars in Fig. 3.1C) are very similar in 
magnitude to ECM movement speeds (brown bars) at all stages considered. 
Interestingly, throughout HH8-11 we observe myocardial progenitor movement 
speeds relative to fibronectin (active) to exceed those of endocardial progenitors (red 
versus blue bars in Fig. 3.1C). It is in agreement with the fact that active movements of 
endocardial progenitors were directed towards the midline (see Fig. 2.7, S2.5), whereas 
myocardial movements had a pronounced anterior directionality (Fig. 3.2B,C).  
Next, we set out to characterize the morphological changes that occur within 
myocardial progenitor fields during HH8-9 – the period of rapid convergence of cardiac 
progenitors at the midline, which encompasses a striking transition from completely 
separated planar “sheets” to a three-dimensional early heart tube at the midline.  
Visualization of individual cells within the myocardial progenitor fields allowed us 
to detect clear differences in behaviors of medially- and laterally-positioned cells (Fig. 
3.4). Pronounced cell rearrangement and elongation at the medial edges can be viewed 
as the source of the force that acts (in parallel with the AIP regression) to mediate the 
120º-130º inversion of the cardiac fields, described by Abu-Issa and Kirby, 2008.  
Further, fibronectin ECM associated with the AIP at HH8-9 included a lateral 
domain with mostly medial-directed displacement of included fibrils, and a medial 
domain, where such displacement had a distinct anterior directionality. Given that this 
ECM is located at the interface of the endoderm and the myocardial field, coupling the 
two contractile tissues, dual interpretation of the data is possible. In the first scenario, 
the endoderm would play a primary role in the contraction, and compress the 
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mesoderm. In the second, the mesoderm would contract (via elongation of the cells as 
seen in Fig. 3.4), and contribute to the contraction of the endoderm. 
To distinguish between these possibilities, and to assess myocardial movement 
with reduced influence of the endoderm, we performed a series of microincisions. First, 
we found evidence for persisting medial aspect contraction and ventral folding (120º-
130º inversion) of the myocardial fields in embryos with cardia bifida. Further, we found 
that if a myocardial field acquires an unconstrained (free) edge, the latter quickly bends 
inwards without any appreciable influences from surrounding tissues. Most interestingly, 
if AIP regression is disrupted symmetrically, and the incision crosses the entire 150-200 
µm width of the myocardial progenitor field, the latter continues to move cranially and 
ventrally in the absence of normal, AIP formation-associated endodermal movements. 
Further, using computational modeling we were able to reproduce the anterior-
directed movements of cardiac progenitor fields by prescribing the uniform contraction 
within the myocardial sheet to generate a cup-shaped bend – a morphology 
characteristic to the myocardium at HH8-9 (Fig. 3.3; Abu-Issa and Kirby, 2008; van den 
Berg et al., 2009). This change alone was not only able to “propel” the myocardial fields 
forward, but also move the rest of the splanchnic mesoderm medially, which could aid 
the AIP regression. At the current stage, our model does not account for the influence of 
the endoderm or that of medial heart field aspect contraction. So, in an interesting way 
Fig. 3.9 corresponds to the distribution of forces in the embryo with midline incision-
induced cardia bifida (Fig. 3.6B). Namely, in the absence of the endoderm driving the 
convergence of the fields at the midline, they move in an antero-lateral direction, an 
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event that results in the formation of two independent “half-hearts” in live embryos 
(Glanzer and Peasley, 1970; Rosenquist, 1970; Satin et al., 1988). 
In the final set of experiments (Fig. 3.11), we address the roles of actin 
cytoskeleton, Rho kinase, FAK, cell proliferation and myocardial-specific expression of a 
constitutively active Rho isoform on endodermal contraction (with the AIP regression 
speed as a read-out) and autonomous myocardial deformations, driving the 
displacements of heart fields past the incision edge in perturbed embryos (Fig. 3.6E). 
We found, that inhibition of cell proliferation by Mitomycin C had virtually no effect on 
either dynamic process. The treatment was effective in reducing cell proliferation, 
typically resulting in over 3-fold decrease in the mitotic index (measured by automated 
counting of phosphorylated H3-positive nuclei in control and Mitomycin C-treated 
specimens; data not shown). Both AIP regression and myocardial deformation were 
sensitive to perturbation on ROCK and FAK function, although endoderm deformation 
was disrupted by lower concentrations on perturbing reagents. Myocardial deformations 
appear to be relatively resistant to actin depolymerization. Strikingly, myocardial 
expression of caRho had mild, yet significant effect on both processes. This last result 
may have interesting implications (discussed in detail in Chapter 5) as to the possible 
mechanisms that couple myocardial and endodermal tissue contractilities. 
In conclusion, we argue that the observed bending of the myocardial sheet, 
which progressively develops in a posterior-to-anterior direction (concomitantly with the 
onset of expression of myocardial differentiation markers within the progenitor fields), 
and cell-shape change-mediated medial heart field aspect contraction represent the 
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forces responsible for the displacement of the myocardial field in the anterior direction. 
Endodermal contraction is responsible for bringing the myocardial fields to the midline 
and juxtaposing them for effective fusion. 
 
Applicability of the proposed mechanism to other model systems of heart development 
 
In zebrafish and Xenopus endoderm and cardiogenic mesoderm are involved in 
signaling interactions. For instance, when Xenopus deep endoderm was co-cultured 
with the heart primordia, cardiogenesis was enhanced (Nascone and Mercola, 1995). In 
zebrafish both myocardial and endoderm development are dependent on GATA5 
function, aberrant in faust mutants (Reiter et al., 1999). Zebrafish casanova (Alexander 
et al., 1999) and one-eyed-pinhead (Schier et al., 1997) mutants both lack the 
endoderm and demonstrate cardia bifida phenotypes. In contrast to endoderm folding-
based foregut morphogenesis of avians and mammals, in zebrafish and Xenopus the 
gut develops from a rod of cells, that undergoes luminization. In zebrafish, such a rod 
forms as a result of midline-directed movements of bilateral endoderm progenitor 
populations. These movements resemble those of the cardiac progenitors (Sakaguchi et 
al., 2006; Arrington and Yost, 2009), and can similarly be disrupted by knockdown of 
syndecan 2 (a transmembrane heparan sulfate proteoglycan that initiates fibronectin 
and laminin assembly). However, in natter mutants (fibronectin; Trinh and Stainier, 
2004) cardia bifida is observed, yet foregut morphogenesis is not affected, suggesting 
that endodermal and cardiac progenitors rely on distinct mechanisms for arrival at the 
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midline. Holtzman et al., 2007, established the requirement for the endocardium for 
successful completion of myocardial progenitor movements during zebrafish heart tube 
assembly. 
Altogether, it is unlikely that zebrafish cardiac progenitors rely on the endoderm 
to physically drive their convergence at the midline. However, it would be interesting to 
investigate if myocardial progenitor populations in zebrafish undergo tissue 
deformations similar to those we describe for avian embryos, during their midline-
directed movement. The need to maintain the ability to undergo deformations in a 
coordinated fashion could explain the strict requirement for epithelial organization 
(maintained by interactions with fibronectin), a condition that Trinh and Stainier (2004) 
demonstrated to be critical for myocardial convergence at the midline in zebrafish.  
What is a possible cellular mechanism underlying bending of the myocardial sheet?  
 
 To begin to understand whether myocardial progenitors utilize any of the well-
studied mechanisms of epithelial sheet bending, such as apical constriction (Sawyer et 
al., 2010) we looked at cell shapes of MF20+ labeled myocardial progenitors in 
transverse sections through the heart fields in embryos perturbed as in Fig. 3.6E (n=3). 
Classic examples of apical constriction-driven processes are usually exerted by 
elongated or wedge-shaped cells, such as, for instance, bottle cells in Xenopus (Hardin 
and Keller, 1988) or ventral furrow cells in Drosophila. Perturbed embryos were chosen 
as they demonstrate more robust bending of the myocardial sheet than unperturbed 
embryos at HH8-9. Figure 3.12 contains a representative example, allowing the 
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illustration of the typical cell shapes at several locations throughout the c-shaped 
myocardial field. As presented in Fig. 3.12B, a group of cells at the medial edge of the 
group of myocardial cells have elongated shapes. The border between these cells and 
their less elongated neighbors is rather sharp (indicated by arrows in Fig. 3.12B; the 
border between the MF20+ myocardial cells and the adjacent splanchnic mesoderm is 
shown with arrowheads in Figs. 3.12B and D). It is likely that these cells are involved in 
the contraction of the medial aspects of myocardial fields (Fig. 3.4). At the same time, 
the cells at the central and lateral aspects of the c-shaped myocardial field demonstrate 
a variety of spindle, rounded, and cuboidal cell shapes. Given these cell morphologies, 
it is very difficult to imagine that myocardial sheet bending would be brought about by 
uniform apical constriction.  
 We made another interesting observation regarding myocardial sheet bending in 
normal HH8-9 quail embryos (n=4). Namely, when the myocardial field transitions from 
flat to convex, the number of cell layers in its wall increases from one to two or three. 
Fig. 3.13 shows two sections (same embryo as Fig. 3.3) taken at different levels along 
the anterior-posterior embryonic axis (A is more cranial than B). Insets include higher 
magnification images through a single cell-thickness of the myocardial field in Fig. 
3.12Bʼ, and a thicker wall of the myocardial field in Fig. 3.12Aʼ. We think that bending is 
unlikely to be the direct result of a local cell proliferation increase, as high 
concentrations of Mitomycin C had no effect on the myocardial movement (which we 
believe to be an outcome of tissue deformation/bending; Fig. 3.11D). Also, several in-
depth studies of cell proliferation within the developing heart concluded that the early 
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myocardium at stages HH8-9 showed low proliferation rates with cell cycle lengths 
exceeding 32 hours (van den Berg et al., 2009; de Boer, 2012). At the same time, cells 
in the adjacent non-myocardial mesoderm divided rapidly. In the model of heart growth 
proposed by van den Berg et al. ventral bending of the myocardial sheet (referred to as 
“luminization” by the authors) coincided with halting of active proliferation. 
 A theoretically possible mechanism that could result in the bending of a 2-3 
layered sheet of cells would be if a number of cells from the bottom sheet repositioned 
into the top one(s). In this way, the bottom-most layer of cells would eventually acquire 
flattened, squamous morphology and develop tension sufficient to account for the 
ventral-ward bending of a myocardial sheet. We currently test this possibility with 
computational modeling. However, more experimental evidence is needed to definitively 
understand the mechanisms driving myocardial tissue deformations. 
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Figure 3.12: Characteristic cell shapes at medial, lateral, and central aspects of 
the deformed myocardial field.  
A – transverse section (10 µm thick) through the embryonic left side of a quail embryo 
that underwent the incision across the AIP arch at HH8 as in Fig. 3.6E, and developed 
for 16 h post-perturbation. Red labeling corresponds to myocardial cells (MF20), green 
– to fibronectin (B3D6), and blue – to cell nuclei (DAPI). Some red labeling of fibronectin 
is due to the interaction between the goat anti-mouse secondary antibodies (used to 
visualize MF20 binding), with B3D6 antibody (mouse), delivered to the tissues by 
microinjection prior to the incision. Nt – neural tube, nc – notochord, s – somite, sm – 
splanchnic mesoderm, mc – myocardium, e – endoderm. Scale bar: 100 µm.  
B-D – higher magnification confocal (left panels) and DIC (right panels) images of 
regions delineated by accordingly marked rectangles in A. Arrows in B indicate the 
transition from columnar to rounded cells, and arrowheads in B and D show transition 
from the MF20+ myocardium to the non-myocardial mesoderm. Scale bars: 10 µm. 
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Figure 3.12
 
	   167	  
 
 
 
 
Figure 3.13: Transition from flat (posteriorly) to bent (anteriorly) organization of 
the heart field occurs concomitantly with an apparent increase in the number of 
cell layers comprising the MF20+ myocardium. 
A and B – transverse sections through the HH8 embryo (also shown in Fig. 3-3). 
Embryonic region shown in A is approximately 200 µm anterior to B.  
Aʼ – a higher magnification image of the region outlined with the rectangle in A.  
Bʼ – a higher magnification image of the area corresponding to the region outlined in B, 
acquired from the next (10 µm posterior) serial section. A: anterior, P: posterior; e: 
endoderm, mc: myocardium. 
Note that myocardium appears to include several cell layers in A (compare 
arrangements of nuclei marked by asterisks in Aʼ and Bʼ).  
Scale bars: 50 µm 
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Figure 3.13
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CHAPTER FOUR: 
 
VEGF signaling over-activation affects cardiac progenitor movements 
and results in defects in cardiac tube elongation 
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Abstract 
Signaling by vascular endothelial growth factor (VEGF) plays an integral part in 
cardiovascular development, yet little is known of its role during early heart 
development. We introduce exogenous rhVEGF165 into quail embryos at the stage 
preceding heart tube formation (HH8) and use time-lapse microscopy to visualize the 
effects of the treatment on heart tube assembly and early elongation. Surprisingly, the 
treatment resulted in significant reduction of the heart tube size in VEGF165-injected 
embryos compared to controls. At the same time, perturbed embryos included 
dramatically enlarged areas of differentiated (MF20+) myocardium positioned caudal to 
the tubular heart and dorsal to the abnormally expanded inflow region. Results of cell 
tracing-based measurements indicate that the speed of myocardial progenitor 
movements towards the midline is significantly reduced by VEGF165 treatment. 
Furthermore, the rate of incorporation of newly differentiated myocardium into the 
cardiac posterior pole is also reduced, and coordinated myocardial deformations are 
affected by VEGF over-activation. Inhibition of VEGF signaling by VEGF-R2 blocker 
SU5416 did not affect the timing of heart tube assembly. Interestingly, neither excessive 
activation, nor inhibition of VEGF signaling affected the rate of foregut elongation – a 
process responsible for the bulk of midline-directed cardiac progenitor movements. 
From the data available to us, we propose that gross enlargement of the cardiac 
inflow/omphalomesenteric vein region, induced by exogenous VEGF exposure, creates 
a barrier that mechanically prevents the myocardial progenitor fields from undergoing a 
coordinated deformation that enables their fusion at the midline. Together, these 
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processes lead to a pathological reduction of heart tube size in VEGF165-treated 
embryos compared to the controls. Our results emphasize that a proper balance of cell 
type constituents, which can be easily shifted by inappropriate levels of VEGF signaling, 
is critically important for cardiac organogenesis. 
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Introduction 
 
Vascular endothelial growth factor (VEGF) signaling through receptor tyrosine 
kinases FLK1 (VEGF-R2, KDR) and FLT1 (VEGF-R1), and neuropilins, plays a central 
role in development of the cardiovascular system. VEGF is a glycoprotein produced in 
multiple alternative splicing isoforms, which differ in their receptor binding characteristics 
and ability to interact with extracellular matrix constituents. VEGF165 isoform is often 
used in gain-of-function studies due to its high potency and bioavailability (Drake and 
Little, 1995; Feucht et al., 1997; Grunstein et al., 2000; Drake et al., 2006). Multiple 
studies have established roles for VEGF as a potent inducer of endothelial cell 
proliferation (Ferrara and Henzel, 1989; Keck et al., 1989), survival (Benjamin et al., 
1999; Gerber et al., 1999), differentiation (Risau and Flamme, 1995), and migration 
(Senger et al., 1996). It can also act as a mitogen and migration stimulant for other cell 
types, such as leucocytes or Schwann cells (Clauss et al., 1990; Sondell et al., 1999).  
The tremendous importance of VEGF signaling in embryogenesis is illustrated by 
the outcomes of gene knock-out studies in mice. If a single VEGF allele is deleted, 
embryos die at E11-12 due to massive vascular abnormalities (Carmeliet et al., 1996; 
Ferrara et al., 1996). Further, if both VEGF alleles, or any of the VEGF receptor alleles 
are removed, the onset of embryonic lethality occurs at E8.5-9.5 (Shalaby et al., 1995; 
Fong et al., 1999; Nagy and Rossant, 1999). The upper threshold of VEGF signaling, 
permissive for normal development, is also defined within narrow margins. The study by 
Miquerol et al. (2000) showed that a 2-3 fold increase of VEGF production causes 
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pronounced cardiac and vascular abnormalities, resulting in midgestational lethality. The 
mutant embryos developed multiple myocardial defects, outflow track abnormalities, 
aberrant ventricular septation and altered coronary artery development. In avian 
models, exogenous VEGF was shown to induce abnormal hypervascularization, dilation 
and fusion of embryonic vessels if delivered at HH8-9 (Drake and Little, 1995), and to 
increase vascular permeability when overexpressed in the limb bud of a day 10 embryo 
(Flamme et al., 1995). When delivered at embryonic day 4.5 in quail, VEGF caused 
multiple cardiac and venous abnormalities (Feucht et al., 1997). More recently, Drake et 
al. (2006) showed that exposure to exogenous VEGF165 caused defects in cardiac 
looping. The studies mentioned above provided important knowledge about abnormal 
cardiovascular phenotypes resulting from VEGF over-activation. However, the 
information is scarce regarding the dynamic aspects of response to VEGF 
overexposure, and its effects on early heart tube assembly.  
In the current study, we deliver recombinant human VEGF165 to quail embryos 
just prior to initiation of heart field fusion and record the induced changes in 
fluorescently labeled cardiac progenitor motility by means of time-lapse imaging. In 
agreement with known roles of VEGF in vascular development, we observe massive 
expansion of the endothelial/endocardial component of the cardiac inflow region and 
adjacent omphalomesenteric veins. Surprisingly, VEGF overexposure leads to 
development of shorter heart tubes, and more caudally - enlarged areas of differentiated 
(MF20+) myocardium, in treated embryos compared with controls. Results from 
analyses of myocardial progenitor movement speeds, dynamics of cell addition to the 
	   174	  
cardiac posterior pole, and the rate of foregut elongation measurements suggest a 
connection between VEGF-induced changes in the size of the cardiac inflow and 
ensuing defects in the heart tube elongation process, observed in response to 
excessive VEGF signaling in embryonic quail. 
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Experimental Procedures 
 
Quail embryo isolation 
 
Fertile eggs of wild type or Tie1::H2B-YFP transgenic quail (Coturnix coturnix 
japonica; Ozark Egg Co., Stover, MO) were incubated at 37°C to reach stages HH6 to 
HH11 (Hamburger and Hamilton, 1951). Embryos were then isolated, placed on paper 
rings, and cultured as in Cui et al., 2009 (modified EC culture; Chapman et al., 2001). 
 
Myocardial progenitor labeling 
 
pCMLC2::mitoRFP plasmid DNA in complex with Lipofectamine 2000 (Invitrogen) 
was delivered into the subendodermal spaces of wild type and Tie1::H2B-YFP embryos 
at HH5-6 by microinjection using a PLI-100 (Harvard Instruments) apparatus. Embryos 
were incubated at 37°C for 4-5 h until the fluorescent signal from reporter expression 
became detectable.  
 
Wide-field time-lapse imaging 
 
Automated microscopy of immunolabeled quail embryos was performed as 
described elsewhere (Czirok et al., 2002; Zamir et al., 2008). Briefly, this imaging 
system is based on a computer-controlled widefield epifluorescent microscope (Leica 
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DMR series) workstation, equipped with a motorized stage and connected to a cooled 
digital CCD camera (QImaging Retiga-SRV). Most experiments utilized a 10X objective 
(.25 NA). The images are acquired using both epifluorescence and differential 
interference contrast (DIC) optics. Acquired images have 12-bit grayscale intensity and 
a resolution of 1.33 μm/pixel. One time point (“frame”) of the time lapse sequence 
typically consists of 4-8 images taken at slightly overlapping xy locations of the embryo 
(“tiles”), with 7-9 focal (z) planes in each tile. The length of the time interval between 
consecutive frames depends on the number of focal planes, fields and optical modes 
and is usually within the range of 2-20 minutes. Up to 12 embryos can be imaged per 
recording. During image acquisition the embryos are kept at 37°C in a thermostatically-
controlled chamber. Custom image processing software (TiLa, KUMC), based on code 
described in Czirok et al., 2002, was used to create high resolution 2D time-lapse 
sequences for cell/ECM tracking and Particle Image Velocimetry (PIV) analyses. To 
enhance contrast, selected epifluorescence image stacks were deconvolved by a 
commercial, blind adaptive deconvolution software (Autoquant X, MediaCybernetics).  
 
Post-fixation immunofluorescence labeling 
 
Embryos were fixed and prepared for immunolabeling according to Little and 
Drake, 2000. Monoclonal antibodies against avian epitopes (B3D6, QH1; DSHB, Iowa 
City, IA), directly conjugated to AlexaFluor 488, 555 or 647, were added at 1:1000 
dilutions, and mouse monoclonal antibody MF20 (DSHB, Iowa City, IA) – at 1:10 dilution 
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in 3% BSA for overnight incubation. Goat anti-mouse secondary antibodies, conjugated 
to AlexaFluor 488, 555 or 647 (Molecular Probes, Eugene, OR), were used to follow the 
MF20 staining at 1:1000 dilution in 3% BSA.  
 
Confocal imaging 
 
Confocal imaging of whole-mount embryo specimens was performed using a 
Nikon 90i upright microscope with a Nikon C1 confocal scan head and Nikon Plan 
Apochromat 10x and 20x objectives. 
 
Preparation of transverse plastic sections 
 
Embryos were dehydrated through a graded ethanol series, placed in JB4 
infiltration medium (Electron Microscopy Sciences, Hatfield, PA) at 4ºC overnight, and 
embedded in JB-4 resin following the manufacturerʼs protocol. Subsequently, 10μm 
sections were prepared. 
 
Manual tracing of cells and other image details 
 
Manual tracing of image details was performed using custom software (see, e.g., 
Czirok et al., 2004). Briefly, this software allows marking points of interest within a 
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series of image stacks, i.e. tracing movement in three dimensions. In this study, only the 
markers' projections to a frontal plane were assessed. 
 
rhVEGF165 treatments 
 
Unless otherwise specified, 250-300 ng of rhVEGF165 (R&D Biosciences) in 
PBS were delivered by a single microinjection to the ventral midline (just anterior to the 
center of the AIP arch) of quail embryos at HH8-8+. This amount was selected because 
it consistently causes a rapid onset of inflow region expansion, allowing assessment of 
induced changes in heart tube assembly in relatively young (HH10-12), and hence more 
optically transparent, embryos. Control embryos received injections with the same 
amounts of BSA (Sigma) dissolved in PBS. Embryos were then incubated at 37°C for 
12-16 h, or subjected to time-lapse imaging. In general, prior to initiation of the image 
acquisition, embryos were incubated at 37°C on the microscope stage for 1-1.5 h.  
 
SU5416 treatments 
 
An 80 mM DMSO stock solution of SU5416 (Tocris Biosciences) was prepared 
according to the manufacturerʼs instructions. Prior to the treatment, the stock solution 
was dissolved to the working concentration of 1 or 2 mM in PBS, and 20 µl of the 
resultant solution were delivered to the ventral surface of the embryos in EC culture. 
Embryos were then incubated at 37°C for 4-12 h, or subjected to time lapse imaging. 
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Results 
 
Treatment with rhVEGF165 provokes massive changes in the anatomy of the 
developing vascular system 
 
 To investigate the development of a VEGF overactivation-induced 
hypervascularization phenotype (Drake and Little, 1995) in time lapse, we subjected 
eight Tie1::H2B-YFP HH8+ embryos to microinjection with a solution of rhVEGF165 as 
described in Experimental Procedures, in two independent experiments. Seven control 
embryos received BSA injections. VEGF-treated and control embryos were then 
subjected to time-lapse image acquisition for approximately 19 hours. Following 
completion of imaging experiments, embryos were fixed, processed histologically, and 
10 µm transverse sections were prepared. Fig. 4.1A includes selected time points of 
representative image sequences describing the development of BSA- and VEGF-
treated embryos. Note the distinct vascular patterning (with dorsal aortae and lateral 
vascular plexus, separated by avascular areas) in the control embryo (left panels in Fig. 
1A). The diameter of the omphalomesenteric veins (OV) was dramatically increased in a 
VEGF-treated embryo compared to the control. Further, in the control embryo the 
omphalomesenteric veins were displaced caudally (while maintaining a relatively 
consistent diameter; Fig. 4.1A) concomitantly with the elongation of the heart tube and 
regression of the AIP. At the same time, in the VEGF-treated embryo the anterior edge 
of the OV retained its initial position (arrowheads in Fig. 4.1A), whereas the posterior 
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OV edge was progressively displaced posteriorly, with concomitant increase in the OV 
diameter. Notably, the endocardial portion of the heart tube did not appear to increase in 
length with advancing time in VEGF-treated embryos.  
The cross-sectional anatomy of a control and VEGF-treated embryo is illustrated 
in Fig. 4.1B. The fragmented appearance of the endocardium and decreased volume of 
cardiac jelly in VEGF-treated embryos are consistent with findings of Drake et al., 2006. 
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Figure 4.1: Exogenous rhVEGF165 treatment leads to defects in vascular 
patterning and a dramatic expansion of the omphalomesenteric veins in quail 
embryos. 
A – selected frames from a time lapse image sequence describing development of BSA-
treated (left panels) and rhVEGF165-treated (right panels) Tie1::H2B-YFP-transgenic 
embryos from HH9 to HH13. Elapsed times from the beginning of an acquisition are 
listed in the top left corners of images. DA – dorsal aortae, HT – heart tube, OV – 
omphalomesenteric veins. Asterisks indicate an avascular space separating the DA 
from each lateral vascular plexus in BSA-treated embryos. Arrowheads point to the 
anterior edge (on the embryonic right side) of the OV, allowing tracing of its posterior-
ward displacement in the BSA-treated embryo and maintenance of a stationary position 
in the VEGF-treated specimen. Scale bars: 200 µm. 
B – DIC images of transverse sections through BSA- and VEGF-treated embryos at the 
level of the heart tube. E – endocardium, M – myocardium, ECM – extracellular matrix 
of the cardiac jelly. Note the disorganized appearance of the endocardium and the 
decreased volume of the cardiac jelly in the VEGF-treated embryos compared to the 
controls. 
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Figure 4.1 
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Exogenous VEGF treatment results in a decrease in the heart tube size with 
concomitant expansion of the MF20+ separated myocardial primordia at the dorsal 
surface of the cardiac inflow region 
 
 To quantitatively measure changes in heart tube size, induced by exogenous 
VEGF treatment, embryos were microinjected with VEGF (n=19) or BSA solution (n=14) 
as described above, and incubated at 37ºC for 14 h. After fixation, embryos were 
labeled with MF20, QH1, and B3D6 antibodies to visualize myocardial cells, 
endocardium/endothelium, and the fibronectin ECM, respectively. Images of each 
specimen were then acquired as z-stacks with a Leica DM6000 epifluorescence 
microscope, at 10x magnification. Some embryos were also subjected to confocal 
imaging for illustration purposes (see Fig. 4.2A). After image acquisition, transverse 
sections through VEGF-treated and control specimens (n=4, 2 for each type) were 
prepared (Fig. 4.2B). Note an increased length of the MF20+ myocardium at the dorsal 
surface of the inflow region in VEGF-treated embryos compared to the controls 
(asterisks in Fig. 4.2B). 
 In order to measure the surface area of the heart tube and separated myocardial 
primordia, the outlines of the above structures were traced manually in z-projected 
images, and the surface area of each selection was quantified using the Measure tool in 
Image J software. In Fig. 4.3A the heart tube (defined here as a continuous structure 
located anterior to the inflow region/OV) was outlined in each embryo in green, and 
areas of separated MF20+ myocardia (located posterior to the heart tube and dorsal to 
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the inflow region/OV) were outlined in red. The bar chart in Fig. 4.3B summarizes 
measurement results. In VEGF-treated embryos the surface area of the heart tube was 
decreased by 0.7 fold, but the size of separated myocardial primordia was increased by 
2.2 fold compared to the control embryos. 
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Figure 4.2: Exogenous VEGF treatment results in a decrease in the heart tube 
size with concomitant expansion of the MF20-positive myocardium included in 
separated primordia flanking the inflow/OV region. 
A – confocal images of control and VEGF-treated embryos with the myocardium (MF20) 
in red, endocardium/endothelium (QH1) in green, and fibronectin ECM (B3D6) in blue. 
HT – heart tube, OV – omphalomesenteric veins. Scale bar: 100 µm. 
B – transverse sections through the embryos shown in A at the level of the heart tube 
(top panels) and omphalomesenteric veins (bottom panels). MF20-positive myocardium 
at the dorsal surfaces of the OV is marked by asterisks. A – anterior, P – posterior. 
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Figure 4.2 
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Figure 4.3: Quantification of VEGF-induced changes in the sizes of the heart 
tubes and separated myocardial primordia. 
A – confocal images of VEGF-treated and control myocardia (same specimens as Fig. 
4.2) with heart tubes outlined in green, and separated MF20+ primordia flanking the OV 
- in red (see definitions in the text). 
B – a bar chart illustrating mean values of surface area measurements for the 
myocardial regions defined in A. Error bars: SEM. 
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Figure 4.3 
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Apparent speed of the myocardial progenitor movement towards the midline is 
decreased by VEGF over-activation 
 
Next, we decided to investigate possible causes leading to the observed 
decrease in heart tube size in VEGF-treated embryos. In Tie1::H2B-YFP embryos 
(n=28; four independent experiments) myocardial progenitors were labeled by 
transfection with the fluorescent reporter plasmid pCMLC2::Mito-RFP as described in 
Experimental Procedures. Fibronectin ECM was labeled in each embryo by 
microinjection of fluorescently-conjugated antibody B3D6 as in Drake and Little, 2000. 
Sixteen embryos (16/28) were treated with VEGF, and remaining specimens – with BSA 
as described above. Post-treatment development was recorded in time lapse for each 
embryo. 
To ask whether VEGF treatment affects myocardial progenitor movements 
towards the midline during the initial heart tube assembly, we did the following cell 
tracing experiment. We selected six image sequences out of the twenty-eight described 
above, three of each of the VEGF-treated and control specimens. In each time-lapse 
recording, we selected a stationary point, located anterior to the ventral midline (the 
edge of the buccopharyngeal membrane). Displacements of 10-15 CMLC2::Mito-RFP+ 
cells in each of the six embryos were traced manually, and the average speed of 
myocardial progenitor movements during the first five hours post-treatment was 
calculated separately for control and VEGF-treated specimens (Fig. 4.4.). As seen in 
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Fig. 4.4, speeds of myocardial progenitor movements decrease over time, but much 
more rapidly in VEGF-treated embryos. 
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Figure 4.4: Comparison of myocardial displacement speeds in control and VEGF-
treated embryos. 
Speeds of myocardial cell displacement during first 5 h following the VEGF or BSA 
treatment were measured as described in the text and plotted. Error bars: SEM 
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Figure 4.4 
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Myocardial deformations that occur during unperturbed heart tube elongation are 
impeded in VEGF-treated embryos 
 
As discussed in Chapter 3, prior to their fusion at the midline myocardial 
progenitor fields change position from ventral to dorso-lateral with respect to the 
coelomic cavities (see Fig. 3.3B). It is known that cardiac morphogenesis is a sequential 
process that occurs in an anterior-to-posterior progression (Linask, 2003). I.e., after 
initial heart tube assembly is complete, the caudal portions of the heart fields undergo 
the same morphological transitions their anterior counterparts experienced, prior to 
entering the heart tube. In this way newly differentiated myocardium is added to the 
heart tube at its posterior aspect, while myocardial progenitors that differentiated earlier 
already undergo more advanced morphogenesis within the heart tube.  
 To visualize the deformations within myocardial fields at stages following heart 
tube assembly, we selected time-lapse sequences that describe the development of 
control (BSA-treated) specimens between stages HH9-11. Multiple z-plane images for 
each time point were color-coded to convey the position of cells along the dorso-ventral 
embryonic axis (with the most ventral plane in red and the most dorsal in blue). In Fig. 
4.5A, the positions of three myocardial progenitor cells (marked with arrows of assorted 
caliber) are traced at advancing time points. Initially located posterior to the heart tube, 
these cells approached the ventral midline, underwent the change in position with 
respect to the dorso-ventral embryonic axis, and eventually became incorporated into 
the heart tube (Fig. 4.5A).  
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To see if the endothelial/endocardial compartment of the forming heart tube 
undergoes dorso-ventral displacements similar to those of myocardial primordia, we 
color-coded the images from time lapse recordings of Tie1::H2B-YFP embryo 
development at HH10-11. As illustrated in Fig. 4.5B, omphalomesenteric veins are 
involved in a “rolling forward” movement, with cells at their ventral surfaces being 
displaced posteriorly, and those at dorsal surfaces – anteriorly in relation to the heart 
tube position.  
 In order to investigate if myocardial movements at post-heart tube assembly 
stages are changed by VEGF treatment, we inspected the time-lapse recordings of 
control (n=12) versus VEGF-treated (n=16) embryos generated as described at the 
beginning of the previous section. In most of the control embryos (10/12, 83%), by the 
end of an approximately 17 h-long imaging experiment, all of the CMLC2::mitoRFP+ 
cells have entered the heart tube as seen in the left panels of Fig. 4.6. At the same time, 
in the VEGF- treated group only 6 out of 16 embryos (37.5%) did not have 
CMLC2::mitoRFP cells outside of the heart tube. The remaining 10/16 VEGF-treated 
embryos (62.5%) contained reporter-expressing cells in the locations posterior to the 
heart tube and dorsal to the expanded inflow region (right panels in Fig. 4.6). The 
location of these cells within separated myocardial primordia (as in Fig. 4.3A) was 
confirmed by post-fixation MF20 antibody labeling (data not shown). 
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Figure 4.5. During normal cardiac elongation, myocardial and endocardial 
compartments of the heart tube progressively undergo ventral displacements 
(“rotation”). 
A, B – selected frames from time lapse image sequences describing movements of 
CMLC2::GFP-expressing myocardial progenitors (A) and Tie1::H2B-YFP-positive 
endothelial/endocardial progenitors at progressive stages of cardiac tube assembly and 
elongation. Images were colorcoded to convey the information about the position of 
displayed objects relative to the dorso-ventral embryonic axis as illustrated by the 
provided reference bar. Arrows in A point to cells, displacements of which were traced 
(each type of arrow corresponds to the same cell/group of several cells in every image).  
Arrows in B illustrate the rotational movement of the omphalomesenteric veins (OV), 
whereby cells at the dorsal surfaces of the OV are continually displaced anteriorly, and 
those at the ventral surfaces – posteriorly during HH10 and later stages. Elapsed times 
from the commencement of image acquisitions are listed in the top left corners of the 
included images. Scale bars: 100 µm. 
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Figure 4.5
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Figure 4.6: Transition of myocardial cells from areas flanking the 
omphalomesenteric veins into the heart tube proper is delayed in VEGF-treated 
embryos. 
Selected frames from time-lapse image sequences that visualize and compare the 
development of a control and a VEGF-treated embryo from HH8 to HH12. Both 
specimens were Tie1::H2B-YFP-transgenic (green labeling), and transfected with 
CMLC2::MitoRFP reporter (red labeling). CMLC2::MitoRFP-expressing cells were 
present at the level of the omphalomesenteric veins (OV) in both the control and VEGF-
treated embryo at the intermediate stage (8.5 h; groups of cells marked with ellipses). 
By the end of the imaging experiment, no CMLC2::Mito-RFP+ cells were detected in the 
OV region of the control embryo (17.1 h; bottom left panel and corresponding inset). At 
the same time, multiple CMLC2::Mito-RFP+ cells were found in the OV area of the 
VEGF-treated specimen (bottom right panel and inset). To ensure visualization of cells 
expressing low levels of CMLC2::Mito-RFP, the contrast of images presented in both 
insets was enhanced to the same degree by identical methods. Scale bars: 100 µm 
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Figure 4.6
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Inhibition of VEGF signaling by the VEGF-R2 inhibitor SU5416 does not affect the initial 
stages of heart tube assembly and elongation 
 
 Twenty-two wild type quail embryos at HH8 were isolated. Twelve of them were 
treated with SU5416 (Tocris Biosciences) at 1 and 2 mM concentrations (6 embryos 
each) as described in Experimental Procedures. The remaining 10 specimens were 
treated with the same volume of DMSO in PBS. Groups of embryos were fixed after 4, 
7, and 12 h of post-treatment incubation. Endothelial and myocardial cells, as well as 
fibronectin ECM, were labeled with antibodies as described above. As seen in Fig. 4.7A, 
myocardial positions and morphology remained relatively unaffected by SU5416 
treatment at all the time-points examined. At the same time, SU5416 effectively reduced 
endothelial/endocardial cell numbers in treated specimens compared to the controls 
(note the virtual absence of the endocardium in the SU5416-treated embryo shown in 
transverse section in Fig. 4.7B).  
 
 
 
 
 
 
 
 
	   200	  
 
 
 
Figure 4.7: Analysis of effects of SU5416-mediated VEGF signaling inhibition on 
heart tube assembly and early elongation. 
A – confocal images representing embryos fixed after 4, 7, and 12 h of incubation with  
1 mM SU5416 (right panels) or DMSO (control; left panels). Embryos were stained with 
MF20 to label myocardium (red staining), QH1 to visualize endothelium/endocardium 
(green), and B3D6 to label fibronectin ECM (blue). Note decreased numbers of 
endothelial/endocardial cells in SU5416-treated embryos. Myocardial morphology is 
similar in both groups at all three time points included in the analysis. Scale bars: 100 
µm. 
B – transverse sections through the control and SU5416-treated embryo (both HH12) at 
the level of the heart tube. The endocardium is represented by a continuous epithelial 
layer in a control embryo (left panel), but is reduced to small cell aggregates in the 
SU5416-treated embryo (right panel). E – endocardium, M - myocardium. 
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Figure 4.7 
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Perturbations of endogenous VEGF signaling levels do not affect the speed of AIP 
regression 
 
AIP regression is one of the major forces driving the cardiac progenitor 
movements during tubular heart assembly (see Chapters 2 and 3, Varner et al., 2012). 
Therefore, we decided to examine if AIP regression speed in HH8-11 quail embryos is 
affected by exposure to rhVEGF165 or SU5416 treatment. The position of the center of 
the AIP arch and the first somite borders (see Fig. 3.11A for illustration) were traced 
manually in DIC time-lapse recordings of control embryos (n=6) or embryos developing 
in the presence of rhVEGF165 (n=5) and SU5416 (n=3). All treatments were set up as 
described above. Tracing data were then used to calculate the speeds of foregut 
elongation at three arbitrarily selected regions (time intervals) within the linear AIP 
regression trajectory (illustrated in Fig. 3.11A). The results summarized in Fig 4.8 
demonstrate that neither rhVEGF165 nor SU5416 treatment affected the AIP regression 
speed at any of the time periods examined. 
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Figure 4.8: Analysis of the effects of VEGF and SU5416 treatments on the speed 
of AIP regression. 
The bar chart illustrates mean speeds of AIP regression at the early, intermediate, and 
late portions of the trajectory (see Fig. 3.11A for explanation), measured in control 
(green bars), VEGF- (red bars), and SU5416-treated (blue bars) embryos. Error bars: 
SEM. 
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Figure 4.8 
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Discussion 
 VEGF is a well-known regulator of angiogenesis and vasculogenesis, 
endocardial cushion formation, and other aspects of cardiovascular development 
(Achen and Stacker, 1998; Ferrara, 2000) and participates in the growing list of 
processes and developmental events that involve non-endothelial cell lineages 
(reviewed in Haigh, 2008). In our study we focused on effects of VEGF overexposure on 
dynamic events that underlie heart tube assembly and early elongation in avian 
embryos.  
 Recombinant human VEGF165 was used by several groups to upregulate VEGF 
signaling and assess induced effects on vascular and cardiac development (Drake and 
Little, 1995; Feucht et al., 1997; Drake et al., 2006). In a study directly relevant to ours, 
Drake et al. (2006) demonstrated that injection of 25-50 ng of rhVEGF165 into quail 
hearts resulted in abnormal endocardial development, leading to the formation of 
separated folds and cords within this cell layer. Also, the authors reported that if VEGF 
overexposure was induced in HH9 (8-9 somites) quail embryos, defects in cardiac tube 
bending ensued, a phenotype not developed if younger (6-7 somites) embryos were 
treated. In comparison to the above study, our experiments were performed using 
higher (5-10 fold) concentrations of rhVEGF, and were targeted towards younger 
embryos (HH8, 4-7 somites). We were able to reproduce the endocardial phenotype 
reported by Drake at all. (Figs. 4.1B, 4.2B), and similarly, did not detect defects in heart 
tube bending in embryos treated prior to HH9.  
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 Interestingly, we found that VEGF overexposure led to a 30% reduction in the 
heart tube size in treated embryos compared to the controls (Fig. 4.3). Since this 
occurred in parallel with the increased extracardiac presence of MF20+ myocardial cells 
(Fig. 4.2 and 4.3), which are delayed from entering the heart tube after their arrival at 
the midline (Fig. 4.6), we favor a model where the effect of VEGF on myocardial 
movements is secondary to its effect on the inflow region and omphalomesenteric vein 
diameter.  
 Alternatively, one could propose a direct negative role for VEGF in regulating 
myocardial movements, whereby the signal would be received and processed by 
receptors on progenitor cell membranes. Albeit a logical possibility to consider, this 
mechanism would require the expression of FLK1 receptor by myocardial progenitors. 
Published evidence suggests that myocardial cells express only very low levels of FLK1 
in chick (Sugishita et al., 2000). Instead, myocardiocytes express and secrete VEGF 
ligand isoforms in the developing heart (Miquerol et al., 1999; Dor et al., 2001).  
Another potential mechanism that could account for the reduction in the heart 
tube length in response to VEGF could involve a VEGF-dependent depletion of the 
mesodermal progenitor pool (from which myocardial progenitors arise) to favor the 
differentiation of endothelial/endocardial cells. This scenario is unlikely, because it has 
been shown that in avian models myocardial and endocardial lineages segregate and 
become committed to a particular fate very early in development, namely within the 
early (HH3) primitive streak (Mikawa and Gourdie, 1996; Wei and Mikawa, 2000), at 
least 10-12 h prior to our chosen time of VEGF treatment administration. 
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One intriguing aspect of the phenotype we observe in response to VEGF 
overexposure is that despite induced hyperfusion of embryonic vessels (Drake and 
Little, 1995), the two omphalomesenteric veins remain separated in treated embryo as 
seen, for instance, in Fig. 4.2B. In transverse sections through the VEGF-treated 
specimens one can see the omphalomesenteric veins juxtaposed 300-900 µm 
distances, yet not connected (data not shown). Voronov et al (2004) measured stresses 
in the vicinity of the forming heart tube during normal development, and found that 
fusing OV experience compression prior to fusing and thus contributing to the inflow 
region in HH10 embryos. Taking into account our observations and the above published 
evidence it seems possible that the myocardial deformations in the vicinity of the inflow 
would serve to facilitate omphalomesenteric vein remodeling into a single endocardial 
tube by physically “pushing them together”. This process is clearly disrupted in VEGF-
treated embryos, making such remodeling impossible despite an over-abundance of the 
vascular fusion-promoting signal. 
 Without a doubt, additional studies are required to achieve a more 
comprehensive understanding of the cellular and tissue events that underlie the 
dramatic changes in cardiovascular development induced by VEGF overexposure.  In 
our ongoing and future studies, we are planning to use our existing imaging data to 
evaluate ECM fibril displacements, and speeds of endocardial and myocardial 
progenitors movement relative to the ECM, as we did for unperturbed embryos in 
Chapters 2 and 3. Quite unexpectedly, in our current study we found that VEGF 
treatment does not affect the regression of the AIP (Fig. 4.8). Given the primary 
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importance of this massive tissue folding event in driving the movements of ECM, 
endocardial and myocardial progenitors to the embryonic midline (see Chapters 2 and 
3), we are intrigued to investigate if the speed of coordinated displacement of the ECM 
and cardiac progenitors (tissue movement) is affected by VEGF, independently of the 
AIP regression.  
 Additionally, we are planning to assess the effects of VEGF signaling inhibition 
(using several chemical blockers of VEGF-R2 tyrosine kinase function) on myocardial 
progenitor and ECM displacements during early heart tube assembly and elongation in 
time lapse, to complement our existing data, obtained in static culture time-course 
experiments (Fig. 4.7). We expect the speeds of myocardial progenitor displacements 
towards the midline to be comparable with those measured in unperturbed embryos. As 
far as similar situations in other model systems are concerned, it is known that in the 
zebrafish endocardium-less mutant cloche, myocardial progenitors are able to reach the 
ventral midline (Stainier et al., 1995). 
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CHAPTER FIVE: 
 
Conclusions and future directions 
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Formation of the cardiac tube is the first organogenesis step in development, as 
the heart is the first organ to assemble and become functional in a vertebrate embryo. 
Despite being an extremely complex process, cardiac tube morphogenesis can be 
viewed from a standpoint of interaction between four participating tissue elements – the 
endocardium and myocardium, contributing two principal cellular layers of the early 
heart, and the endoderm and extracellular matrix, that were for a long time considered 
to provide an environment (substrate) for cardiac progenitor movements. Until recently, 
the endoderm was prescribed a predominantly signaling role in cardiogenesis (Lough 
and Sugi, 2000; Alsan and Schultheiss, 2002; Warkman et al., 2008). The extracellular 
matrix of the developing heart has many known functions and is represented by a 
variety of molecules (Bowers and Boudino, 2010). Among those, fibronectin clearly 
plays one of the central roles during heart tube assembly (Linask and Lash, 1986; 
Linask and Lash, 1988a; Linask and Lash, 1988b; Wiens et al., 1996; George et al., 
1997; Trinh and Stainier, 2004; Arrington and Yost, 2009). 
From studies on multiple vertebrate and invertebrate model organisms, a large 
amount of information is available about molecular signaling that acts during early heart 
morphogenesis (van Wijk et al., 2007; Wagner and Siddiqui, 2007; Gessert and Kuhl, 
2010); transcriptional and epigenetic regulation programs, activated in differentiating 
endocardial and myocardial progenitors (Cripps and Olson, 2002; van Weerd et al., 
2011; Lopez-Sanchez and Garcia-Martinez, 2011; Ohtani and Dimmeler, 2011); and 
single gene mutations that lead to defects in early heart tube formation in vertebrates 
(Kawahara et al., 2009; Matsui et al., 2007; Sakaguchi et al., 2006; Li et al., 2004). At 
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the same time, the question remains how cardiac progenitors facilitate large-scale tissue 
rearrangements during their morphogenetic movements. 
As shown in a number of recent studies by our group and others (Sepich et al., 
2005; Zamir et al., 2006; Zamir et al., 2008; Szabo et al., 2011; Aleksandrova et al., 
2012), movements of embryonic cell populations at different stages of embryonic 
development result from a combination of displacements in a manner correlated with the 
surrounding tissue environment (“tissue motion”), and those relative to it (“active 
movement”). The question is often asked as to the driving forces of tissue motion (Chuai 
and Weijer, 2009). Our results (Chapters 2 and 3) point to the regression of the AIP in 
combination with the coordinated deformation of myocardial progenitor fields as the 
most likely drivers of tissue movement in the vicinity of the developing heart tube. 
In Chapter 2, we present evidence for transfer of preassembled ECM fibrils from 
their initial locations within the precardiac mesoderm to the target positions within the 
heart tube, by tissue motion. Given the ability of ECM to specifically interact with 
morphogenetic factors (Hynes, Science 2009), this finding could have implications for 
our understanding of how morphogen signaling gradients are set and maintained within 
the precardiac mesoderm and, subsequently, the heart tube. Recently, Milgrom-
Hoffman et al. (2011) provided evidence that endocardial cells derive from vascular 
endothelium in the mouse embryo. Similarly, in quail, we see that the proximity to the 
AIP defines the fate of a given cell as endocardial or endothelial. Further, passive 
objects (latex beads), positioned in locations subject to the midline-directed tissue 
movement, are similarly able to enter the heart tube.  
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Despite all the literature postulating that cardiac progenitor movements to the 
midline occur relative to the fibronectin ECM and/or the endoderm, our study is unique 
in our attempt to visualize the said movements in vivo using specific ECM and cardiac 
progenitor labeling strategies, and to quantitatively assess the relative motion speed 
and directions. In 1963, deHaan used iron particles to mark the endoderm in chick and 
subjected the embryos to “time-lapse cinematography”. Of interest, the conclusions of 
the study (although concerning earlier, HH5-7, stages of development) stated that the 
myocardium moves anteriorly (“cephalically”) relative to the endoderm.  
The data presented in Chapter 3 was used to develop a subcellular element-
based model that, even at this early stage, is able to describe myocardial movements 
rather faithfully (Figs. 3.7-9). The model will be further refined to account for the 
observed contraction (shortening) of the medial myocardial field aspects, deforming 
influence of the AIP regression, etc. The modeling approach illustrated here is 
significantly different from that used by Varner et al. (2012), and potentially can be used 
for a wider range of applications. Instead of being based on a single bended contractile 
beam, our model represents both the anatomy of the myocardium and the surrounding 
mesoderm, as well as the specific mechanical activity (bending and spatially restricted 
contraction) we suggest for the myocardium. Model simulations then allow us to explore 
the tissue scale consequences of the assumed myocardial behavior. Thus, our 
mechanical model also allows us to establish a connection between the tissue and cell-
level behaviors. 
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The model of myocardial field movements that implies coordinated deformation of 
progenitor fields would allow the explanation of multiple observations by our group and 
others. Further, we believe that the “active” (deformation-driven) myocardial movements 
might contribute to the convective tissue motion that is, in turn, responsible for the bulk 
of the endocardial progenitor movements (discussed in Chapter 2). However, the 
degree of this contribution is likely to be secondary to that of the AIP regression/foregut 
elongation. It is logical because endocardial progenitors are embedded within the ECM 
(Fig. 2.1; Linask and Lash, 1993) that separates the myocardium and the endoderm – 
an ECM layer myocardial cells move relative to.  
The mechanisms responsible for myocardial sheet folding (bending) need to be 
investigated as an intriguing continuation of this study. Cellular morphologies within the 
cup-shaped bend do not suggest a possibility for “classic” wedge-shaped cell-driven 
bending to occur in this situation (Sawyer et al., 2010). However, myocardial cells may 
present a case whereby very subtle change of cell shape in each individual cell (like that 
observed for endodermal cells in C. elegans, which undergo internalization as a result of 
very mild apical constriction; Lee et al., 2006) may lead cumulatively to a pronounced 
bending of a sheet.  
Coordinated cell shape changes, exhibited by myocardial cells, have been 
described in cardiac morphogenesis in zebrafish. The study by Auman et al. (2007) 
demonstrated that regionally confined cell shape changes underlie the emergence of 
ventricular chamber curvatures in the developing heart. In chick, early work by Manasek 
	   214	  
et al. (1972) proposes myocardial cell shape change as a potential mechanism for 
cardiac looping. 
 A potential mechanism that could contribute to the observed dorsal bending of 
the myocardial progenitor fields may involve gradual accumulation of the 
glycosaminoglycan molecules between myocardium and the underlying endoderm, able 
to attract water and create an internal pressure within the tissue. De Jong et al. (1990) 
stated that precardiac mesoderm secretes ECM components that “inflate” the 
myocardial epithelium. Nakamura and Manasek (1981) demonstrated that treatment of 
early heart tubes with hyaluronidase causes them to deflate due to the loss of the 
cardiac jelly volume. Glycosaminoglycan hyaluronan is a major constituent of the ECM 
in the developing heart (Orkin and Toole, 1978), important for various aspects of 
morphogenesis such as early heart valve development (Markwald et al., 1975, 1977; 
Lagendijk et al., 2011). It is produced by both endocardium and myocardium beginning 
at the stages immediately preceding heart tube formation (Orkin and Toole, 1978). 
Hyaluronan accumulation was shown to propel epithelial displacement during inner ear 
formation in Xenopus (Haddon and Lewis, 1991). Furthermore, in gastrulating sea 
urchin embryos localized deposition of ECM with its subsequent hydration (expansion) 
was proposed to drive epithelial sheet bending and invagination underlying archenteron 
formation (Lane et al., 1993). 
Given the above examples of ECM-driven tissue deformations it would be both 
interesting and necessary to investigate the effects of the loss of hyaluronan (via 
hyaluronidase treatment) on myocardial curling and convective tissue movements. 
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However, treatment of developing embryos with hyaluronidase failed to inhibit cardiac 
looping - another tissue deformation-driven event in cardiac morphogenesis (Baldwin 
and Solursh, 1989; Linask et al., 2003). Further, mouse deficient for hyaluronan 
synthase Has-2 were able to develop heart tubes, but exhibited multiple cardiac defects, 
including abnormally thin myocardium, at the time of their death at E10.5 (Camenisch et 
al., 2000).  In our experiments to date, we found a wide variety of cardiac jelly volumes 
associated with very similarly deformed myocardial primordia in transverse sections of 
embryos subjected to lateral incisions (as Fig. 3.6E). 
 Our results on directionality and magnitudes of the convective tissue movements, 
presented in Chapters 2 and 3, lend support to the conclusions of Varner et al. (2012) 
on the primary role of the endoderm in bringing the heart fields to the midline. 
Quantitative data obtained in this study confirm that speeds of the midline-directed 
movement of both types of cardiac progenitors, as well as of the two prominent ECM 
constituents (fibronectin and fibrillin-2; summarized in Fig. 3.1C) is coordinated with the 
AIP regression speed in unperturbed embryos (Figs. 3.11B and 4.8). Consequently, in 
order to understand the driving force of early cardiogenesis, the field needs to decipher 
molecular, cellular, and tissue mechanisms responsible for AIP regression. So far, 
available information is rather scarce. It is known that a KRAB zinc finger transcription 
factor Chato, a known regulator of convergence-extension movements in all three germ 
layers, plays roles in the endoderm elongation and gut closure in mice (Garcia-Garcia et 
al., 2008). Recently, an important part in controlling early foregut morphogenesis had 
been assigned to the atypical Rho GTPase Rhou, implicated in regulating epithelial 
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architecture within the developing endoderm (Loebel et al., 2011). 
Our results in Chapter 3 suggest an attractive possibility that endoderm 
contractility at the AIP can be influenced by the adjacent mesoderm. As seen in Fig. 
3.11E, a myocardial-specific expression of the constitutively active form of Rho 
produces a small but statistically significant decrease in the AIP regression speed 
compared to GFP-transfected controls in quail embryos. The endoderm and mesoderm 
are coupled through the pronounced ECM layer (Figs. 3.1A, 3.5), and tissue 
deformations indicative of contraction are evident within the mesodermal layer (Figs. 3.3 
and 3.4). At the same time, careful inspection of our imaging records of MitoTracker-
labeled embryo (such as those presented in Fig. 3.2) failed to reveal evidence of similar 
cell shape changes within the endoderm.  It is possible that such a small effect of Rho 
disruption is due to the low transfection efficiency in our experiments, which we estimate 
to rarely exceed 10% of the total myocardial population. To further dissect the roles of 
myocardial contraction in AIP regression, one could attempt myocardial-specific 
expression of dominant negative and constitutively active isoforms of other known 
regulators of actin-based motility and cell shape regulation, such as the GTPases Rac 
and Cdc42, Rho kinase (ROCK) and others. Another way to introduce mechanical 
discontinuity into the cohesive myocardial sheet would be to induce controlled cell death 
within a subset of cells using any of the conventional strategies, such as tissue-specific 
expression of a herpes virus thymidine kinase (Su et al., 1997; Vile and Hart, 1993), 
diphtheria toxin (Harrison et al., 1991; Saita et al., 2001) or constitutively active caspase 
3 (Condorelli et al., 2001). 
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Gene expression studies indicate that the AIP has a unique gene expression 
signature compared to the adjacent endodermal tissue. For instance Fgf8 is expressed 
by the endoderm in the narrow stripe that corresponds to the position of the AIP (Streit 
and Stern, 1999; Bailey et al., 2006; Lopez-Sanchez et al., 2009). Stalsberg and 
DeHaan (1968) demonstrated that endoderm is “rolling over” the AIP into the developing 
gut. This makes this endodermal structure functionally similar to the primitive streak – a 
site where cells become transiently, “in passing”, exposed to a variety of molecular 
signals (Mikawa et al., 2004).  
 Without a doubt, live imaging studies can contribute a great deal of valuable 
information to the understanding of cell rearrangements at the AIP. In our preliminary 
experiments we were able to detect some differential movements within the 
MitoTracker-labeled endoderm (Aleksandrova et al., unpublished). However, the light-
sensitive nature of MitoTracker and some other similar dyes we tested does not allow 
imaging with sufficient frame rate for a long enough time period to provide all the 
needed information on cellular repositioning at the AIP. Hopefully in the near future new 
transgenic strains of chick or quail with endoderm-specific reporter expression will be 
created, providing as valuable a tool for understanding endoderm morphogenesis, as 
the Tie1::H2B-YFP quail strain (Sato et al., 2010) has been for vascular 
endothelial/endocardial biology. 
 Another open question of tremendous importance is that of the molecular 
signaling regulators of the tissue deformation processes responsible for heart 
morphogenesis.  Developing myocardial progenitors are exposed to signaling by Fgf 
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and Bmp family members (Lough and Sugi, 1995). Both pathways have known roles in 
cell shape regulation in other developmental processes. Fgf signaling was implicated in 
regulating apical constriction in zebrafish (Harding and Nechiporuk, 2012). Bmp/SMAD 
signaling was shown to be involved in cell shape transition from columnar to squamous 
during inner ear development (Ohta et al., 2010). 
Thus, it would be interesting to determine if known morphogen regulators of 
cardiac differentiation may also play previously unappreciated roles in tissue 
deformations/convective tissue movements in the anterior embryo. In Chapter 4 we 
create a situation where VEGF (a specific “endothelial” mitogen and morphogenetic 
factor; Leung et al., 1989) is used to drive a dramatic increase of the inflow 
region/omphalomesenteric vein diameter. This change does not affect the speed of AIP 
regression, but decreases myocardial progenitor movement speeds and abrogates 
myocardial deformations at the stages following initial heart tube assembly, collectively 
resulting in a pronounced reduction of the heart tube size. This combination of effects 
creates a valuable system to investigate the impacts of each of the driving forces of 
tissue movement acting in the vicinity of cardiogenic fields. Also, by altering the quantity 
of VEGF delivered to the developing embryo, the severity of inflow dilation can be 
modulated and the invoked effects on tissue movement similarly dissected. Thus, 
continued analyses of VEGF-treated embryos will provide new insights as to the effects 
of VEGF over-activation on tissue motion. We expect to be able to prescribe the 
mechanical barrier supplied by the enlarged inflow region in our computational model, 
and investigate the outcomes of such perturbation on model behavior. Similar 
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experimental and modeling approaches can be applied to studying the effects of other 
known regulators of cardiogenesis on endocardial and myocardial progenitor cell motility 
and tissue deformations within the anterior embryo.  
 Coordinated deformations continue to occur after initial heart tube formation in 
differentiating myocardial primordial, which progressively incorporate into the growing 
organ (Fig. 4.5). This may have interesting implications with regards to another critical 
step of cardiogenesis, namely cardiac looping. Cardiac looping initiates as soon as the 
early heart tube is established at the midline (HH10; Manner et al., 2000) and involves 
the transformation of a straight linear organ, attached to the foregut throughout its 
length, into a C-shaped structure, which is bent towards the right side of the embryo 
during normal development. This early event is followed by further bending 
deformations of the developing heart, and in combination with later-occurring septation 
processes is involved in advanced chamber morphogenesis. A large body of work 
defines two steps within the C-looping process, whereby it results from a combination of 
ventral bending and rightward rotation (Manner et al., 2000; Voronov et al., 2004; Taber 
et al., 2010). Interestingly, out of these two events ventral bending appears to be driven 
by the processes intrinsic to the heart tube, as suggested by Manning and McLahlan 
(1990) and confirmed by more recent studies (Latacha et al., 2005; see Taber, 2006 for 
review). It would be extremely interesting to investigate if, and how, the forces 
contributed by uniform contraction and dorsal bending of the myocardial field contribute 
to the heart tube bending and/or rotation.  
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 Collectively, the results presented in this dissertation revealed some previously 
unappreciated aspects of endocardial and cardiac jelly morphogenesis, offered new 
information on tissue mechanisms of myocardial progenitor displacements, and 
established a link between the balanced presence of all early heart constituents, 
appropriate tissue deformations in the anterior embryo, and success of early heart 
formation and elongation. We are certain that exploration of new avenues based on and 
emerging from our research will provide further insights into the biomechanical 
mechanisms of cardiac morphogenesis. 
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